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SUMMARY 
Background 
Transient ischaemic attack (TIA) and minor stroke are associated with a high risk of 
recurrent stroke which can be predicted with a clinical rule and reduced with urgent 
treatment. Delay in accessing assessment and vascular risk factor modification should 
therefore be as short as possible, yet little is known in the UK about where patients seek 
care and the key influences of the time to contact healthcare services. However, using 
cohort studies to answer questions on healthcare access requires an assessment of how 
well such cohorts represent the wider population. Within the primary care consultation, the 
recognition of TIA is an important step in the care pathway as definitive treatment is initiated 
by specialists, yet TIA presentations are not common for individual GPs and difficulties in 
diagnosis may be due to low clinical exposure in routine practice or inadequacies in training. 
For patients where GPs suspect that TIA may be the cause of symptoms, inaccurate risk 
prediction and diagnosis of TIA can result in delay to definitive care and the existing tools for 
prognosis and diagnosis have been exclusively derived from clinical assessments in 
secondary care rather than primary care. 
RESEARCH QUESTIONS 
1. Is the OXVASC population representative of the national population in terms of age 
and deprivation? 
2. Do differences in age and deprivation between OXVASC practices affect the 
presentation of patients with TIA to healthcare? 
3. Is healthcare access after TIA or minor stroke influenced by the following factors; 
choice of healthcare provider, time of symptom onset, clinical features of the event, 
deprivation and previous history of cerebrovascular disease? 
4. Did the change in general practitioner contract influence healthcare access after TIA 
or minor stroke? 
5. Do GP trainees fail to recognise high risk TIA cases that have been missed by 
established GPs? 
6. What are the recruitment and completion rates for a web-based vignette study of TIA 
recognition by GP trainees? 
7. Does alteration of one case vignette parameter influence TIA recognition and 
management decisions? 
8. Do GPs’ and specialists’ records of the same patients with suspected TIA agree 
about the clinical features? 
9. Does GP/specialist disagreement vary according to final clinic diagnosis? 
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10. What impact does GP/specialist disagreement have on the performance of the 
ABCD2 score for accurate triage of patients with TIA? 
11. What impact does GP/specialist disagreement have on the discrimination metrics of 
existing clinical prediction tools for TIA diagnosis? 
12. Which clinical predictors are included in a prediction rule for TIA diagnosis derived 
from primary care records in suspected TIA? 
13. What are the calibration and discrimination metrics for a model of TIA diagnosis 
derived from primary care records in suspected TIA? 
14. Does choice of statistical model affect discrimination metrics for TIA diagnostic 
models? 
METHODS 
Questions 1 and 2 were answered with a comparison of the age and deprivation structure of 
the Oxford Vascular Study (OXVASC) population and the national population, as well as 
inter-practice variation in age and deprivation and its effect on the ratio of TIA to major 
stroke. Questions 3 and 4 were answered by determining the routes to healthcare and delay 
to call for medical attention for patients with TIA and minor stroke ascertained between 2002 
and 2006 in OXVASC. Questions 5,6 and 7 were answered by recruiting GP trainees to a 
pilot study of a web-based vignette questionnaire. This presented, in random order, missed 
high risk TIA cases (patients ascertained with stroke who had presented to primary care in 
the previous 30 days with transient neurological symptoms), matched cases of TIA where 
one parameter was altered to test its influence on decision making and distractor cases 
without a cerebrovascular diagnosis. Questions 8,9,10 and 11 were answered with an 
analysis of referrals to the OXVASC TIA clinic from primary care with GP and specialist 
records compared to assess disagreement over clinical features. The ABCD2 score was 
calculated for all referred patients from primary care records and compared with the ABCD2 
score from hospital records for the accuracy of detection of high risk status in primary care. 
The discriminating ability for TIA diagnosis of the only existing TIA recognition tool in the 
literature and the ABCD2 score were compared. The effect of using primary care records 
rather than secondary care records to populate the scores was assessed using receiver 
operator characteristic curves. Questions 12, 13 and 14 were answered by qualitatively 
analysing primary care clinical records from consultations and referral letters, to determine 
groups of similar symptoms for potential predictors for a decision tool, and then deriving 
diagnostic models using three alternative modelling techniques – logistic regression, 
classification trees and random forest analysis 
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RESULTS 
1. Compared with the population of England, the registered population at OXVASC practices 
were less deprived across all age ranges, although the population age structure and change 
in relative deprivation across age ranges were equivalent. 
2. The age and deprivation structure of practices in the OXVASC study varied significantly 
but there was no relationship between these parameters and the ratio of ascertained TIA to 
major stroke.  
3. Of 359 patients with TIA and 434 with minor stroke, 25 were excluded who were outside 
the study area at the time of their event. The majority of patients (73%) sought care from 
general practice. The median (IQR) time to call for medical attention was longer for patients 
choosing primary care rather than the emergency department (11.0 (46.0) hrs vs 1.0 (4.0) 
hrs, P<0.001). In the primary care population those calling for attention following events 
occurring outside office hours was longer than for those calling following in hours events 
(12.0 (41.0) hrs vs 4.0 (44.5) hrs, P <0.001). For the cohort of patients who sought care in 
general practice, those using an on call primary care service had significantly shorter delays 
to call than those (the majority, 72%) who waited until their general practice was open (1.0 
(2.46) hrs vs 24.8 (48.5) hrs, P<0.001). There was no effect of deprivation, or prior history of 
cerebrovascular disease on choice of provider or delay to call. Weakness and speech 
disturbance were associated with shorter times to call for medical attention, and visual and 
sensory disturbance with longer times to call. 
4. The only significant effect of the new GMS contract was a small increase in those using 
an emergency primary care service for events occurring in the out of hours period (20% vs 
32%, P = 0.034)  
5. Among GP trainees who responded to the invitation to take part in a questionnaire survey 
of clinical diagnosis and management from vignettes there was variable recognition of TIA in  
the high risk TIA cases that had been missed in routine clinical practice. For the three actual 
missed cases TIA was diagnosed in 9%, 72% and 27% (n=11) 
6. Of 54 Oxford deanery GP trainees invited to participate in the high risk TIA diagnosis 
study, the recruitment rate was 35% (n=19) and of those who responded, the completion 
rate of all cases was 58% (n=11).  
7. Recognition of TIA appeared to be influenced by the alteration of single parameters but a 
study powered to detect parameter influences on recognition would require 300 trainees and 
therefore collaboration across multiple deaneries.  
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8. There was disagreement in records of clinical histories between primary and secondary 
care for the symptoms that are used in the ABCD2 risk prediction score. Agreement for 
motor symptoms and speech symptoms showed kappa values of 0.58 (S.E. 0.04) and 0.68 
(S.E. 0.04) respectively. 
9. Altman-Bland plots demonstrated wide disagreement in ABCD2 scores and this varied 
with diagnosis. Comparing ABCD2 score disagreements showed that specialists would tend 
to score TIA patients higher and non-TIA patients lower than GPs (mean (S.E.) difference,  
0.1 (0.07) for TIA vs -0.29 (0.07) for non-TIA patients p<0.001). 
10. Primary care based ABCD2 risk scores detected 89.7% of high risk anterior circulation 
TIA patients and 61.5% of high risk posterior circulation TIA patients as judged from 
secondary care ABCD2 scores. Inaccurate triage in primary care based on these parameters 
is likely to result in one case of stroke every four years in a population of 91,000. 
11. The existing potential decision rules for TIA diagnosis among patients with suspected 
TIA had higher discrimination metrics in secondary care records than in primary care 
records. Area under the receiver operator characteristic curve (AUC) (S.E.) from secondary 
care assessments for discriminating all TIA, anterior circulation TIA and posterior circulation 
TIA from non-TIA were 0.71 (0.02), 0.75 (0.02) and 0.59 (0.03) respectively using the 
ABCD2 score and 0.82 (0.02), 0.85 (0.02) and 0.70 (0.03) using the Dawson TIA recognition 
tool. AUC values for basing scores on primary care records for all TIA, anterior TIA and 
posterior TIA discrimination from non TIA were 0.62 (0.03), 0.65 (0.03) and 0.48 (0.04) for 
the ABCD2 score and 0.70 (0.02), 0.75 (0.03) and 0.52 (0.04) for the Dawson TIA 
recognition tool. 
12. Primary care clinical records in 496 referred patients were analysed and 17 predictors 
were defined for model derivation. Unilateral limb weakness was not a predictor of TIA 
diagnosis, and focal sensory limb deficit was predictive of non-TIA diagnoses in a logistic 
regression model. The derived score had nine variables requiring calculation.  
13. For the logistic regression model on internal validation, calibration was acceptable 
(Hosmer Lemeshow goodness of fit test p = 0.65) and AUC values (S.E.) for discriminating 
all TIA, anterior TIA and posterior TIA were  0.81 (0.02), 0.82 (0.02) and 0.77 (0.04) 
respectively. 
14. A classification tree model using the entire dataset had AUC (S.E.) values for 
discriminating all TIA, anterior TIA and posterior TIA of 0.80 (0.02), 0.80 (0.02) and 0.80 
(0.03) respectively. The random forest analysis although more complex was inferior in 
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discriminating ability in all diagnostic groups. A simplified classification tree using five 
questions had a negative predictive value for TIA diagnosis of 96%. 
CONCLUSION  
The OXVASC registered population does not represent the national population in terms of 
deprivation, although the age structures are similar, and so the strength of associations with 
deprivation in the cohort may not be generalisable. The majority of patients after TIA and 
minor stroke seek care in general practice and will wait to be seen at their registered practice 
if their symptoms start in the out of hours period. Delay in calling for medical attention is 
strongly influenced by timing of symptom onset and availability of routine primary care at that 
time. The organisation and delivery of primary care influences healthcare seeking behaviour 
and is a barrier to achieving the National Stroke Strategy targets, although the GMS contract 
has had a small positive impact on out of hours access. GP trainees may show similar 
difficulties in recognising high risk TIA cases as established GPs but a larger definitive study 
is required to determine this as well as the influence of single alterations in vignettes on 
diagnosis. Disagreement exists between GPs and specialists over the clinical histories of 
events in patients with suspected TIA, which affects triage with the ABCD2 score and results 
in poor validations of diagnostic tools that have been derived from secondary care records. 
The use of primary care datasets in patients referred to secondary care produces complex 
logistic regression scores and simpler classification trees with high rule out function to aid 
referral decisions but predictors do not match the classical TIA phenotype by excluding 
weakness, due to a selection bias that results from using patients that have been referred 
rather than initially presenting in primary care. Inclusion of all high risk phenotypes in 
derivation datasets, avoiding selection bias from referred populations and external validation 
are required. This could be achieved by deriving and validating decision rules in the general 
population with transient symptoms that presents in primary care, rather than in the selected 
population of patients where a GP has determined the need for a TIA clinic assessment, 
although there are barriers to recruitment in such studies. 
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Chapter 1      Introduction 
1.1 Observations from Clinical Practice 
As a Specialist Registrar in General and Stroke Medicine, I was struck by how often patients 
with completed stroke would arrive in the Emergency Department (ED), but rarely would the 
ED have the opportunity to assess patients with its precursor, transient ischaemic attack 
(TIA). This would contrast with patients who had transient symptoms of chest pain who 
would very frequently attend during or after an episode of pain. It seemed from these 
observations that healthcare seeking behaviour after transient symptoms potentially due to 
cerebral ischaemia may be very different from healthcare seeking behaviour after transient 
symptoms potentially due to cardiac ischaemia. The underlying pathological processes can 
be quite similar but the actions taken by patients can be very different. 
After re-training in General Practice, I encountered the related problem of deciding which 
patients with transient or mild persisting neurological symptoms should be referred for further 
specialist assessment. As a GP, one of my main clinical roles is to accurately identify low 
prevalent but serious disease from a background that includes a range of presentations 
overlapping with those of serious conditions. I am also mindful of the need to use resources 
appropriately and not to expose patients to the unnecessary harms of over investigation and 
treatment. 
These issues have become increasingly important with the realisation that delays in 
receiving risk reducing interventions after the onset of symptoms of TIA or minor stroke can 
determine rates of recurrent stroke.  I became interested in investigating how primary care 
could be contributing to the problem of delays in optimal treatment for patients at high risk of 
stroke and also what changes could be implemented so that the problem could be alleviated. 
The burden of cerebrovascular disease is heavy as it causes disability and death. Stroke 
causes the greatest number of years lived with disability of all brain diseases in Europe (1) 
and it is the third most common cause of death in the United Kingdom, resulting in 137,000 
deaths from 2007 - 2009 (2). The total cost to the UK economy from direct treatment, 
ongoing social care and loss of productivity in people of working age has been estimated at 
£9 billion per year (3).  
Reducing the burden of cerebrovascular disease will therefore have benefits for the 
individual and their families, the healthcare system and the economy as a whole. I wanted to 
study how primary care could contribute to this healthcare goal. Working in Oxford gave me 
the opportunity to examine how the Oxford Vascular Study (OXVASC) could help in 
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answering research questions concerning the improvement of the patient pathway from 
symptom onset to definitive treatment. 
1.2 Reducing cerebrovascular disease burden – treatment or prevention of acute 
ischaemic stroke? 
The majority of strokes are due to acute ischaemia and this has been documented 
consistently across countries, using varying methods of case ascertainment, in a recent 
review of 56 prospective population based studies which span across national income, 
recruiting cohorts from 1970 to 2008 (4). Ischaemia results from in-situ atherothrombosis or 
thrombo-embolic disease from a distal site, usually intra-cardiac thrombus, thrombus forming 
on a ruptured plaque in the arterial tree of large arteries or systemic thrombus via an intra-
cardiac shunt. The major risk factors for acute ischaemic stroke alongside genetic 
susceptibility are either chronic non-communicable diseases or risk factors for these 
diseases: diabetes, atrial fibrillation, ischaemic heart disease/peripheral vascular disease, 
chronic kidney disease, obesity, hypertension, hypercholesterolaemia, smoking and obesity. 
Treatment of established ischaemic stroke has benefited from the increasing evidence base 
for intravenous and intra-arterial thrombolysis (5) with subsequent demonstrations from 
prospectively collected audit data of the safety of thrombolysis in routine practice (6). 
Although deaths are increased with the use of thrombolysis (mainly early after treatment) 
there is a significant reduction in the numbers of patients who are dependent long term after 
stroke and the commonly chosen composite outcome of death or dependency at three to six 
months reflects the net benefit of acute stroke treatment.  
The burden of stroke is also influenced by the structure of health care delivery as well as 
specific medical interventions. Admission to an acute stroke unit rather than a general 
medical ward  also affects stroke outcome with a reduction in death or dependency at one 
year (7). Variations in coordinated stroke-specific care may also offer additional benefits at 
crucial times after stroke, as greater reductions in long term dependency and 
institutionalisation for selected patients have been demonstrated using early supported 
discharge from stroke units (8). 
The scope for reducing total cerebrovascular disease burden from acute treatment is limited. 
Extrapolating from randomised controlled trials, the majority of patients treated with 
thrombolysis will not actually benefit from it, as on average 20 patients need to be treated to 
prevent one patient being either dead or dependent at six months after stroke (5). 
Furthermore, as there is a limited time window for the safety of thrombolysis, recently 
extended to 4.5 hours post stroke (9), factors need to be addressed that influence time to 
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presentation to medical services after stroke as well as time to deliver thrombolysis after 
presentation (e.g. transfer to a specialist unit).  
One nationwide study from Sweden has assessed the numbers of patients with ischaemic 
stroke who received thrombolysis and although improvements were seen from 2003 to 2010, 
only 8.7% of acute stroke patients received this intervention(10). By comparison, in the UK in 
2010, 5% of all patients with stroke received thrombolysis (11) and this was not limited by 
pre-hospital delay, as this figure represents only 25% of all eligible patients, i.e. patients who 
attended within the correct timeframe and had a proven ischaemic stroke. Thus given the 
limited gain at population level from acute stroke treatment, due either to efficacy or access, 
improved stroke prevention strategies are required to reduce disease burden. 
1.3 Stroke prevention – primary and secondary strategies 
There are essentially two preventative strategies to reduce cerebrovascular burden; 
prevention of either a first ever event (primary prevention) or prevention of a recurrent event 
(secondary prevention).  
Primary prevention involves identifying modifiable risk factors and then controlling them with 
lifestyle alteration or medication. Identification in this setting could take place as a result of 
screening e.g. the current Department of Health Vascular Checks programme (12) or 
opportunistically if patients present to healthcare services for another reason and either the 
patient requests, or the clinician suggests, some form of screening test for a vascular risk 
factor e.g. blood pressure or a blood sample. 
Secondary prevention is initiated after a first cerebrovascular event, in order to reduce the 
probability of future cerebrovascular events occurring. Delivery of such a strategy requires 
the recognition that an event has occurred and then implementation of factor control, 
addressing the currently known cardiovascular risk factors of blood pressure, blood lipids, 
glycaemic control in diabetes, lifestyle alteration and evidence-based interventions of anti-
platelet agents or anticoagulants. 
In order to reduce the overall burden of disease, it is particularly important for patients and 
the healthcare system to recognise and appropriately react to mild or transient 
cerebrovascular events. This will maintain individuals in a disabling stroke-free status for as 
long as possible. 
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1.4 The importance of transient ischaemic attack (TIA) and minor stroke for 
secondary prevention 
TIA and minor stroke are cerebrovascular events which result in either very limited or no 
disability. Their recognition and treatment presents an opportunity to reduce subsequent 
death or disability due to recurrent events.  
The clinical definition of TIA, used most frequently in epidemiological studies, is a focal brain 
or monocular dysfunction, that resolves within 24 hours, presumed to be due to reduced 
blood flow (13). Given that over a third of patients with clinical TIA have an infarct on 
magnetic resonance imaging (MRI) (14), a new imaging-based definition has been proposed 
(15). This adds a further specification to the TIA diagnosis, namely that imaging rules out a 
structural brain lesion, although adopting this now will change prevalence and subsequent 
recurrent stroke risk in fresh epidemiological cohorts. The established clinical definition is 
used in this thesis, consistent with that used in the Oxford Vascular Study (OXVASC), a 
prospective population-based study of all vascular events occurring in a general practice 
registered population of 91,000 patients (16). 
Although there are a number of definitions of minor stroke without consensus in the literature 
(17), in this thesis, minor stroke is defined as a sudden onset persistent deficit which is mild, 
has an explanatory cerebral lesion and results in a National Institute of Health Stroke Scale 
score of less than 5 points (18).  
The risk of recurrent stroke is high in the first few days and after TIA or minor stroke. 
Routinely collected data from the Kaiser Permanente health system in California 
demonstrated 10% of patients attending an emergency department (ED) after TIA re-
presented with stroke after 90 days, and half of these strokes occurred within the first two 
days (19). Prospective population-based cohort data of patients presenting to general 
practices and EDs has similarly shown a high early risk of recurrent stroke after TIA and 
minor stroke (20;21).  
Patients at greatest risk of recurrent stroke after TIA can be identified using clinical 
prediction rules. A simple rule derived from the Oxford Community Stroke Project (OCSP) 
data (22) and validated in OXVASC data used age, blood pressure and clinical features 
(ABCD) to predict stroke risk (23). To improve validation in an international cohort the 
presence of diabetes was added, forming the ABCD2 score (24). The ABCD and ABCD2 
scores have had reports of both high utility (25-29) and low utility (30-34) for predicting 
recurrent stroke, but nevertheless the ABCD2 score is recommended as a stroke prediction 
tool in current guidelines internationally (34-37) for determining the urgency of specialist 
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assessment. Accuracy of predicting recurrent stroke is increased with the inclusion of brain 
imaging findings (38;39) together with a history of multiple TIAs and carotid imaging (40) 
although imaging results are not available at the first contact with healthcare services, either 
in primary care or in most EDs. 
The importance of urgent specialist assessment after TIA and minor stroke for reducing 
recurrent stroke risk has been inferred from observational studies. In the Early Use of 
Existing Preventive Strategies for Stroke (EXPRESS) study nested within OXVASC, urgent 
assessment and treatment resulted in an 80% relative risk reduction in recurrent stroke at 90 
days, compared with a historical cohort subjected to routine referral practice (41). Similarly, 
follow up of patients presenting to an urgent TIA clinic on the same day as their symptoms 
occurred (SOS-TIA study) showed an 80% relative risk reduction compared with predicted 
stroke risk from baseline ABCD2 scores (42).  
Thus stroke risk after TIA (and minor stroke) is high in the first few days after events, is 
predictable using clinical scores and can be reduced with urgent assessment and treatment. 
This creates a crucial role for primary care in reducing the burden of cerebrovascular 
disease, by identifying and appropriately referring patients for secondary prevention, 
particularly as the majority of these patients initially attend primary care (43). Furthermore 
given the frequency with which stroke is preceded by TIA, the total burden of disease will be 
reduced by optimal secondary prevention after TIA - 25% of patients with stroke in treatment 
trials report a TIA beforehand, with almost half of these occurring in the week before the 
stroke (44). 
1.5 Primary care and secondary prevention – the importance of delay and delayed 
presentation 
In order to reduce recurrent stroke, primary care needs to ensure that the patient with TIA or 
minor stroke is recognised and assessed as soon as possible after the event. This enables 
risk stratification for urgency of assessment, and for TIA patients scoring 4 or more on the 
ABCD2 score, a specialist assessment with access to investigations and treatment should 
be carried out within 24 hours of symptom onset (36). 
Thus primary care needs to understand how it can reduce any delay between symptom 
onset and specialist assessment for patients who have TIA or minor stroke. Delay from 
symptom onset to definitive treatment was explored by Andersen in women after a diagnosis 
of breast or ovarian cancer (45) and a general model of delay deduced (termed “Total 
Patient Delay”) that involves both patient responses and subsequent healthcare system 
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responses. Patient responses are characterised by processes that govern the successive 
time intervals: 
1. appraisal delay (time from the first symptom to patient recognition that the somatic 
experience might be a symptom of an illness)  
2. illness delay (time from recognition to the decision to seek medical attention) 
3. behavioural delay (time from deciding to seek medical attention to scheduling an 
appointment with a clinician) 
Healthcare system responses are characterised by the following successive time intervals: 
1. scheduling delay (time from first call for medical attention to first clinical assessment) 
2. treatment delay (time from first medical attention to definitive treatment) 
This model is relevant to patients with TIA and minor stroke as the perception that a 
transient or mild symptom is actually due to an illness may not be straightforward. While 
there is poor awareness of the specific symptoms of stroke amongst the general public (46-
50) this may not actually impact on appraisal delay as patients may still think they are ill, but 
without necessarily making the correct self-diagnosis (51), particularly if symptoms are more 
severe (52). Conversely patients could correctly recognise symptoms as due to stroke but 
not act to access emergency medical attention (53). 
Given the short time window for intervention after TIA or minor stroke, it is essential to 
understand the patient level factors, e.g. highest education attained, deprivation, previous 
stroke or TIA that could influence the time from symptom onset to the first call for medical 
attention. This could influence the optimal public health intervention to reduce delay from 
symptoms to healthcare contacts.  Although educational interventions have been tried 
previously to reduce delay from stroke symptom onset to calling for medical attention (54-56) 
there has been no consensus on the optimal intervention to reduce this delay. 
The choice of attending primary care or ED is also important as there are inherent delays in 
accessing primary care due to a booked appointment system, compared to an ED which 
offers a walk-in service. This contributes to scheduling delay and perceived access of care 
has been shown to influence the choice of first interaction with healthcare (primary care or 
ED), particularly in the out of hours period, i.e. outside normal office hours of work (57).  
Perceptions of availability of primary care may influence delay between symptom onset and 
first medical attention after TIA or minor stroke. If patients choose to seek healthcare from 
primary care rather than ED and delay seeking care due to perceived lack of availability, 
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then this aspect of patient behaviour therefore should be considered as a primary care 
related factor. 
1.6 Primary care and secondary prevention – reducing treatment delay 
Treatment delay is the time period from the first medical assessment to receiving definitive 
treatment. For patients seeking healthcare from general practice, this time period includes 
the following steps 
1. GP recognises that TIA or minor stroke are diagnostic possibilities 
2. GP initiates referral to either  a TIA /Stroke rapid access clinic or to ED 
3. Patient is transferred to ED or clinic makes contact with the patient to arrange a 
date/time for assessment 
4. Patient begins new medication or is referred for carotid surgery (entailing a further 
delay to surgical assessment and thereafter date of operation) 
There are two key roles for primary care in reducing the above treatment delay. Firstly, 
correct recognition of TIA or minor stroke. The false negative rate for TIA or minor stroke 
diagnosis in primary care is unknown i.e. patients with TIA or minor stroke who seek care 
from their GP but the diagnosis is not considered and they are not referred for further care. If 
patients are not referred at the initial consultation then this results in delay to definitive care. 
Secondly, primary care referrals to TIA clinics should have a reasonable prevalence of true 
TIA and currently clinic audits have estimated this to be around 50% (58;59). Whilst it is 
neither realistic nor appropriate that GPs should have 100% specificity for any suspected 
diagnosis in primary care (where all referred patients for a suspected diagnosis actually have 
that diagnosis), if large numbers of patients without a TIA diagnosis are referred from 
primary care to secondary care for a TIA/stroke specialist rapid access clinic then this will 
saturate a fixed capacity out-patient clinic system. This in turn would make it more difficult for 
patients with true TIA and particularly those at estimated high risk to be seen within the 
urgent timeframes that are set out in the National Stroke Strategy for England and Wales 
(60). There are currently no reported studies of interventions to improve the positive 
predictive value of a GP referral to a TIA clinic, with the specific aim of reducing delay for 
true TIA cases and in particular high risk cases. The most recent National audit data shows 
that only 43% of TIA patients at high estimated stroke risk are seen within 24 hours (61). If 
clinic capacity were to be increased by reducing the numbers of false positive referrals then 
a greater proportion of high risk TIA patients could be seen within the correct urgent 
timeframes. 
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1.7 Need for a literature review 
The initial observations from my professional clinical experiences together with the evidence 
outlined above led me to define the evidence gap by conducting a literature review. The 
remit of the review was to examine  
1. Current knowledge about delays in presentation to healthcare after the onset of symptoms 
of cerebral ischaemia and determinants of delay, particularly the organisation of primary 
care. 
2. Current knowledge about correct recognition of symptoms compatible with cerebral 
ischaemia in primary care and factors influencing recognition. 
3. Currently available prediction tools that could be used to aid primary care practitioners 
after recognising the possibility of cerebral ischaemia as a cause of symptoms i.e. to refine 
the population of patients that would benefit from referral to specialists. 
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Chapter 2    Literature Review 
2.1 Introduction 
This chapter will review the existing evidence relevant to the following three issues; delay in 
accessing care after TIA or minor stroke, the ability of GPs to recognise TIA or minor stroke 
and diagnostic tools that could reduce inappropriate referrals from GPs to cerebrovascular 
specialists. 
The published databases searched were the National Library of Health (Medline) and 
EMBASE (simultaneously using the OVID interface) and The Cochrane Library via its own 
website. The primary and secondary search strategies are in Appendix 2. 
2.2 Delay in accessing specialist care 
Most developed healthcare systems have a portal of entry to specialist care either in the 
community i.e. primary care, or a triage and diagnostic service in secondary care i.e. the 
emergency department (ED). Examining what is known about delay in accessing definitive 
specialist care requires analysis of the determinants of delay along these pathways. Firstly I 
will address the issue of delayed presentation to healthcare after acute vascular event 
symptom onset, as well as the determinants of the choice of first route into the healthcare 
system (which has speed implications in terms of specialist access). Then I will examine 
what is known about the pre requisites of presentation – knowledge of symptoms and of 
action prompted by symptoms, together with educational interventions to improve levels of 
such knowledge in the general population and in at risk populations. Finally I will examine 
reports of demographic predictors of access to primary care and whether these could explain 
health inequalities in stroke via the mechanism of delay in receiving specialist care. 
2.3 Determinants of delay in presentation to healthcare 
Delayed presentation to healthcare after the onset of illness entails a risk of a worse clinical 
outcome. Improving recognition of illness by reducing appraisal delay (45) and encouraging 
earlier contact with healthcare by reducing illness and behavioural delays (45) are important 
public health goals.  
Delay in presentation to healthcare after the onset of symptoms has been extensively 
studied in progressive conditions where early intervention improves long term survival such 
as cancer. However, identifying demographic factors associated with delay may be specific 
to the disease in question. For example, demographic factors associated with appraisal 
delay vary with the type of cancer, although common system factors such as misdiagnosis 
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and delay in onward referral for definitive investigations have been identified (62). Analyses 
of health service data agrees that demographic influence on delay varies according to 
diagnosis (63). 
Healthcare seeking behaviour in general has been assessed with written vignettes sent to 
UK patients of descriptions of two scenarios – a lump in the axilla and chest pain.  No effect 
of ethnicity, socioeconomic position or sex was observed in the responses (66% of the total 
sample) on the reporting of urgent health care seeking behaviour (64). This was interpreted 
as evidence that demographic associations with delay in providing care must be due to the 
healthcare system response, and not individual healthcare seeking behaviour. 
2.3.1 Determinants of delay after vascular events – myocardial infarction (MI) 
Determinants of delay may be also dependent on the type of healthcare system. In the 
United States (US), delayed presentation after acute MI has been observed in older women, 
patients with diabetes, African American ethnicity, patients with a lower socioeconomic 
position, less education and less comprehensive private insurance (65).  In a privately 
insured payment healthcare system, certain risk factors for delayed presentation may also 
compound the likelihood of poor clinical outcomes – for example lower socioeconomic 
position (SEP) is associated with a reduced control of diabetes (66). The association 
between delayed presentation after MI and female sex, lower SEP and diabetes has been 
observed consistently in the US (67). For patients with a lower SEP, delayed presentation is 
partly due to concerns over cost (68).  
2.3.2 Determinants of delay after vascular events – cerebrovascular disease 
At the extremes of delay, we know that patients do not present at all after symptoms 
compatible with stroke like episodes, and US data shows that lower income, smoking and 
absence of previous diagnoses of stroke are associated with a complete lack of healthcare 
seeking (69). Furthermore for those that do present to healthcare after stroke, the size of 
delay appears to be stable over time. An observational study of arrival times to EDs after 
stroke onset compared from 1993 to 1999 showed that although more African American 
patients arrived within three hours, there was no change in the percentage of patients 
arriving within two hours (70).  
In patients that do present to healthcare, observed determinants of delay vary with the 
healthcare setting. A greater than six hour delay in presentation after stroke in the Catalan 
healthcare system in Spain was associated with lower educational attainment, diabetes, 
lower SEP, living alone, and incorrect recognition of the cause of symptoms (71). Lower SEP 
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is also associated with small increases in pre-hospital assessment and transportation via 
emergency ambulance services in the US (72). The Copenhagen Stroke Study 
demonstrated associations with delay after stroke and being alone, being retired, having less 
severe symptoms and no prior history of TIA but no associations with other demographic or 
clinical features (73). However, investigating delay outside formal research studies i.e. using 
routine datasets, can potentially lead to errors due to inaccurate recording in medical records 
of stroke onset time (74). 
Interviews with patients presenting after stroke have identified that the presence of 
bystanders adds a further influence on delay. Alongside female sex and reduced severity 
increasing delay, the views of others present at the time of symptoms influences the action 
taken by patients in the US (75). Furthermore, interviews with bystanders accompanying 
stroke patients in Wales found that they had variable recognition that a stroke was in 
progress, a minority thought that the patient’s symptoms were severe whilst some took a 
‘wait and see’ approach and only took action when they thought that spontaneous resolution 
was unlikely (76).  
US data from interviews of patients with TIA or stroke who attend hospital have indicated 
that using emergency services rather than primary care, or private transport direct to 
hospital, was associated with reduced delay as well as an urgent bystander response (77). 
This study also demonstrated that female sex was associated with increased delay and 
perceived severity reduced delay. The Delay in Accessing Stroke Healthcare Study (DASH), 
also in the US, found that after controlling for all associations with delay in multivariable 
analysis, using emergency services and bystander recognition of stroke were the only 
significant predictors of delay in arrival at hospital (78).  
Perceived severity reducing delay also explains the findings of an audit of consecutive stroke 
admissions in South Korea that although a small proportion of patients arrived within three 
hours, those doing so had greater deficit than those arriving after three hours (79). Choosing 
a community based service for the first medical attention after stroke together with not 
perceiving symptoms as serious have also been associated with delayed presentation in 
Singapore and again this appears to be stable over time (80;81).  
Although many interview studies of patients attending ED after a stroke have not identified 
specific clinical features that prompt more urgent action, other than general perception of 
severity, a US study specifically designed to investigate the effect of symptoms of TIA or 
stroke found that delay was greater for posterior circulation presentations of dizziness and 
difficulty in walking, compared with the largely anterior circulation symptom of speech 
difficulty where patients acted more quickly (82).  
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A smaller US study also found that the territory affected within unilateral anterior stroke 
presentations can influence delay with speech more likely to result in early presentation than 
unilateral weakness (83). The decision to seek healthcare after TIA is also likely to be 
influenced by the type of deficit, with a survey of patients without previous cerebrovascular 
disease showing that one episode of speech deficit would be sufficient to prompt a 
consultation whereas sensory disturbance alone would not (84). Posterior circulation 
symptoms may also be associated with delay from assessments of urgent action after 
symptoms in stroke free cohorts. In the general US population, interviews with people 
chosen randomly by telephone number selection found that visual disturbance was least 
likely to prompt an urgent response to seek healthcare (85). 
2.4 Patient recognition of stroke symptoms and action 
Qualitative data suggests that appraisal delay is significant after stroke onset (86) and this 
may be partly due to denial of deficit (87). This suggests that patient knowledge has a role to 
play in the development of delay in accessing healthcare although there are conflicting 
inferences from the literature. Knowledge and correct recognition of stroke have not been 
associated with quicker arrival times in hospital from one German study (53) but a similarly 
conducted study in the US did find that recognition that symptoms were due to stroke 
resulted in earlier presentation (88). Interviews with a small number of Korean patients after 
stroke have been used to build a decision tree model to explain reasons for delay, and 
severity rather than recognition was included in a model with modest ability to predict delay 
in an external validation (89). 
Prior knowledge of the key features of stroke and TIA and acquired understanding of the 
need to take urgent action will clearly influence delay in presentation to healthcare, both by 
patients and bystanders. Correct recognition of stroke symptoms is low in the general 
community in the US (90) and in patients admitted to hospital after stroke (91), although this 
by itself does not imply that patients would not act in an emergency after symptom onset. 
Echoing the findings from patients after stroke, data from interviews in the general 
population in the UK suggests that perceived severity would entail urgent action (92).  
Stroke knowledge may be dependent on personal exposure to the condition. In a young 
general population in Switzerland, stroke knowledge was increased with personal 
experience of a patient with stroke but not with professional healthcare status or university 
education (93). Samples of stroke free patients in an area of high stroke risk in North 
Carolina (‘The Stroke Belt’) demonstrated that stroke knowledge was related to age and 
ethnicity with an inverse relationship in that those at higher risk tended to have less 
knowledge of stroke (94).  
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Telephone interviews in the general population, selected from random telephone number 
generation, in the US have demonstrated very little improvement over time in knowledge of 
stroke symptoms, risk factors and the potential for urgent treatment (thrombolysis) from 1995 
to 2005 (47). However, in patients with TIA or minor stroke from a Dutch study, knowledge of 
risk factors and their control can be much higher than knowledge of symptoms of stroke itself 
(95). In a German study, a large representative older general population showed that 
knowledge of stroke risk factors was good with the media most often cited as the source of 
knowledge (96).  
2.5 Interventions to improve stroke knowledge and action 
There have been wide variations in the scale of interventions to improve both stroke 
knowledge and action, although determining the enduring effect of an intervention via 
reducing delays in presentation is less often observed. A targeted intervention in a small 
rural community in the US demonstrated durable improvements in stroke knowledge but only 
in a subset of patients that were tested after the initial intervention (50% of the sample), but 
due to the small sample size and short follow up, the effect of education on action after 
stroke could not be tested (55). Multiple media delivery methods to the general population in 
North Carolina using interviews on radio and television as well as newspaper articles were 
tested for their effect on times to presentation for stroke in a before and after analysis (97). 
More patients, as a percentage of total attendances in each time period, arrived at specialist 
care units after stroke within 24 hours in the intervention period. The effect of media 
advertising on presentations of stroke and TIA in Canada suggests that a persisting 
presence is needed, as ED attendance dropped after an advertising ‘blackout’ (98). This 
suggests that one-off interventions may not have an enduring effect on the primary outcome 
of attending healthcare after symptom onset.  
The nature of the media used to disseminate educational messages may be relevant in that 
messages delivered by television rather than by newspaper had greater effect on stroke 
knowledge, as assessed from randomly selected members of the population exposed to the 
interventions in the US (99). This has also been suggested by a small trial using a short 
animation to teach the clinical features of stroke based on weakness of the Face, Arm or 
deficit of Speech and Time to call for help (FAST) which showed persisting high levels of 
stroke knowledge but again no ability to test how this would translate into action in response 
to stroke symptoms (54). The potential for a campaign that solely contains the features of 
FAST to capture all cases of TIA and stroke was assessed in 12 months of stroke 
presentations to regional hospitals in Greater Cincinnati and Northern Kentucky (100). FAST 
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would have detected 90% of TIA and ischaemic stroke patients but fewer patients with 
haemorrhagic stroke (70%).  
Given the US data showing that ethnic differences exist in time to presentation after TIA and 
Stroke and also that Afro-Caribbean people may have a higher stroke risk from 
epidemiological data from the South London Stroke Register independent of demographic 
confounders (101), an examination of ethnic differences in design and delivery of 
educational interventions is relevant.  One US trial examining whether culturally relevant 
educational material may be more effective in enduring stroke knowledge is yet to report 
(102). However, a before and after assessment of a community based intervention involving 
African American beauticians educating their clients during appointments demonstrated that 
knowledge of stroke symptoms and the need for urgent action increased as a result (103). 
Although one large scale (75,000 population base)  trial of mass mailing of letters on stroke 
symptoms and suggested course of action resulted in more patients with stroke arriving 
within three hours of symptom onset (34% vs 28%, with the difference accounted for by 
reduced delay in women only) (104),  others have found that education appears to influence 
knowledge with little impact on behaviour (105;106). 
2.6 Determinants of delay - healthcare system factors 
Delay in accessing specialist care after TIA and stroke has healthcare system factors. After 
negotiating an initial contact in general practice or a hospital ED, an assessment and then 
referral process is required to arrange specialist assessment. 
2.6.1 ED and Hospital 
For patients choosing ED, accessibility of acute hospitals is clearly a determinant of time to 
admission after stroke. An Australian study reported that location at the time of the stroke 
was the only predictor of delayed admission, but in rural settings geographical variables and 
associated travelling times have a wider absolute range (107). For patients accessing care 
using emergency retrieval systems, recognition of stroke is important but priority for transfer 
to hospital does not need to rely on this. A study of US emergency 911 call tapes found that 
although the call handlers did not recognise symptoms as being due to stroke, the nature of 
the clinical features elicited a high priority response (108). 
Changes to the pathway of care in ED for patients with TIA and stroke can reduce delay in 
access to key investigations such as cranial imaging, a pre-requisite for safe administration 
of thrombolytic agents in acute ischaemic stroke. Use of ‘acute stroke calls’ to encourage a 
coordinated emergency response on ED arrival resulted in reduced time to CT brain and 
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subsequent length of stay at one Australian hospital (109). The implementation of a decision 
support tool in the form of a flow diagram for investigations of suspected TIA in one US 
hospital ED found that most (83%) patients were treated according to the pathway and a low 
90 day stroke risk of 1.3% was observed on follow up (110). Speeding up access to 
diagnostics in ED rather than organising them during an acute hospital admission may also 
be more cost effective in the US context (111). A review of Australian hospitals’ care for 
patients with stroke and TIA suggests that where stroke services are organised, there is 
improved care for patients with TIA (112). 
For patients with cerebrovascular events occurring during a hospital stay, there is 
considerable variation in response depending on the clinical specialty environment in which 
they are nursed. Delay in assessment and treatment was higher on general medical and 
surgical wards compared with neurology wards in a retrospective analysis of inpatients at 
two academic secondary care centres in the US (113). 
A distinction between routine working hours and the ‘out of hours’ period is evident in the 
majority of hospitals for most services, apart from ED and intensive care environments. It is 
therefore plausible that an effect of the time of stroke and the time of presentation to hospital 
may affect access to specialist care. No effect of ‘in hours’ compared with ‘out of hours’ 
presentations in thrombolysis rates or clinical outcome was seen in a large prospectively 
collected stroke register in Germany (114). However, small differences in stroke mortality 
have been estimated from large national cohorts in the US (115) and Canada (116) with 
weekends and evening presentations associated with a greater risk of death. 
For outpatient management of TIA and minor stroke, clinic frequency is a major determinant 
of delay in specialist assessment. A UK weekly clinic was associated with a median delay of 
16 days from initial event to specialist assessment (117). Outpatient TIA clinics in New 
Zealand also show delays of greater than one week again related to frequency of provision 
(118).  
2.62 Primary Care 
For patients presenting in primary care, access to a doctor is a key step in the onward 
referral for specialist assessment. GP appointments, particularly for same day requests for 
care, are arranged by communication with a practice receptionist in the UK. This in itself is 
not straightforward, as making an appointment in primary care is a complex social process 
and therefore subject to multiple patient, receptionist and practice factors (119).  The ability 
of practice receptionists to respond to descriptions of symptoms and arrange an appropriate 
appointment can influence delay to definitive care. A Welsh study of 45 general practices 
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found that the response of many practice receptionists to telephone descriptions of 
amaurosis fugax and cortical TIA was a routine or urgent GP appointment with a mean time 
to being seen of two days (120). 
System delays can exist in accessing specialist care depending on the referral routes that 
GPs choose after suspecting TIA or stroke, which is partly determined by local availability of 
services. A questionnaire study of German primary care providers (the majority were GPs 
with others being community based internal medicine specialists) reported that out patient 
management may be recommended for stroke, depending on their perception of the 
therapeutic benefit of admission (121). Interestingly, poorer outcomes were seen for patients 
admitted with stroke in Scotland compared to those managed in the community (122) 
although examining the effect of place of care on outcomes for acute stroke is likely to be 
subject to considerable confounding by indication as referral choice will be strongly 
influenced by severity at first clinical assessment. 
2.7 Determinants of access to Primary Care – patient choice and provision from 
health policy 
The determinants of primary care usage for acute onset illness in general are relevant to the 
factors which influence speed of access of primary care after TIA.  
Improving access to primary care was one of the major health policy objectives of the 1997 – 
2009 Labour government (123). Specifically practices needed to be able to devote sufficient 
resource to be able to offer an appointment within 48 hours of a patient request. Given the 
need for rapid assessment after TIA, the effect of this policy on requests for same day care 
is important, as practices could achieve this target of 48 hours at the expense of same day 
appointments. One questionnaire study of practices who did and did not adopt the 
‘Advanced Access’ policy found that more same day appointments were available as a result 
of the policy (124). Although a same day appointment may not be with the doctor that a 
patient would ordinarily choose to consult, discrete choice experiments of patient opinion 
about primary care access have shown that waiting time is a priority over choice of GP for 
new health problems (125), suggesting that for acute presentations after TIA, patients will 
see whichever GP has the earliest available appointment. In a questionnaire satisfaction 
study, patients were not more satisfied with the Advanced Access system as there is little 
flexibility over the day on which patients can be seen (126). 
A further Department of Health policy to increase access to primary care was the 
establishment of ‘NHS walk in centres’ which offered seven days a week care and 8am to 
8pm opening hours (127). These were piloted as nurse-led and offering mainly treatment for 
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minor illness. An analysis of the first wave of such centres using a before and after time 
series analysis did not show significantly altered ED and GP use within a three km radius of 
the centre or any change in out of hours (OOH) primary care usage (128). Thus primary care 
consulting for registered patients is unlikely to have changed significantly as a result of walk 
in centres. 
2.7.1 Primary care in the out of hours (OOH) period 
For patients choosing primary care for their first healthcare contact after TIA, the effect of 
whether events occur during routine hours or in the OOH period is a potentially important 
determinant of delay. A patient’s own GP is an efficient provider of OOH care - a randomised 
controlled trial of OOH care found that usual GPs made fewer home visits, spent less time 
on home visits when they were required and issued fewer prescriptions compared with a 
deputising service (129). Until the new general medical services (GMS) contract in 2004 
patients were calling their own practice for healthcare in the OOH period (130).The likelihood 
of accessing OOH primary care before the contract change, i.e. one’s own GP, was higher 
with increasing deprivation (131). However, this is not because more deprived patients seek 
healthcare in primary care rather than ED in the OOH period, as high OOH primary care 
usage and high ED usage occur in parallel in more deprived areas (132). 
Age and illness severity are important factors in choice of healthcare provider in the OOH 
period. A study of all emergency contacts within a population in the OOH period shows that 
patients aged 60 -80 have a higher rate of GP consultation than ED consultation whereas 
younger adults have similar ED and GP consulting rates (133). Furthermore the range of 
conditions seen suggests a different population of patients choose ED and primary care in 
the OOH period in a Dutch study (134). This is echoed by a retrospective time series 
analysis of the effect of introducing an OOH GP where none existed previously on ED 
presentations in Australia – a gradual effect was observed with a reduction in non urgent 
cases and an increase in urgent cases suggesting that patients may self-select a service 
based on severity of illness (135). Patients who are more anxious about their symptoms 
choose ED rather than primary care (136) and anxiety has some predictive value for 
vascular disease having been included in a diagnostic clinical prediction rule for patients 
presenting to primary care with chest pain (137). 
Nevertheless, the decision to use OOH services also depends on the opinion of the service 
available and the patient’s proximity to ED (138), although qualitative interview data 
suggests that significant uncertainty remains over whether OOH calls are appropriate (139).  
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2.7.2 Choosing primary care or ED after a TIA in the out of hours period 
A previous report on the distribution of diseases among patients using ED or a GP in the 
OOH period have used population based time defined cohorts, and TIA as a specific 
condition was too infrequent to appear as category on its own in either setting (140). Again, 
healthcare system specific variation may be present as the choice of OOH primary care or 
ED after TIA was found to be very different in an international comparison with the majority 
of patients attending an ED in Canada and a GP in the UK (141). The majority of patients 
with stroke before the change in GMS contract also contacted primary care rather than 
emergency services in the first instance, in spite of accurate recognition of stroke (142).  
There are significant consequences of choosing primary care rather than ED after symptom 
onset for stroke in that the median times to assessment are well beyond the extended 
window for thrombolysis for stroke (143). 
2.8 Socio-economic position and stroke outcomes – measurement and 
presentation delay as a confounder 
Stroke mortality has reduced in recent years in most European countries but the reductions 
in the lowest income groups may not be as great (144). Delay in accessing stroke care has 
been associated with lower SEP (2.3.1) and lower SEP is also associated with a more 
severe stroke deficit at initial assessment as well as stroke at a younger age from a 
contemporary hospital cohort from Scotland (145). US data suggests that lower SEP 
increases stroke mortality independent of age, sex and stroke severity (146), potentially due 
to differences in hospital treatment rather than initial stroke deficit  (147)- the markers of SEP 
that predicted stroke outcomes were occupation and household income but not educational 
level. Income not only predicts mortality but may also be the best predictor for stroke risk. 
Data from New Zealand found that household income was the strongest socio-economic 
predictor of stroke risk from case control methodology (148). Given the poorer stroke 
outcomes after delayed access to care, there is a potential for a confounding relationship to 
exist between SEP and both delay and poorer outcome from stroke.  
Follow up of cohorts who are stroke-free at baseline demonstrates that stroke incidence is 
higher with lower SEP (149-152) and the degree of inequality in stroke risk among middle 
aged men varies by country (153). The risk of recurrent stroke is also affected by SEP and 
this effect may be greater for women than for men (154). Furthermore a review of blood 
pressure distribution across levels of SEP shows that there is higher blood pressure in 
patients with lower SEP, greater for women than men, and this is mostly explained by 
association between body mass index and SEP (155).  
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There is some variation in observations of the increased stroke risk and stroke mortality with 
lower SEP. UK data has not demonstrated an association between lower SEP and case 
fatality after stroke but it is associated with poorer control of vascular risk factors and stroke 
at younger age (156). In the French population-based Dijon stroke study, higher stroke 
incidence in a locality was associated with the degree of income inequality in that locality as 
well as the wealth markers of car ownership and employment. These relationships were 
stronger in women, and no marker of SEP appeared to predict stroke incidence in men 
overall (157). 
2.8.1 Reversal of health inequality in stroke with ageing 
In the very elderly in the US, the association of income and educational level with stroke 
incidence was reversed over the age of 75 years, with stroke associated with higher income 
and educational level, and the significance of this association was not reduced after 
controlling for race, risk factor control, presence of a social network or depression (158). A 
similar methodology in a larger study of an elderly stroke free cohort at baseline found that 
strokes occurring after the age of 65 are not associated with lower education and income 
(159), and has been confirmed in a further multicentre study in France where over the age of 
65 years, higher rather than lower income is associated with stroke (160). UK data concurs 
with the reverse effect of area deprivation on stroke risk in the very elderly (161). In the 
elderly, marital status and sex are confounded with financial resources in that being widowed 
or never married confers higher stroke risk but this risk is lessened after adjustment for 
income (162). 
2.8.2 The influence of socioeconomic position – childhood or adulthood? 
However, the above studies used markers of current SEP to measure deprivation e.g. 
current household income or area measures of deprivation. There may be differential effects 
of deprivation in childhood compared with deprivation experienced as an adult on 
cardiovascular event risk. Childhood SEP has a stronger association with stroke mortality 
than adult measures of SEP (163) but this is not the case for coronary heart disease 
(164;165), suggesting that there is not a generic vascular disease effect.  
Childhood SEP effects may explain other observed demographic associations with stroke 
risk. In US data, childhood SEP predicted 10 year stroke risk in African Americans and 
Caucasian Americans with a higher stroke incidence seen in African Americans but, after 
adjustment for both childhood and adult SEP, the racial differential was minimal (166). 
Father’s occupational class is a strong determinant of stroke risk and there is also a strong 
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legacy effect in that their upwardly mobile offspring who have non manual jobs have the 
same stroke risk as men in manual jobs (167).  
2.8.3 Socio-economic inequality in stroke outcomes – unequal treatment by the 
health system? 
Hospital care may exacerbate inequality. Higher SEP is associated with a greater chance of 
post stroke cerebral imaging in a contemporary cohort of 200,000 patients in English 
hospitals (168), however no consistent pattern of SEP and access to care is evident across 
all components of stroke care (169). There are higher rates of symptomatic carotid disease 
in patients with lower SEP but no associated increase in carotid endarterectomies in these 
patients (170). However, no effect of SEP was seen on delay in referral to a TIA clinic in 
Scotland (171). 
Management in primary care can result in inequalities in stroke outcomes. Post stroke 
management in primary care in the Netherlands demonstrates an effect of SEP on control of 
diabetes and BP for women but not for men (172). In the UK prior to the National Stroke 
Strategy, the major determinant of receiving secondary prevention post stroke was age, with 
the oldest patients who are at highest risk of events receiving the least amount of secondary 
prevention (173). After the introduction of the pay for performance contract which offers 
incentive payments for undertaking annual reviews in primary care for patients with stroke, 
patients with a lower SEP were found to be less likely to attend and be ‘exception reported’ 
(174). 
2.8.4 Socio-economic position and cohort studies – measurement and 
representativeness 
There are different approaches to forming groups with similar levels of deprivation in 
published stroke and TIA research. Some use absolute values of income irrespective of the 
proportion of events contained within those groups, particularly in large community based 
studies (160) or large hospital cohorts (146), whereas some use fixed categories of 
educational attainment or occupation (147;150). The effect of deprivation on stroke 
outcomes was tested by grouping postcode area deprivation into quartiles in the NEMESIS 
stroke incidence study, although it did not recruit patients with TIA (175).  
One hospital based study of stroke risk after TIA identified patients from health 
provider/insurance records without an assessment of national representativeness (19) 
although regional representativeness was analysed in the health plan users prior to data 
collection (176).  Among community based TIA studies, The North Dublin TIA study has not 
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reported national representativeness (177) and neither has the Perth Stroke Study which 
included patients with TIA (178).   
In general community based TIA and stroke studies have not assessed national 
representativeness. This is relevant in that under-sampling of deprivation in a cohort may 
result in a type 2 error where lack of influence of deprivation may be concluded even though 
it may exist within the population at national level. 
2.9 Diagnosis of TIA and stroke 
Diagnosing cerebrovascular events is a challenge in primary care and ED, particularly for 
TIA where typically there are no persisting neurological deficits at the time of presentation, 
and diagnosis relies on history alone. Diagnostic research in the field of TIA suffers from a 
lack of a gold standard for diagnosis (15). This is less problematic for minor stroke as there 
must be imaging abnormalities of infarction for a diagnosis along with persisting neurological 
signs. Although some TIAs are associated with abnormalities on diffusion weighted magnetic 
resonance imaging (DW -MRI) (179-181), it is not a necessary condition for diagnosis. TIA 
patients with normal DW-MRI are seen and have a higher risk of recurrent events compared 
to a background population, indicating that clinical diagnoses without neuroimaging findings 
are still likely to be correct (182). 
2.9.1 Specialist disagreement and TIA diagnosis 
The diagnosis of TIA is a complex process, relying on an interpretation of the history given 
by the patient or a bystander. There are no diagnostic tests from blood or cranial imaging 
that take the place of a diagnosis from a description of the transient event. Although 
consensus statements exist on the definition of TIA (15), there does not seem to be the 
same specialist consensus over who has actually had a TIA. The likelihood of a TIA 
diagnosis among 55 patients referred to a TIA clinic in Stanford, USA was assessed 
independently  by three vascular neurologists using case records (183). Differently graded 
rating scales were used to capture likelihood and unlikelihood of TIA, and although the 
neurologists individually showed some degree of category preference, there was most 
disagreement over the category of ‘unlikely TIA’ (agreement coefficient of 0.16).  
A Dutch study assessed agreement over TIA diagnosis but allowed the neurologists to take 
histories from the patients and 56 patients were seen by two clinicians independently (184), 
which showed higher agreement than the US clinic note based study (Cohen’s kappa = 
0.65). The Dutch study was later repeated using slightly different methodology with greater 
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agreement found if symptoms were initially recorded using basic clinical description rather 
than diagnostic terms (185).  
Furthermore, specialist disagreement is not limited to diagnosis in cerebrovascular disease. 
Specialists can disagree over the severity of neurovascular deficit, particularly for aphasia 
and facial palsy (186), as well as in determining the affected vascular territory from clinical 
features of the cerebrovascular event (187).  
The generalist and specialist may have different concepts of TIA as a disease entity. 
Spanish non-neurologists and neurologists include different symptoms that can be caused 
by TIA and this contributes to the poor predictive value of non-neurologists’ suspected 
diagnosis of TIA (188). 
2.9.2 Symptom questionnaires and the value of self-reporting by patients 
Questionnaires have assessed patients’ reporting of previous TIA and stroke as well as 
symptoms that could be due to TIA and stroke. In the Norwegian Tromso study, patients’ self 
reported history of stroke had a high predictive value of 75% for an actual recorded stroke 
event (189) but UK data suggests that there is significant ‘over recall’ i.e. false positives for 
stroke diagnosis together with under recall i.e. false negative recall (190).  
Questionnaires that aim to assess the burden of cerebrovascular disease and unmet need in 
TIA and stroke care assess the prevalence of symptoms compatible with TIA and stroke in 
stroke-free cohorts. In the Reasons for Geographical and Racial Differences in Stroke 
(REGARDS) study, recruited subjects with a mean age of 65 years and no previous 
presentations to healthcare with TIA or stroke had a 20% prevalence of symptoms of 
TIA/stroke (191). However, self report of TIA symptoms depends on the prevailing concept 
of TIA at the time of study design and one UK study included loss of consciousness (192) 
which is no longer considered to be due to TIA. Nevertheless, using questionnaire based 
symptom prevalence studies the number of patients with un-assessed TIA in the US has 
been estimated as greater than five million (193). 
2.9.3 Questionnaires and TIA diagnosis 
The diagnostic performance (compared with clinician diagnosis) of questionnaires for TIA 
vary with the population tested. The Questionnaire to Verify Stroke Free Status (QVSFS) 
has been validated in stroke and general medical out-patient clinics with varying reports of 
96% negative predictive value (NPV), 71% positive predictive value (PPV) (194) and 100% 
NPV and 36% PPV respectively (195). A six item derivative of the QVSFS which only 
contains questions about clinical symptoms was used in Veterans Affairs clinics in the US 
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with reported sensitivity of 82% and specificity of 62% in a population of patients with a 
prevalence of stroke of 50%, which equates to a PPV of 68% and an NPV of 78% (196). 
These results suggest that a rule out function is more reliable than making positive 
diagnoses.  
In the Asymptomatic Carotid Atherosclerosis Study (ACAS), an algorithm for TIA diagnosis 
based on questionnaire responses in a selected population of patients presenting with TIA or 
stroke like symptoms, had an 88% sensitivity and 71% specificity for cerebrovascular 
diagnoses compared with an expert panel for patients reporting stroke-like episodes within 
the trial (197).  
Reliance on questionnaires may result in a bias towards diagnosing anterior rather than 
posterior events. A diagnostic algorithm in the Atherosclerosis Risk in Communities (ARIC) 
study was more likely to diagnose self reported symptoms as TIA if they were anterior rather 
than posterior circulation (198). Nevertheless, the ARIC algorithm estimated a community 
prevalence of 5-6% of TIA/Stroke (199) and there is face validity to the algorithm in that 
those diagnosed with TIA had higher risk of stroke over a subsequent 11 year follow up 
period (200).  
A TIA questionnaire by Wilkinson in 10,000 US care home residents showed that 6.4% had 
suggestive symptoms of TIA and 15.4% had possible symptoms but in a sample of 1700 
respondents, the PPV of the questionnaire for TIA diagnosis by a neurologist was 7% (201).  
A nurse administered version of this questionnaire in a population of patients referred after 
suspected TIA to a UK hospital clinic had a positive predictive value of 66% for combined 
TIA and stroke diagnoses reflecting the much higher prevalence for TIA and stroke 
compared with the care home population (202). 
2.9.4 GPs’ ability to diagnose TIA and stroke – responses to case vignettes 
There are very few reports of studies that assess how GPs diagnose cerebrovascular 
events. Questionnaire studies using case vignettes have been used to test GPs’ recognition 
of TIA and subsequent management either with free text without cueing TIA, or with a 
restricted set of diagnoses which automatically cues TIA as a diagnostic possibility. All 
studies have used artificially constructed cases and are restricted to anterior circulation 
presentations.  
Explicitly varying a parameter in case vignettes has been used to test GPs’ ability to suspect 
TIA and the influences on decisions to refer for assessment. Quik-van Milligen constructed 
five matched pairs of cases, varying one aspect of the history in each pair. Anterior 
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circulation symptoms were used, which was justified by the authors from the low prevalence 
of posterior circulation presentations (203). The five history parameters varied were; age 
(dichotomised to <65 or > 65), single vs multiple episodes, history of non-specific symptoms 
vs no history, brief (few minutes) vs longer (20-24 hrs) duration and cortical vs retinal pattern 
of symptoms. The cases were mixed with ten distractor cases (five had neurological disease 
and five had infectious disease) and sent to Dutch GPs, with 376 responding (59% of the 
sample). The authors state that cases were placed in a random order, although it is not clear 
if the order was at random for each questionnaire i.e. individual questionnaires had a 
different presentation order. The GPs were asked “What is your diagnosis?” with free text 
response and “What are you going to do?” with a restricted choice of suggested options 
including reassurance, investigations, new prescriptions and referral. 
They found that GPs were more likely to diagnose TIA for cortical rather than retinal patterns 
of symptoms, younger rather than older age (contrary to the prevalence rate (16)), recurrent 
rather than single attacks, and an absence of non-specific symptoms. Referral to a 
neurologist was more likely for cortical rather than retinal symptom patterns, although overall 
there were more referrals to specialists in the retinal vignettes if ophthalmology referrals are 
included. However this study was reported in 1992 and was therefore carried out before 
guidelines and national strategies were in place for optimal evidence-based management for 
TIA. 
Permutations in multiple parameters within a single case vignette have been used to assess 
the features that influence diagnosis and referral for one presentation of anterior circulation 
TIA - transient monocular visual disturbance (204). In this study of the responses of 866 
Dutch GPs (54% of their sample), one TIA case was used from a bank of 16 cases created 
from two possibilities for each of four characteristics; blurring of vision vs complete visual 
loss, all of the visual field affected vs part of the visual field, duration of a few minutes vs a 
few hours and the patient did or did not report covering each eye in turn during the episode. 
The age was kept at 56 years, a suggested ‘neutral’ age which would encourage the GPs to 
focus on clinical presentation as the basis for decision making. Only one of the possible 16 
cases was sent to each GP with three distractor cases included (lumbosacral radiculopathy, 
syncope and polyneuropathy). 
The range of GP responses were from fixed lists for diagnosis and for management. The 
likelihood of each diagnosis of retinal migraine, optic neuritis, glaucoma, retinal detachment, 
amaurosis fugax, cortical TIA or other was rated visually by placing a mark on a line from 
‘very improbable’ to ‘highly probable’. Offered management options included reassurance, 
medication (free text choice) and referral (specifying routine or urgent and to whom) and the 
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GPs rated how strongly they agreed with each suggested course of action by marking a line 
from ‘agree’ to ‘not agree’. Amaurosis was considered more likely for brief, visual loss (rather 
than blurring) affecting the complete field of vision. Performance of a cover test by the 
patient did not affect the perceived likelihood of the diagnosis. Of those diagnosing 
amaurosis or cortical TIA, 72% and 64% respectively recommended specialist referral but 
again, this study was reported in 1999 before recent advances in evidence based benefit, 
and timing, of treatment. 
A study of Polish GPs’ examined whether age or affected territory (within the carotid 
distribution) influenced correct diagnosis or referral decisions using six carotid territory TIA 
vignettes (205). The study authors again justified the restriction to the anterior circulation by 
a low prevalence of posterior circulation symptoms. The three pairs of vignettes consisted of 
firstly keeping age constant but varying cortical or retinal ischaemia, the second pair 
consisted of retinal symptoms with age variation (above and below 65 years) and the third 
pair consisted of cortical symptoms with similar age variation. Each case also contained 
information about previous episodes and a history of non-specific symptoms, similar to the 
Quik-van Milligen study (203). Diagnostic responses were free text but management 
responses were semi-structured with GPs indicating whether they would perform additional 
tests, initiate medication or refer for specialist assessment. 
In 89 respondents (89% of the sample), correct diagnosis of both cortical TIA and amaurosis 
was less likely with recurrent episodes and a history of non-specific symptoms. For the 
cases without a history of non-specific symptoms and without previous episodes, younger 
age reduced the likelihood of a correct diagnosis of cortical TIA but age did not affect the 
correct diagnosis of amaurosis. In general the likelihood of correct diagnosis was higher for 
cortical TIA than for amaurosis, a similar finding to the Quik-van Milligen study (203). 
Although they do not present total referrals for each case, age did not affect referral to 
neurologists after cortical TIA or amaurosis. In the direct comparison between cortical and 
retinal territory, more patients with cortical symptoms were referred to a neurologist and 
more patients with retinal symptoms were referred to an ophthalmologist. 
2.9.5 Recognition tools for diagnosis of cerebrovascular disease – easier for stroke 
than for TIA 
Validated tools for diagnosis of cerebrovascular disease exist for stroke, and the original 
motivation for their derivation was earlier transport of patients to hospital from the community 
i.e. to aid paramedics in their recognition of stroke. Stroke recognition tools are centred on 
physical signs with key features from the history which identify stroke mimics. The absence 
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of physical signs in TIA (by definition) contributes to the difficulty in deriving simple 
diagnostic tools. 
The Cincinnati Prehospital Stroke Scale (CPSS) is a three item scale scoring arm drift, facial 
droop and speech clarity and in a small sample of paramedics and ED support workers it 
showed good reproducibility (206). However, a prospective assessment of its use via a one 
hour training session in a 12 month before and after study showed no effect on recognition 
of stroke or time spent ‘on scene’ (207).  
The Melbourne Ambulance Stroke Screen (MASS) involves initially testing for facial droop, 
hand grip (rather than the arm drift of CPSS) and speech disturbance (208). If any of these 
features are present, then the rule out features of age <45 years, history of epilepsy, and 
blood glucose levels (for hypoglycaemia) are assessed as well as the then thrombolysis 
ineligibility criterion of being bedridden or chair-bound. The MASS improved paramedic 
sensitivity in detecting stroke (78% to 94%) and reduced time to medical review in the ED by 
notification of potential stroke before arrival. This improvement was sustained three years 
after city wide implementation in terms of sensitivity of diagnosis and specificity (209). In this 
study, CPSS was calculated retrospectively from case notes and both MASS and CPSS had 
high NPVs around 95% with PPVs of 56% for CPSS and 65% for MASS. 
The Los Angeles Prehospital Stroke Screen (LAPSS) starts with the rule out features of 
history of epilepsy, age <45, abnormal blood glucose together with the thrombolysis 
ineligibility features of being bedridden or chairbound and symptom duration of 24 hours or 
more. If patients ‘pass’ this test then three motor tests are used – unilateral facial droop, arm 
weakness and grip strength (i.e. no speech component compared with the CPSS and 
MASS) (210). The LAPSS was tested retrospectively using clinical data for patients entered 
into acute stroke trials with a high sensitivity for stroke detection of 93% (210). A prospective 
validation of LAPSS used by US paramedics on 206 eligible emergency transfers to hospital 
showed a PPV of 86% and an NPV of 98% for a diagnosis of stroke (211). 
The Face, Arm, Speech Test (FAST) uses the presence of unilateral facial weakness or arm 
weakness or speech disturbance as a stroke recognition tool (212). It differs from the CPSS 
as the examiner assesses speech by observation rather than asking the patient to repeat a 
sentence. It was validated by comparing paramedics assessment of the three clinical 
features with those of an admitting stroke physician in one UK hospital (213). 78% of 
admitted stroke or TIA patients had FAST signs and the strongest level of agreement 
between paramedics and stroke physicians was for arm weakness (Cohen’s kappa of 0.8) 
and slightly weaker agreement for the presence of speech disturbance (kappa = 0.7) (213). 
Consecutive suspected stroke referrals from paramedics using FAST as a recognition tool 
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were compared with ED and GP referrals using clinical judgement, and this demonstrated 
similar PPVs for stroke across the three referral routes (214). The FAST recognition tool has 
a clear bias towards anterior circulation stroke detection as evidenced by fewer posterior 
circulation strokes referred from the paramedics compared with ED and GPs (214). 
A tool designed to improve the referral of patients with stroke from ED to acute stroke teams 
rather than from paramedics assessing patients in the community uses a combination of 
history, clinical features and blood glucose. The Recognition of Stroke in the Emergency 
Room (ROSIER) scale starts with checking blood glucose and correcting hypoglycaemia if 
present, then runs through negative predictors for stroke – loss of consciousness/syncope, 
ictal activity (which score -1 if present, 0 if absent). Positive features of stroke score 1 point 
each – face, arm or leg weakness, speech deficit and visual field defect (215). A prospective 
validation phase of the ROSIER scale showed a 93% sensitivity and 83 % specificity for 
stroke diagnosis with PPV of 90% and NPV of 88% (215). These measures of diagnostic 
performance were higher than for FAST, CPSS and LAPSS which were also calculated in 
the same cohort of patients. In a high prevalence setting (consecutive admissions to an 
acute stroke unit), nurses using the ROSIER scale had an equivalent sensitivity and positive 
predictive value as doctors using clinical acumen for stroke diagnosis (216). A small 
validation study in an external setting showed a high PPV (94%) for stroke diagnosis (217). 
Other studies have examined predictors for stroke or TIA diagnosis rather than deriving a 
scale. One study of ED presentations with dizziness, vertigo or postural imbalance found 
that positive predictors of TIA or stroke were higher age and male sex and negative 
predictors were isolated symptoms and non-hispanic or white ethnicity (218), although the 
methods were weak as there was no follow up and diagnosis was from record review. 
Distinguishing TIA from non-TIA in the ED is as difficult as in primary care with a similar 50% 
prevalence of true TIA in consecutive cases with suspected TIA (219). 
However, predictors of true TIA in the ED population may be different to primary care 
attenders, as a study deriving a logistic regression model for TIA diagnosis from ED referrals 
found that significant discriminators were gradual onset symptoms, non-specific complaints 
and a history of prior transient neurological symptoms resulting in an area under the receiver 
operating characteristic curve of 0.79 (220). The ABCD2 score did not provide any 
discriminating utility in the study. 
Features that predict stroke in a cohort of admitted patients in a UK study were absence of a 
history of dementia, no signs of systemic illness, any focal neurological sign, an exact time of 
onset, abnormal vascular findings, clinical features sufficient for an Oxford Community 
Stroke Project classification (total or partial anterior circulation, lacunar, posterior circulation), 
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a deficit sufficient for a National Institute of Health Stroke score >1 and neurological signs 
consistent with a unilateral cerebral lesion (221). Given the degree of expertise required to 
elicit these features, it would not be possible to use them to derive a scale for a generalist or 
non-clinician. 
The only specific tool for TIA diagnosis in the literature was derived using multivariable 
logistic regression from routinely recorded secondary care clinical notes (222). Given that by 
definition a patient with TIA has non-persisting symptoms, the tool is based on the clinical 
history. A score weighted using the beta coefficients of the regression model consisted of 
negative points for headache, loss of consciousness/syncope and ictal features, positive 
points for diplopia, past history of stroke/TIA, unilateral face/limb weakness, speech 
disturbance and increasing age. Internal validation performed with a 2:1 cost ratio used for 
misclassifying TIA as non-TIA was used to derive an optimal cut point for clinical usage 
(222).  
The ABCD2 score, although designed for prognostic use (24), may have a role in TIA 
diagnosis. It has a higher score in patients with an ED physician diagnosis of TIA who are 
deemed to have had a true TIA by case record review from a neurologist, compared to those 
patients deemed not to have had a TIA (223). A hospital clinician calculated ABCD2 score 
has been used to distinguish between true TIA and non-TIA in patients referred by GPs and 
ED physicians to TIA clinics. One study reported an area under the receiver operator 
characteristic curve of 0.75 (224) and another of 0.68 (177) for TIA diagnosis using ABCD2. 
Other potential tools include blood tests and machine learning algorithms. A search for novel 
biomarkers using mass spectrometry, by examining patterns caused by combinations of 
proteins in serum and comparing these in patients with stroke and controls has shown a 
77.5% sensitivity and 72% specificity in a small number of matched patients (225). The 
diagnosis of TIA using neural networks which take an alternative prediction methodology 
using existing history and examination factors to generate a learning network of associations 
has not been validated in external cohorts (226). 
2.9.6  Potential impact of GP-specialist difference in ABCD2 score 
The England and Wales National Stroke Strategy (60) and NICE guidance (36) recommend 
that the ABCD2 risk prediction score is used at the first point of contact with healthcare 
services after TIA or minor stroke in order to predict the risk of recurrent stroke. However the 
ABCD score in its original form was derived from clinical histories taken by secondary care 
clinicians(23), and in further iterations as ABCD2(24), ABCD2-I(38), ABCD3 and ABCD3-
39 
 
I(40), only secondary care taken histories or investigations (the “I”) have been used as 
derivation and validation datasets. 
Restricting derivation and validation datasets to secondary care histories is entirely 
appropriate if that is the context in which the prediction tool is to be used. For ABCD2-I and 
ABCD3-I, at least in the UK, only secondary care clinicians will have access to the 
appropriate investigations to use these iterations of the ABCD score. Therefore predicting 
the risk of recurrent stroke after TIA or minor stroke with ABCD2-I or ABCD3-I will only be 
undertaken in hospital in which case deriving and validating scores from histories taken by 
hospital clinicians is appropriate.  
However, throughout North America (15), Europe, Australia (35) and New Zealand (37), the 
ABCD2 score is recommended for use at the first healthcare contact after TIA which typically 
takes place either in the ED or in primary care. To date no studies have reported on the 
validation of the ABCD2 score either from ED clinical assessments or from primary care 
assessments of patients after TIA. 
Very little published work has examined the agreement among different clinicians (either 
intra-specialty or inter-specialty) of the ABCD2 score. One small retrospective study using 
ABCD referral proformas compared all referrals (50% were primary care, 50% ED) and only 
examined agreement in ABCD score for true TIA diagnoses, finding significant disagreement 
between ‘non-stroke specialists’ and ‘vascular neurologists’ (227). Interestingly this study 
also found disagreement between neurology registrars and consultants, although this was 
less marked than for the non-stroke specialists. 
2.9.6 Arterial territory – a determinant of patient presentation and professional 
recognition? 
Cerebral localisation of function results in different clinical presentations according to 
affected arterial territory for ischaemic lesions as well as for the direct tissue damage from 
haemorrhage. The structure of arterial inflow to the brain and brainstem creates the major 
categories of anterior and posterior lesions, and left and right sided lesions. An analysis of a 
German stroke registry found marked differences between left and right hemisphere strokes, 
with larger numbers of TIA and ischaemic stroke patients with symptoms attributable to left 
cerebral lesions compared with right sided lesions (228). However, there was an equal right 
– left distribution for haemorrhagic lesions in the registry suggesting that vascular pathology 
per se should not have any bias to affect one side or another. Given the other features that 
may make haemorrhage recognisable to patients and lead to presentation to healthcare 
such as headache, it may be the case that dominant sided ischaemic lesions i.e. left for the 
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majority, are more noticeable as dominant hand and speech are more likely to be affected. 
Furthermore, anterior lesions may be more easily diagnosed than posterior lesions. The 
positive predictive value of referral was much higher in a specific anterior circulation TIA 
clinic (86%) than the general TIA clinic figure of 50% (229).  
2.10 Summary 
The determinants of delayed presentation to healthcare after TIA and stroke and the choice 
of initial healthcare provider may vary with the healthcare system. Although delay is related 
to lower socioeconomic position and worse clinical outcomes, it is not likely that the 
associations between deprivation and stroke outcomes are mediated via delay in access to 
care – the relationship is complex with childhood and adulthood socioeconomic position 
having varying effects as well as varying associations with age at the time of stroke.  
Stroke knowledge and action (by the patient and bystander) are different and can be 
influenced differentially even if both are the focus of the same educational intervention. The 
action of accessing healthcare is related to perceived severity and the decision to access 
care in the out of hours time period may be different from within routine hours. 
Healthcare delivery influences the delay in receiving secondary prevention after TIA and 
stroke, with both primary care and secondary care influencing delay either by patient 
perception of availability, referral mechanisms or secondary care provision. 
Limited data is available to assess how GPs diagnose TIA with methodological flaws in 
existing studies from use of artificial cases, non-randomisation of case order on 
questionnaires, cueing as to the potential for a TIA diagnosis and restriction to anterior 
circulation syndromes. Excluding posterior circulation presentations is not logical as the risk 
of recurrent stroke is as high as after anterior circulation events (230). Recognition tools are 
well developed for stroke but not for TIA, and none are based on primary care recorded data 
and consequently a tool to improve referral decisions does not yet exist. 
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Chapter 3 The Evidence Gap 
3.1 Introduction 
The literature review has identified a number of evidence gaps that are relevant to 
understanding how primary care could reduce delay from symptoms to treatment for patients 
with cerebrovascular events that confer a risk of major stroke. 
3.2 The Oxford Vascular Study - use of cohort studies  
The accuracy with which cohort studies in general, and OXVASC in particular, can represent 
their national population has not been established. This is relevant as I wish to infer 
generalisable results by examining the patient pathway to definitive healthcare interventions 
for patients with cerebrovascular disease. The demographic variables of age and deprivation 
are strongly associated with the incidence of cerebrovascular events and patterns of 
healthcare system use. If there are differences in both age and deprivation structure 
between the OXVASC population and the national population then these must be taken into 
account when assessing the implications of results. 
Cerebrovascular disease cohorts have been identified either by presentation to secondary 
care or by following up a population of patients defined by contiguous geography. Studies 
which recruit patients at general practice level rather than through secondary care may be 
subject to clustering effects specific to individual practices. A cohort defined by registration at 
a general practice may therefore reflect specific local geographical features that may also 
influence generalisability of results. Failure to present to healthcare after cerebrovascular 
events has been associated with lower SEP and therefore large differences between 
practice populations in SEP may result in differences in presentation of TIA or minor stroke. 
Younger practice populations will have a lower incidence of TIA and minor stroke, thereby 
reducing clinical exposure to minor cerebrovascular presentations in primary care which 
could affect recognition by clinicians. 
Research Questions 
1. Is the OXVASC population representative of the national population in terms of age 
and deprivation? 
2. Do differences in age and deprivation between OXVASC practices affect the 
presentation of patients with TIA to healthcare? 
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Research question 1 was answered by comparing the age and deprivation structure of the 
OXVASC population with that of the population for England, using data available in the 
public domain.  
Research question 2 was answered by firstly establishing the variation in age and 
deprivation structure of individual practice populations in OXVASC and then examining the 
extent to which the structure of the registered population influenced presentation of TIA to 
healthcare. TIA presentation was assessed using the ratio of TIA to major stroke at practice 
level and was analysed with Poission regression and graphical display.  
3.3 Initial Interface between patient and the healthcare system 
3.3.1 Determinants of access to healthcare 
The influences on the two core components of healthcare access, the choice of healthcare 
provider and the time to call for medical attention and have not been determined in a 
population based prospective study of patients with TIA and minor stroke. This is relevant in 
understanding how to reduce delays in the care pathway from symptom onset to definitive 
interventions. Community ascertained cohorts of patients with TIA or minor stroke that have 
examined delay have used calendar day rather than analysing delay to call as a continuous 
variable and this is a methodological weakness. The timing of symptom onset of TIA or 
minor stroke has not been previously analysed as a determinant of healthcare access. 
Previously identified predictors of calendar day delay (clinical features, deprivation and 
previous cerebrovascular disease) have not been examined with delay as a continuous 
variable from symptom onset to time to call for medical attention.  
The effect of the organisation of primary care on delay in presentation after non-disabling 
cerebrovascular events has not been assessed. There is no evidence concerning how 
changes in primary care delivery influence where patients seek care or how long they take to 
make initial contact. The change in the general practice contract in 2004 allows for such an 
analysis, as a very well publicised and closely debated change in out of hours provision 
occurred. Given that delays in definitive care may vary depending on whether ED or primary 
care is the first contact after symptoms, the key outcomes to be studied are choice of 
healthcare provider and the delay in making the initial contact.  
Research Questions 
3. Is healthcare access after TIA or minor stroke influenced by the following factors; 
choice of healthcare provider, time of symptom onset, clinical features of the event, 
deprivation and previous history of cerebrovascular disease? 
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4. Did the change in general practitioner contract influence healthcare access after TIA 
or minor stroke? 
Research question 3 was answered by firstly establishing the choice of healthcare provider 
and the delay between symptom onset and calling that provider for medical attention, and 
then determining differences in these outcomes between groups defined by the identified 
predictors in the OXVASC cohort. 
Research question 4 was answered with a before and after analysis of choice of provider 
and delay to call during equivalent time periods pre and post the GMS contract change.  
3.3.2 Recognition of TIA in primary care 
The most important cases of TIA to identify in primary care are those that are high risk for 
recurrent stroke, and the most difficult cases are those that are missed at initial consultation 
in primary care. The methodological weaknesses in existing vignette based studies testing 
TIA recognition in primary care are the restriction to anterior circulation symptoms, artificial 
case histories, very high prevalence of TIA in vignettes resulting in cueing of the diagnosis 
and the lack of randomisation of order of presentation. Alteration of single details of vignettes 
has been used to test hypotheses of the reasons for clinical decision making in general and 
have been applied to TIA vignettes in recognition studies but with the above methodological 
weaknesses. It is not clear if failure to recognise TIA is systemic, in that GPs are never 
trained to the standard of full recognition of the variation in TIA presentations, or whether 
they receive this knowledge during training but the low prevalence of the condition at 
individual practitioner level results in an atrophy of this knowledge with time.  
As there have been no studies of GP trainees’ recognition of TIA from vignettes, there is no 
evidence to inform strategies to improve recognition of TIA (to alter training or alter post 
graduate education). This also implies that a pilot study needs to be undertaken to determine 
the design parameters of recruitment and completion rates to inform an appropriately 
powered definitive study testing TIA recognition in GP trainees. 
Research Questions 
5. Do GP trainees fail to recognise high risk TIA cases that have been missed by 
established GPs? 
6. What are the recruitment and completion rates for a web-based vignette study of TIA 
recognition by GP trainees? 
7. Does alteration of one case vignette parameter influence TIA recognition and 
management decisions? 
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Research question 5 was answered with an internet-based questionnaire pilot study of GP 
trainees using case vignettes with a narrative description of results given the pilot status. 
The cases were constructed from the primary care records of a cohort of patients in 
OXVASC who presented in general practice after transient neurological symptoms 
consistent with TIA, but the diagnosis of TIA was not considered by the treating GP, and the 
patient went on to have a stroke within 30 days of the initial consultation. The missed TIA 
cases were therefore not artificial, included both anterior and posterior circulation symptoms, 
and were presented in random order. Distractor (non-TIA) cases were also presented to 
reduce the prevalence of TIA in the questionnaire to 50%. 
Research question 6 was answered from analysing the numbers of trainees starting the 
questionnaire and completing the cases in full as a proportion of the denominator invited to 
take part.  Research question 7 was answered by including a matched case with each case 
of missed TIA that varied in one parameter that I judged to have been a potential cause for 
failure to detect TIA.  
3.4 GP and Specialist Disagreement – risk tools and diagnosis 
Potential clinical rules for TIA prognosis (ABCD2) and diagnosis (222, hereafter known as 
the ‘Dawson tool’), have been derived using clinical records made by specialists. There is no 
evidence about whether primary and secondary care records are in agreement over the key 
clinical features that drive the utility of the rules and whether disagreement is greater for 
patients who do not have TIA. This has implications for whether currently existing decision 
tools could be used appropriately in primary care to identify TIA patients at high risk of 
recurrent stroke for urgent clinic appointments. The only specific TIA recognition tool in the 
literature, the Dawson tool has not been subject to an external validation outside the clinic 
site where it was derived. Furthermore the ABCD2 score has been used to discriminate 
between TIA and non-TIA as causes of transient symptoms and although it was not originally 
derived as a diagnostic tool it shows reasonable accuracy in specialist recorded histories. 
Differences in Dawson tool and ABCD2 scores between GPs and specialists will impact on 
the extent to which a rule used in primary care can increase the positive predictive value of a 
referral for suspected TIA and crucially not miss patients with TIA.  
Research Questions 
8. Do GPs’ and specialists’ records of the same patients with suspected TIA agree 
about the clinical features? 
9. Does GP/specialist disagreement vary according to final clinic diagnosis? 
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10. What impact does GP/specialist disagreement have on the performance of the 
ABCD2 score for accurate triage of patients with TIA? 
11. What impact does GP/specialist disagreement have on the discrimination metrics of 
existing clinical prediction tools for TIA diagnosis? 
Research question 8 was answered by examining all referrals with suspected TIA from 
primary care to assess the degree of disagreement for individual patients in clinical histories 
taken by GPs and by specialists. Research question 9 was examined by analysing the 
degree of disagreement in patient groups defined by final clinic diagnosis. Research 
question 10 was examined by the proportion of high and low risk TIAs that would have been 
inaccurately triaged with ABCD2 scores calculated from the primary care clinical histories 
and the number of strokes that may be expected by inaccurately triaged high risk TIA 
patients waiting for one week before definitive risk factor reduction. Research question 11 
was examined by comparing the calibration and discrimination metrics for TIA diagnosis 
using the Dawson tool and the ABCD2 score in specialist histories and comparing these 
metrics with those from Dawson tool and ABCD2 score in primary care histories. 
3.5 New Prediction Rules for TIA in Primary Care 
There are no prediction rules for TIA diagnosis that have been derived from primary care 
records. Improving the recognition of TIA in primary care and increasing the predictive value 
of a primary care referral for TIA diagnosis will require a prediction rule that uses clinical 
features detected in primary care, and therefore it should be derived from primary care 
records. If primary care diagnostic models are different from specialist diagnostic models 
then the clinical predictors used must be different.  
There is no evidence to suggest the most appropriate modelling strategy that represents the 
underlying relationships between predictor variables and outcome. Both logistic regression 
and classification tree methods have been used for derivation of prediction models in 
general but comparisons of techniques have not been reported for TIA diagnosis. Prediction 
using ensemble methods for classification and in particular, the random forest technique, 
have theoretical advantages over predictions from single models of a given dataset but there 
are no studies reporting benefits of such modelling methods over standard techniques for 
TIA diagnosis.  
Research Questions 
12. Which clinical predictors are included in a prediction rule for TIA diagnosis derived 
from primary care records in suspected TIA? 
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13. What are the calibration and discrimination metrics for a model of TIA diagnosis 
derived from primary care records in suspected TIA? 
14. Does choice of statistical model affect discrimination metrics for TIA diagnostic 
models? 
Research question 12 was answered by analysing the clinical records of all referrals with 
suspected TIA from primary care to a TIA clinic over a four year period. I restricted this to 
patients presenting with transient symptoms, as for those with persisting symptoms and 
signs there is less clinical doubt about decision making. General practice records of 
consultations and referral letters were used to create symptom categories from groups of 
similar textual descriptions of the presenting problem at first consultation in primary care. 
Research question 13 was answered by constructing a calibration curve from predicted 
probabilities from the model output and discrimination metrics calculated using model-based 
rules both with and without weighting by beta coefficients. Research question 14 was 
answered by comparing discrimination metrics for three different statistical models of TIA 
diagnosis. 
3.6 Summary 
The following reports of detailed methods and results address these evidence gaps, from the 
security of generalisable inferences from OXVASC, through the initial interface between 
patient and the healthcare system and the ability of clinicians to identify high risk 
presentations, as well as the utility of existing and potential future tools to enable more 
appropriate resource use in secondary care. 
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Chapter 4 Oxford Vascular Study – methods and generalisability 
4.1  Introduction 
Making inferences from cohorts to national populations requires an assessment of their 
similarity. Given that age and deprivation can affect healthcare seeking behaviour, the 
research questions answered are 
1. Is the OXVASC population representative of the national population in terms of age and 
deprivation? 
2. Do differences in age and deprivation between OXVASC practices affect the presentation 
of patients with TIA to healthcare? 
These questions are answered with comparisons between the OXVASC registered practice 
population and the population of England in terms of age and deprivation structure. The 
distribution of age and deprivation between the practices is compared and then potential 
impact of differences in these parameters on presentation of TIA is assessed. 
4.2  The OXVASC methods - population and practices  
The Oxford Vascular Study (OXVASC) is a prospective study of all vascular events 
(TIA/stroke, ischaemic cardiac events and peripheral vascular events) occurring in a 
population of 91,000 patients registered at nine general practices in urban and rural 
Oxfordshire (231).  Population based studies including all incident cases within stroke 
medicine are important as the patients that are excluded from trials have a higher mortality 
but equivalent recurrent vascular event rate (232). 
Patients are recruited after presentation to primary care or the ED (‘hot pursuit’) or via 
regular searches of the general practices’ computer records (‘cold pursuit’) (231). The 
general practices in OXVASC are those of the Oxford Community Stroke Project carried out 
20 years previously (22). At recruitment, a structured proforma is used by either a research 
nurse or clinical research fellow to collect demographic data and clinical data about the 
presentation event and then follow up is either active via regular visits to a research clinic 
run by Professor Peter Rothwell (PMR) or via monitoring of the electronic GP record for 
vascular events. OXVASC methods were approved by the Oxford Clinical Research Ethics 
Committee (ref CO.043). 
Although the data analysed in this thesis are from patients who were recruited from1st April 
2002 (the start of the study) to 1st April 2007, data on the distribution of age, sex and 
deprivation of the 91,000 registered patients were not available from the primary care trust 
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(NHS Oxfordshire) until August 2010 and is constituted by the patients registered at the 
OXVASC practices on the date 31.8.2010. Although there will have been some registered 
population turnover from 2007 to 2010, this is a continual process and would have been 
going on from 2002 to 2007. Given that practices have considerable boundary stability, the 
postcodes in the registered population are likely to give a stable estimate of the deprivation 
structure of that practice population even if there is a small percentage turnover of people 
residing at those postcodes. 
4.3  Comparison of the OXVASC population with the total England population and 
inter-practice comparisons– age and deprivation  
Substantial differences between the OXVASC population and the background England 
population may limit inferences concerning patient behaviour as well as affecting derivation 
of predictors for TIA diagnosis. Practice populations can also differ substantially in terms of 
the demographic structure of age and deprivation. Given the very high incidence in elderly 
populations (16) as well as the effect of deprivation on cerebrovascular disease (149), this 
may result in different incidence rates for TIA and minor stroke at practice level. This in turn 
implies that the GPs who refer to OXVASC may have different clinical experience with TIA 
and stroke with different opportunities for upkeep of diagnostic and management skills. 
Socioeconomic position was measured using the Indices of Multiple Deprivation (IMD) 2007. 
The Office of the Deputy Prime Minister, responsible for policy development in the area of 
social exclusion, published a map of deprivation using an Index of Deprivation in 2004 (233) 
and this was updated in 2007 (234). The 2007 IMD consists of a sum of measures along 
seven dimensions of income deprivation, employment deprivation, health deprivation and 
disability, education skills and training deprivation, barriers to housing and services, crime 
and living environment deprivation. The summary IMD statistic in England and Wales is 
assigned to small regions of roughly 1,500 residents, formed in 2004 from similar contiguous 
geographical areas. These are termed lower super output areas (LSOAs). All England 
LSOAs are ranked in terms of their IMD scores and so a national rank is also available for 
each LSOA. 
The age and deprivation structure of the OXVASC population was compared with the total 
England population data from the Office for National Statistics, which gives an age 
breakdown (grouped into 0 - 15 years, 16 – 29 years, 30 – 44 years, 45 – 64 years and > 65 
years) for each LSOA (235). The total England data was merged with a separate Office for 
National Statistics file with IMD scores for each LSOA (236) to create a complete age and 
deprivation structure. The OXVASC population was grouped according to the same age 
bands for direct comparisons which were made visually from graphical display. 
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Inter-practice comparisons within the OXVASC population for mean age were carried out 
with analysis of variance, and for median IMD scores with the Kruskall-Wallis test due to the 
skewed nature of that distribution.  
4.4  Demographic effects and recognition of TIA 
Major strokes, by virtue of their absolute requirement for hospital care and certainty of 
diagnosis from imaging can be viewed as a reference at practice level for cerebrovascular 
burden. Given the high early risk of stroke after TIA (20), if one particular practice was 
subject to a bias of patients not presenting early after TIA then one would expect a change in 
the ratio of TIAs to major strokes occurring in that practice population, as patients would 
present with stroke (and be ascertained from hospital into OXVASC) during a period of delay 
after TIA. Also, if there was little exposure to TIA or minor stroke presentations (either due to 
reduced patient presentation to healthcare or to true low incidence) and such cases were 
missed due to lack of familiarity then the ratio between ascertained TIA and ascertained 
major stroke per practice would be affected. 
Thus if patient healthcare seeking behaviour or GP accuracy of TIA detection are affected at 
practice level then the number of ascertained TIAs may differ by practice, potentially varying 
with age distribution or IMD distribution. However the number of major strokes will not be 
affected by healthcare seeking behaviour after major stroke or GP accuracy of detection of 
transient cerebrovascular presentations. 
Thus an appropriate estimation of the effect of different age and deprivation demographics 
on presentation (and referral) would be if a relationship existed between the ratio of TIA to 
major stroke and age or deprivation structure of the practices. 
In order to examine effects of age and deprivation structure, the sampling distribution of the 
TIA to major stroke ratio should ideally be known. The likely distribution of the two variables 
used to calculate the ratio, numbers of TIA and numbers of major stroke will be Poisson 
rather than normal. Furthermore they are in the same underlying population and will be 
correlated and therefore techniques that assume independence are not appropriate. 
In order to investigate the association between practice factors of age distribution and 
deprivation on the rate of TIA, I modelled the effect of mean IMD and of % ≥ 65 years 
separately, using a Poisson regression (SPSS version 17). As the underlying distribution of 
the ratio of TIA to major stroke is unknown I was not able to use this as a dependent 
variable. Instead, I used the numbers of major strokes as an offset in the modelling equation, 
to act as a unit of reference. Poisson regression uses maximum likelihood to estimate model 
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parameters, a process which chooses the model parameters as the ones that are most 
likely, given the data. This analysis of optimal model parameters is an iterative process 
which uses a number of starting points and aims to converge on one set of model 
parameters at the end of each parameter search. Failure of convergence on one set of 
model parameters is possible with small numbers of practices in which case simple graphical 
displays can be used to investigate the associations between these factors and the ratio of 
these two rates.  
I am grateful to Dr Richard Germuska at NHS Oxfordshire who provided the postcodes for 
the 90,235 patients registered at the OXVASC practices.  
4.5 England and OXVASC population 
Figure 4.1 displays a plot summarising the population structure as available from the UK 
Office of National Statistics (0 - 15 yrs, 16 - 29 yrs, 30 – 44 yrs, 45 – 64 yrs and > 65 yrs) for 
all lower super output areas (LSOAs) in England and for the registered population at 
OXVASC practices. The relative size of the circle at each age band represents the % of the 
total population contained within the relevant age ranges. From visual inspection, the relative 
sizes of the age bands are equivalent in OXVASC and in England, but there are differences 
in mean IMD scores, with the OXVASC population living in more affluent LSOAs than the UK 
average. The relationship between mean IMD across age bands within each population is 
similar with the highest mean IMD in the 16 – 29 year band and lowest in the >65 year band. 
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Figure 4.1 Age and deprivation structure of population of England and population 
of OXVASC registered patients 
4.6 OXVASC Population – total and practice differences 
Figure 4.2 shows a more detailed population pyramid by age deciles for the OXVASC 
registered population with sex differences, demonstrating an excess of females in the upper 
age deciles.
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Figure 4.2  OXVASC Population – deciles by sex 
The overall age structure differs across the nine practices, particularly where there are high 
numbers of student registrations (Practice 1) as demonstrated by the large population band 
in the 20 -30 year age group shown in figure 4.3.  
Table 4.1 shows the mean (SD) for age in each practice and the total population. Analysis of 
variance demonstrates that the differences in age distribution are statistically significant (F = 
228.51, p<0.001). Levene’s test for homogeneity of variances was significant (352.43, df=8, 
p<0.001) and so the Games-Howell post hoc comparison test was chosen to investigate 
which practices were significantly different from the rest of the group. Practices 1 and 5 
which have lower mean values were significantly different from all other practices at p<0.001 
for all comparisons.  
However, given that there is variation in age composition of the practices it raises the 
possibility that there may be practice specific bias in characteristics of the registered 
population. As such, pooling data on patients across practices may not be appropriate as it 
will not take clustering of characteristics into account. Such clustering effects may be more 
likely if small numbers of the at risk population for TIA or minor stroke are registered at a 
given practice. 
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Figure 4.3  Age (years) and sex structure of the nine practices forming the OXVASC 
population. 
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 TOTAL 
PATIENTS 
Age  
mean (SD) 
≥ 50 
yrs         
% ≥50 
yrs 
≥ 65 
yrs 
% ≥ 65 
yrs 
PRACTICE 1 12846 33.10 (17.60) 2230 17.4 893 7.0 
2 4548 41.13 (22.10) 1678 36.9 644 14.2 
3 5062 41.30 (23.40) 1931 38.1 979 19.3 
4 15709 41.37 (23.76) 5836 37.2 2947 18.8 
5 8686 34.90 (20.64) 1930 22.2 859 9.9 
6 12392 41.91 (23.83) 4760 38.4 2314 18.7 
7 12661 40.66 (23.11) 4633 36.6 2061 16.3 
8 11117 39.92 (22.75) 3766 33.9 1758 15.8 
9 7214 41.38 (22.34) 281 39.1 113 15.7 
Total 90235 39.35 (22.51) 29585 32.8 13589 15.1 
Table 4.1 Absolute numbers and % of patients aged ≥ 50 and ≥ 65 registered at each 
OXVASC practice. 
4.7 The ‘at risk’ population and the ‘high incidence’ population 
95% of patients with TIA and MIS ascertained in OXVASC are aged over 50 and this 
population i.e those ≥50 yrs registered at OXVASC practices can be described as the ‘at 
risk’ population.  After the age of 65, the incidence of TIA and MIS rises sharply (16) and this 
sub-population within each practice is therefore likely to yield a large proportion of events. 
Given that smaller units of recruitment may lead to bias, the absolute numbers of the at-risk 
population and high incidence population is required. Figure 4.3 displays the absolute 
number of patients greater than 50 years old registered at the 9 practices within each ten 
year band. 
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Figure 4.4  Numbers of registered patients with age> 50 within each ten year band 
of the nine general practices forming the OXVASC baseline population. 
This shows the large variation in absolute practice numbers of at risk patients although the 
age band structure within each practice in the registered population over 50 appears stable 
across practices. Given that the incidence of TIA increases in the elderly and that 75% of all 
TIA and MIS occur in those greater than 65 years old it is important to confirm that absolute 
numbers of patients at risk in these older age groups are present in numbers sufficient to 
minimise bias which for example could manifest as reduced ability to detect TIA or MIS 
simply due to very low numbers of events per GP occurring in a given practice population. 
Table 4.1 shows the absolute numbers of patients that are in the ≥50 age group and ≥65 age 
group at each practice and as a % of the total at the practice. The practice with high student 
registrations (practice number 1) has the lowest percentage of the at risk population (≥ 50 
yrs) at 13.4% and the lowest in the high incidence population (≥65 yrs) of just 7% (n=893). A 
large practice with very few high incidence patients suggests that the GPs in the practice will 
have little exposure (on a per GP basis) to the type of presentations associated with TIA and 
MIS, compared with a similar sized practice with a much larger group of high incidence 
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patients. Practice number 6 conversely has a larger fraction of the high incidence age group 
at 18.7% (n = 2314) with greater opportunity for familiarity with TIA/minor stroke on a per GP 
basis. 
4.8  Distribution of deprivation – IMD 2007 scores 
For the total OXVASC population the IMD distribution is skewed with more patients residing 
in LSOAs with lower IMD scores, i.e. more affluent areas as shown in figure 4.4 
 
Figure 4.5  Distribution of IMD 2007 scores for patients registered at all practices. 
For the OXVASC population as a whole, comparing the ≥65 year old population with the 
population <65 years shows that there is a statistically significant difference in deprivation 
distribution with older patients living in more affluent LSOAs (≥65 median IMD =7.44 vs < 65 
median IMD = 9.80, Mann Whitney z = -25.9, P<0.001). Practice level populations were also 
examined for age and deprivation differences. 
The mean IMD in each practice may mask differences in the distribution of deprivation within 
key population sub groups. The average IMD score for each practice is shown in table 4.2. 
Marked differences are seen in the deprivation scores for the total populations and in the 
subset populations of interest.  
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In general, table 4.2 shows that the high incidence groups have a mean IMD lower or similar 
to the practice mean. Practice numbers 1, 3 and 5 have the highest mean IMD scores in the 
≥ 65 age group, yet they have some of the lowest absolute numbers in this group (total for 
practices 1,3,5 = 1897 patients, % of total ≥ 65 = 19.5%). Thus the majority of the high 
incidence group of patients in OXVASC are registered at other practices with lower mean 
IMD scores. 
 < 50 yrs ≥ 50 yrs < 65 yrs ≥ 65 yrs All patients 
PRACTICE 1 16.09 (7.86) 12.43 (7.55) 15.72 (7.90) 11.90 (7.34) 15.45 (7.92) 
2 8.78 (4.30) 8.00 (4.20) 8.61 (4.29) 7.78 (4.15) 8.49 (4.28) 
3 15.60 (6.42) 12.15 (6.82) 14.98 (6.62) 11.36 (6.70) 14.28 (6.78) 
4 9.76 (6.46) 8.81 (5.70) 9.55 (6.33) 8.80 (5.59) 9.41 (6.21) 
5 22.50 (8.37) 22.11 (8.98) 22.38 (8.41) 22.68 (9.36) 22.41 (8.51) 
6 7.22 (2.74) 7.34 (2.68) 7.23 (2.72) 7.42 (2.70) 7.27 (2.72) 
7 8.66 (5.91) 8.32 (5.98) 8.53 (5.72) 8.58 (5.34) 8.53 (5.66) 
8 9.67 (6.23) 8.60 (5.30) 9.41 (6.12) 8.78 (5.20) 9.31 (5.98) 
9 7.87 (3.75) 7.46 (3.74) 7.79 (3.79) 7.26 (3.51) 7.71 (3.75) 
Table 4.2  Mean (SD) IMD scores for all registered patients and by grouping into at 
risk and high incidence age groups. 
Given the skewed distribution of IMD score, differences between practices in IMD 
distribution were tested using a non-parametric test which found statistically significant 
differences in the high incidence population (Kruskall-Wallis test χ2 = 27796, df=8, p<0.001) 
4.9  Assessing the impact of different age and deprivation structures in practices 
on recruitment 
A priori, the effect of reduced % at risk and reduced % high incidence populations will be to 
dilute the clinical experience at individual GP level. Thus not only will there be reduced 
incidence of TIA and MIS at practice level but potentially the accurate detection of symptoms 
may differ as well. This could also be affected by level of deprivation in the high risk group 
which can influence incidence and presentation to primary care.  
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Thus if patient healthcare seeking behaviour or GP accuracy of TIA detection are affected at 
practice level, then the number of ascertained TIAs may differ by practice, potentially varying 
with age distribution or IMD distribution. By contrast the number of major strokes (defined as 
NIHSS score >5) is much less likely to be affected by healthcare seeking behaviour or GP 
diagnostic accuracy. 
The investigation of the effect of age and deprivation distribution at practice level on TIA 
incidence was attempted with Poisson regression.  Using stroke incidence as an offset, the 
regression models against both % population ≥ 65 years at each practice and mean IMD in 
the ≥ 65 years population at each practice did not converge. Instead, relationships between 
the ratio of TIA to major stroke were plotted against practice level % population ≥ 65years 
and mean IMD in the ≥ 65 age group and assessed visually. 
Figure 4.5 displays the plot of TIA: Major stroke in the practices ordered by increasing % of 
total population in the high incidence age group. The ratio does not increase with increasing 
% population ≥ 65 years, suggesting that a low per GP event rate does not systematically 
result in ‘under finding’ of TIA. 
Figure 4.6 displays the plot of TIA: Major stroke in the practices ordered by increasing mean 
IMD score in the ≥ 65 population. Again there does not appear to be a relationship between 
this ratio and increasing deprivation in the high incidence population. 
 
Figure 4.6  Scattergram of practice TIA: major stroke against increasing % of 
registered population ≥ 65 years old. 
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Figure 4.7 Scattergram of practice TIA: major stroke against increasing mean IMD 
score in practice registered population ≥ 65 years old 
4.10  Summary 
The OXVASC population is not representative of the national population in terms of 
deprivation, although the age structure is similar to that of the national population and the 
relative deprivation between age groups is similar. There is under sampling from areas of 
high deprivation in the IMD score histogram of the registered population at OXVASC 
practices. Given the small numbers residing in highest IMD scored postcodes, the use of 
quartiles creates larger and equal numbers within groups of increasing deprivation but at the 
price of potentially not detecting effects that are evident at highest levels of deprivation. As 
the OXVASC population is less deprived than the national population, the strength of 
associations between deprivation and healthcare seeking behaviour in the cohort may not 
reflect the strength of association in the national population.  
Differences in age and deprivation of the populations at the different practices in OXVASC 
do not affect the presentation of TIA to healthcare.  Although there are significant differences 
in age and deprivation structure of the practice populations, the ratio of TIA to major stroke 
does not vary systematically with increasing high risk population at a given practice or with 
mean IMD in this population. Hence recognition and referral of TIA does not systematically 
vary with these parameters. As such, it is valid to pool patients from different practices and 
analyse them as one group. 
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SECTION 3 Initial Interface Between Patient and Healthcare System 
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Chapter 5 Methods 
5.1 Introduction 
This chapter outlines the methods used to address the evidence gap concerning access to 
the first medical assessment after the onset of symptoms of either TIA or MIS and the ability 
to recognise that TIA or MIS may be the cause of symptoms.  
Education over how to access services in a timely manner to facilitate urgent assessment 
and treatment requires an understanding of potential factors that influence patients’ choices 
over initial healthcare provider. Previous experience of TIA, minor stroke or major stroke 
may influence choice of provider and delay to call for medical attention so whether the event 
that prompted medical attention was incident or recurrent may be associated with provider 
choice and delay.  
The research questions on healthcare access are 
1. Is healthcare access after TIA or minor stroke influenced by the following factors; choice 
of healthcare provider, time of symptom onset, clinical features of the event, deprivation and 
previous history of cerebrovascular disease? 
2. Did the change in general practitioner contract influence healthcare access after TIA or 
minor stroke? 
The key components of health care access, choice of healthcare provider, and delay to 
calling that provider were measured in the OXVASC cohort 2002 – 2006. Associations 
between delay to call for help and the choice of provider are examined in the first research 
question. The effect of patient level factors of demographic and clinical features and the 
effect of healthcare system factors (routine primary care availability and the change in the 
GMS contract) on provider choice and delay were tested with strength of statistical 
associations. The impact of altering primary care availability was estimated from the number 
of patients who had a TIA in the out of hours period and went on to have a recurrent stroke 
before their practice re-opened. 
TIA or MIS may not be recognised at that first healthcare contact and this is also a cause of 
delay to definitive treatment, either because underlying pathology is suspected and patients 
are referred to an intermediary specialist or because no significant cause for the 
presentation is suspected and patients are sent home. As TIA and MIS are seen infrequently 
by individual GPs it is not clear if failure to recognise the cause of symptoms is due to low 
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familiarity from low clinical exposure or because GPs are not trained sufficiently to recognise 
the various presentations of TIA and MIS. The research questions were 
3. Do GP trainees fail to recognise high risk TIA cases that have been missed by established 
GPs? 
4. What are the recruitment and completion rates for a web-based vignette study of TIA 
recognition by GP trainees? 
5. Does alteration of one case vignette parameter influence TIA recognition and 
management decisions?  
These questions were answered with a questionnaire of vignettes of high risk TIA 
presentations missed in primary care (with matched cases altered by one parameter) which 
was piloted in GP trainees, testing diagnosis and management. 
5.2  Definition of In Hours and Out of Hours (OOH) 
 A number of general practices offered Saturday morning surgeries under the old GMS 
contract and in order to compare patients’ healthcare seeking behaviour for events occurring 
in hours and OOH, it is necessary to define these time periods. All OXVASC practices 
offered Saturday morning emergency surgeries (personal communication from each practice 
manager) so for patients who had events in these time periods before the new GMS 
contract, Saturday mornings between 09:00 and 12:00 were considered to be in hours, as 
the registered general practice was open. Although patients could contact a known GP from 
the registered practice throughout the 24 hour period of each day the premises had weekday 
office hours opening and the time periods of 08:00 to 18:30 were chosen in the old contract 
time period to reflect this. This is also the time that practices are open under the service of 
the new GMS contract. 
Thus for the old contract in hours were 08:00-18:30 Monday to Friday and 09:00 – 12:00 
Saturday, and for the new contract in hours were 08:00 – 18:30 Monday to Friday only. All 
other times are defined as OOH. 
5.3  Methods for research question 1 – determinants of choice of provider and 
delay to call 
Choice of provider was defined as the setting of the first medical assessment (ED including 
the separate Eye Hospital emergency department, registered general practice, out of hours 
GP, other hospital clinic or occurring whilst an in-patient). Proportions of patients attending a 
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given provider in the in hours and OOH periods were compared using z tests assuming 
independent proportions (Microsoft Excel software).  
Median delay in calling for medical attention after TIA and minor stroke was analysed for the 
following comparisons using Mann-Witney U test 
1. Incident events vs recurrent events 
2. In hours events vs out of hours events 
3. Primary care attendance vs secondary care attendance  
4. Most deprived quartile vs least deprived quartile 
5. Clinical features (weakness, sensory loss, visual change, speech disturbance) - presence 
vs absence 
5.4  Data quality  
5.4.1 Quality and Outcomes Framework (QoF)  
The QoF incentivises GPs to detect and control chronic disease e.g. diabetes and 
hypertension. Given that the QoF was introduced at the mid-point of the time period for data 
collection for the above sample it would be of interest to examine whether the prevalences 
for chronic diseases and risk factors are different for patients recruited after TIA and minor 
stroke in the old and new contract time periods 
5.4.2 Events occurring during holidays  
In a population based study with active ascertainment some patients may well have events 
that occur when they are outside their usual area of residence, which could influence not 
only their choice of healthcare provider but also the delay in calling for help. In order to test 
the effect of the GMS contract and GP opening hours in general on patients’ choice of 
provider and delay in calling them, I excluded 25 patients who had events whilst out of the 
UK and were therefore in an unfamiliar healthcare setting at the time of symptom onset.  
5.4.3  Measuring delay and missing data 
Delay after TIA has been previously measured using calendar days in a combination of 
research and routine data in Oxford (43) and similarly in a comparison between UK and 
Canada for TIA presentations (141).  Delay in this thesis was instead measured in hours for 
the interval between symptom onset to the first call for medical assistance - either telephone 
to a GP provider, call to emergency services or the time of self-presentation at a GP practice 
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or ED. For patients who were unable to give timings at their recruitment interview, these 
were derived from GP consultation notes, GP letters or ambulance transfer sheets. If these 
were unavailable, then call times were imputed using the modal class of call time from 
available data. 
Given that some patients ascertained in OXVASC sought care many months after their event 
(which in the majority of these cases was mainly mentioned in passing when attending for 
other reasons) median times to call for help were used as the most appropriate measure of 
central tendency of the skewed distributions of delays to call. 
5.5  Evidence for combining contract time periods 
I hypothesised that the new contract would affect choice of provider (primary care, OOH 
primary care and ED) but not delays to call that provider i.e. those using primary care would 
do so with the same delay to call in 2002-2004 as in 2004 – 2006.  
This hypothesis was investigated by comparing median call times for all patients in the old 
contract and all patients in the new contract with the Mann-Witney U test (SPSS 17). 
5.6  Research question 2 – the influence of the General Medical Services (GMS) 
contract change on healthcare access 
In April 2004, the new GMS contract for primary care was introduced (130). Alongside a pay 
for performance structure set out as the Quality and Outcomes Framework (QoF), the 
mandatory 24 hour responsibility for patient care ended. Practices could opt out of this 24 
hour care model, which the vast majority did given that the only penalty was a small 
reduction in practice income. Local Primary Care Trusts (PCTs) took over the responsibility 
for ensuring access to primary care services outside office hours which were defined as 
18:30 to 08:00 from Monday to Thursday and 18:30 on Friday to 08:00 on Monday i.e. 24 
hours on Saturday and Sunday. A proposal to extend general practice opening hours was 
put forward by the UK government for negotiation with the General Practitioner Committee of 
the British Medical Association in 2008 (237). 
All the OXVASC practices opted out of the 24 hour care model and therefore their practice 
opening hours were the only times when a patient could access their registered general 
practitioner. The out of hours contact with primary care is initiated either by ringing the 
registered practice and then receiving details about contacting the out of hours (OOH) 
service or having the surgery telephone number redirected to the OOH provider 
automatically.  
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As patients were ascertained in OXVASC for two years before the GMS contract change, 
there is an opportunity to analyse the effect that the change in GMS contract had on 
decisions to contact primary care in the out of hours time period. At the time of this analysis 
it had already been established that service level issues may have an influence on the delay 
to calling for help but no evidence of how the delivery of primary care could influence the 
delay to specialist assessment (43). A number of potential influences can be hypothesised. 
1. Perceived lack of availability would prompt patients to attend ED rather than ringing 
their practice and being redirected to the OOH primary care service. 
2. Knowing that the practice is closed, patients are aware that they are not disturbing 
their own doctor and this might prompt more patients to ring the OOH provider 
3. For patients that will only see their own practice, more may wait until the surgery is 
open again before making any healthcare contact. 
In order to assess the impact of the new GMS contract I chose to analyse two equivalent 
time periods before and after its introduction. As OXVASC began collecting data on the 1st 
April 2002, two years were chosen before and after the change in contract, therefore all 
patients with TIA and MIS that were ascertained in the time period 1st April 2002 to 31st 
March 2006 were selected for analysis. 
Proportions of patients attending a given provider in the new and old contract time periods 
were compared with z tests assuming independent proportions (Microsoft Excel software). 
5.7 Early Recurrent Strokes – do GP opening hours contribute? 
One of the advantages of the OXVASC population based study with active ascertainment is 
that patients who present with major stroke are recorded and previous events in these 
patients that were thought to be due to TIA or MIS are also documented.  
If GP opening hours are indeed a barrier to care then, given the high early risk of recurrent 
stroke, one would expect to find patients who had a TIA or MIS during the OOH period who 
went on to have a recurrent stroke before their registered practice re-opens. I therefore 
sought patients who did not seek care after TIA/MIS in the OOH period and were 
ascertained in OXVASC only after a recurrent stroke before the time that their practice 
reopens. This assumes that, as they had not gone to the ED, they may have been waiting for 
their practice to reopen before seeking care. 
Alternative primary care centres were proposed in the NHS review led by Lord Darzi, 
Minister of State for Health (238), where primary care access would be increased to 08:00 to 
20:00, seven days a week. If all primary care delivery were to be structured in this way then 
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there may be benefits in reducing recurrent stroke for patients presenting to services after 
TIA and MIS, provided that there is capacity in secondary care to respond in a timely 
manner.  
I calculated the number of strokes that may have been prevented with ‘Darzi centre’ opening 
hours, by examining the number of TIA or MIS cases occurring in the extra period of opening 
hours that such a centre would offer.  
5.8  Distribution of call delay and practice opening hours 
The pattern of call delay was displayed visually by plotting call delay against the time of 
event to demonstrate how the time of event and the opening hours of general practice 
influence call delay. The frequencies of time bins of calls to general practices were plotted as 
further evidence of the link between practice opening hours and timing of requests for 
medical assistance. 
5.9 Rationale for testing recognition of TIA    
5.9.1 Bias in clinic-case derived tools – ‘missed’ high risk TIA 
The classical presentations of TIA are well known to clinicians and the clinic referral cohort 
of TIA and mimics of TIA have similar characteristics in regard to these features, such as 
weakness and speech disturbance. However, there may be cases of TIA sharing common 
features that are less well known to GPs and therefore may be missed after initial 
presentation in primary care. If these particular TIAs are high risk, then they will present a 
short time afterwards with stroke. 
A major bias of the Dawson diagnostic tool for TIA is that it is derived using patients who 
have been referred to clinics, and as such GPs or ED clinicians have been concerned 
enough about the underlying diagnosis in these patients to refer for a specialist opinion.  
Patients who may present to both primary care and ED with high risk TIA but are not 
considered to have TIA by the treating clinician will not be included in the reference pool of 
clinic referrals. Such cases may share atypical features (as clinicians may not have 
considered the diagnosis) resulting in a biased tool where not all TIAs have been included at 
derivation. This is particularly problematic if the missed cases are associated with early 
recurrent stroke.  
As OXVASC recruits patients after all vascular events, all patients that present with stroke 
rather than TIA are also ascertained. All ascertained patients have primary care records 
examined for relevant risk factors and their control e.g. office blood pressure level, as well as 
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previous presentations to healthcare (either records from primary care or letters from ED) 
with events that could be due to cerebrovascular disease. 
This represents an opportunity to examine in more detail patients who were recruited after a 
major stroke but may have had a TIA beforehand and presented to primary care after 
transient phenomena but were not diagnosed as having TIA. By virtue of case definition 
these transient events are very high risk for recurrent stroke. 
The patients that are included are those who had a recurrent stroke within 30 days of a TIA 
but presented to medical attention in the time window after TIA and before the recurrent 
stroke. A time to recurrent event of ≤ 30 days after TIA was chosen because it could be 
argued that some presentations, if atypical, are less likely to represent a high risk TIA if the 
recurrent stroke occurs beyond this time window. 
Although this yet again introduces a bias as patients with high risk events that do not present 
after TIA are not included, there is no reliable record taken prospectively after the initial TIA 
in such cases. Furthermore if one makes the assumption that such presentations are 
associated with a persistent lack of presentation to healthcare then there will not be an 
opportunity for a clinician to ‘miss’ the diagnosis of TIA prior to presentation with stroke. 
The care-seeking behaviour of patients in OXVASC who had a recurrent ischaemic stroke 
within 30 days of a TIA was used to identify those patients who presented to primary care 
but the diagnosis of TIA was not considered. Other referral routes from primary care were 
assessed to define ‘missed events’ in primary care.  
Data were available for all patients with ischaemic stroke after TIA, ascertained for the first 
eight years (2002 to 2010) of OXVASC.  
5.9.2  What is a ‘missed’ cerebrovascular event? 
A liberal definition of a missed event would include all patients who have had a delay in 
receiving optimal therapy because the diagnosis was not considered at the initial 
consultation. This could be for a number of reasons after presenting to primary care -   
1. The diagnosis was not considered and the patient had a recurrent stroke which 
resulted in further presentation to healthcare for investigation and treatment. 
2. The diagnosis was not considered until a later date before any recurrent events and 
then a referral was made for investigation and treatment. 
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3. The diagnosis was not considered but a referral was made to other specialist teams 
e.g. ophthalmology who then made the diagnosis and referred onwards for 
investigation and treatment. 
Out of the above patient groups, point 1 defines those patients who are likely to be at highest 
risk of recurrent stroke and also where primary care may have the greatest difficulty in 
making a diagnosis. Point 2 defines patients at lower risk as there are no recurrent events 
after initial presentation during any period of delay. Point 3 defines a group where GPs 
suspect that there is an underlying condition to diagnose but refer to an intermediary 
specialist who then either asks the GP to refer on for a TIA assessment or refers the patient 
directly without further involvement of primary care. This latter group requires an analysis of 
referral routes to TIA clinic and identification of those patients who arrived via an 
intermediary specialist. 
5.9.3  ‘Hidden TIA’ and prediction rule development 
Patients with TIA can be correctly recognised by a referring clinician yet have a recurrent 
stroke requiring hospitalisation before being assessed in a TIA clinic. In OXVASC, these 
patients are ascertained as a stroke, rather than a TIA. Therefore by restricting the derivation 
of decision rules to patients seen in clinic (not only in OXVASC but also in other centres 
such as Glasgow in the Dawson tool), this will reduce the assessment of true TIA cases 
referred by GPs as the total set of GP suspected TIA will be missing the patients with 
highest early risk. 
This creates an interesting bias as ideally the highest risk patients should be identified by a 
diagnostic or referral support tool but they did not appear in the Dawson derivation set by 
definition (as only clinic-seen patients were included) and have not been used in the 
derivation of decision rules above, partly to allow for a fair comparison with the Dawson tool.  
The incidence of these high risk cases was assessed to determine impact on clinic- based 
derivation datasets. 
5.9.4  Other missed opportunities – intermediary specialist referral 
Given that the effects of transient cerebral ischaemia will result in dysfunction of a regional 
part of the body associated with a particular area of brain or retina, it is perhaps unsurprising 
that GPs may refer to intermediary specialists (i.e. not TIA specialists). The referral will be 
based on the presumption that the affected body part is dysfunctional, rather than the 
controlling homuncular cortical area or retina. This may be more of a problem in patients with 
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visual symptoms which can be interpreted at first consultation as ocular in origin (due to 
lenticular, humoural or retinal disease).  
Bias could be introduced if such patients had recurrent strokes before being seen in a clinic, 
or if persisting non-disabling symptoms developed and in OXVASC (and in other clinic-
defined cohorts used for TIA diagnosis) were ascertained as a stroke rather than TIA. The 
extent to which intermediary specialist referral in OXVASC introduces a bias in using clinic-
defined TIA populations for diagnostic decision rules will be assessed by estimating the 
incidence of affected patients. 
5.10  Using missed TIA to assess diagnostic decision making - case vignette 
methods 
In order to examine whether the high risk TIA cases that were missed represent cases that 
GPs in general would find difficulty identifying as TIA, a study is required that tests decision 
making in clinical situations that, as far as possible, resemble the clinical situation that faced 
the GPs seeing these identified cases.  
Case vignettes are short case descriptions of key clinical features from history, examination 
and where relevant, investigations. They have been used to test GPs’ diagnostic ability (239-
242), the improvement in GPs’ diagnostic ability after training (243;244), GPs’ management 
of cardiovascular conditions (245-248) and perception of risk of events (249). Case vignettes 
have been validated as reflecting clinical decision making in clinical practice (250) and have 
been used across different clinical specialties for assessing the contributions of different 
variables to making diagnoses and management decisions (251-256). Furthermore, 
vignettes have been validated as an assessment of quality of care and also for measuring 
variation in clinical practice (257).  
Specifically,  vignettes have been used to investigate diagnostic error with the presentation 
of a single misleading detail (258). Varying the content of a single vignette has been used to 
understand the factors taken into account by clinicians when they make diagnostic errors in 
bipolar disorder (259). 
The literature review identified the key problems with current vignette evidence on TIA 
diagnosis in primary care; artificial histories potentially not reflecting real presentation to 
GPs, cases restricted to anterior circulation, lack of randomised order of questions for each 
participant and cueing that TIA is a diagnostic possibility which does not reflect the clinical 
decision making context at initial consultation in primary care. More importantly, it is crucial 
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that patients at highest risk of recurrence should be detected and then appropriately 
managed with urgent referral to specialist TIA services. 
5.11  TIA decision making – Rationale for GP trainees as participants 
I selected GP trainees to be the participants. After leaving GP training, fledgling GPs will no 
longer be taking part in a systematic educational programme and whilst learning will 
continue it will be on the basis of individual choice. Thus areas for study and review are 
chosen by individual GPs from taught courses, online learning modules and journal reading 
to comply with the requirements of revalidation. If the cases missed by practising GPs are 
also missed by GP trainees then this suggests that current post graduate education does not 
equip GPs to detect key TIA presentations. If GP trainees detect the missed TIA cases, then 
this argues that there may be an element of knowledge atrophy due to the infrequent nature 
of the condition at individual GP level. The solution to the problem of missed high risk TIA 
cases could therefore be altering post graduate education or an intervention to keep low 
prevalence but serious conditions in the minds of GPs. 
5.12 Research Questions 3, 4, and 5 - Questionnaire Design  
In order to test the diagnostic skill resulting from exposure to hospital-based clinical 
experience and educational programmes, I chose to base the vignettes on patients who 
sought care in general practice after TIA,  where TIA was not suspected by the GP, yet the 
patients went on to have a recurrent stroke within 30 days. These are patients who should 
not be missed in primary care as they are high risk but there may be difficulties in making the 
diagnosis. This answers the question of whether GP trainees fail to recognise high risk TIA 
cases that have been missed by established GPs? 
However, a pilot trial was needed in order to determine the key parameters of recruitment 
rate and completion rate of a questionnaire for GP trainees. There are no similar GP trainee 
surveys in the literature so the design parameters could not be estimated using published 
reports. These would be needed for a large scale trial to calculate power to detect 
differences in detection rates within matched pairs. This answers the question of recruitment 
and completion rates among GP trainees for a web based questionnaire survey. 
In order to examine potential reasons for the TIA cases to be missed, I selected a plausible 
hypothesis for each case and created a matched case where the only materially different 
factor was related to the hypothesis as to why the case was missed. A number of causes 
could be relevant but in order to create a matched pair I chose one that appeared to be most 
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likely. This answers the question of whether alteration of one parameter in a vignette affects 
recognition and management decisions. 
To prevent cueing of TIA, I created a questionnaire of ten vignettes with five TIA cases and 
five cases due to other pathologies that are prevalent within an elderly population. One of 
the cases was a non-dominant parietal TIA presenting as ‘confusion’ and the matched case 
was confusion without focal parietal features, i.e. not TIA. This enabled an equal number of 
TIA and non-TIA cases in the questionnaire. 
A questionnaire was created via the online tool, surveymonkey (www.surveymonkey.com) 
which allows for secure data collection and 24 hour access for participants to choose when 
to complete the study. The questions were randomised such that each time the weblink was 
accessed, a different order of questions was created for the survey.  
5.13 Study Design for Recognition of High Risk Missed TIA Using Vignettes 
The following design was approved by the University of Oxford Clinical Trials and Research 
Governance Service and submitted via the Integrated Research Application System (IRAS) 
for approval from the National Research Ethics Service (NRES) – REC reference 
11/EM/0252. 
 
Primary Objective:   
To assess the ability of GP trainees to appropriately manage high risk TIA   
Secondary Objectives:  
To assess the recruitment rate to an email invitation to a clinical vignette study 
To assess the completion rate of the full questionnaire of 10 vignettes. 
To examine the influence of clinical variables on recognition of TIA. 
To examine the perceived educational value of completing the questionnaire. 
Summary of Study Design 
Cross-sectional questionnaire study of responses to clinical vignettes. Participants will 
undertake one questionnaire and the responses to 10 vignettes will take 25 minutes to 
complete.  
Primary and Secondary Outcome Measures 
Primary outcome measure: 
1. % correct management decision to refer for a specialist TIA assessment for each 
case of TIA. This is the primary outcome as it is the key step in accessing effective 
73 
 
interventions for the patient. Even if the GP does not think that the diagnosis is 
likely, the decision to refer will enable rapid access to definitive risk reducing 
treatment.  
Secondary outcome measures:  
1. Recruitment rate (% of GP trainees invited who responded to the survey) 
2. Full completion rate (among those who completed the survey, % cases with full 
responses) 
3. % correct TIA diagnosis 
4. % cases where parameter change altered decision making in matched pairs of 
vignettes 
5. Self-rating of perceived educational value after being given feedback on 
performance 
Study Participants 
All GP trainees (ST1-4) in the Oxford deanery 
Study Procedures 
GP trainees will be emailed with an invitation to take part in a study of “common 
problems that occur in primary care”. They will be informed that this is part of a 
research study and that they will be given feedback on the group performance after 
completing the questionnaire. Their views on the educational value of the 
questionnaire and feedback will be sought.  
Informed Consent 
The email will state that their responses will be recorded anonymously via a web 
based survey as part of a research study and that they are under no obligation to start 
or complete the questionnaire. An information sheet giving further details about the 
study that is not contained within the invitation email will form the first web page of the 
questionnaire. A formal informed consent procedure will not be undertaken but 
consent will be implied by completing the questionnaire. 
Study Assessments 
A link to a secure website (hosted by www.surveymonkey.com) will contain 10 clinical 
case vignettes with free text response to the questions “What would you do next?” and 
“What do you think is the most likely diagnosis?”. The first question in the survey will 
simply ask which year of training the respondent is in (ST1-4) and whether they have 
undertaken any elderly medicine hospital training as a specialist trainee or foundation 
doctor. 
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A reminder email will be sent out two weeks after the initial email. 
 
After the responses have been entered and completed, a further email will be sent out 
with an explanation of the correct management for each case and at that point the 
trainees will be invited to rate the educational experience of the exercise by another 
link to a separate web-based survey where they will be asked to score the educational 
value from 1 (no value) to 5 (highest value) with a free text box to add any comment. 
Definition of End of Study  
The end of study is four weeks after the last email is sent out. 
Number of Participants 
A total of 54 GP trainees are in the Oxford deanery rotation and this is the total pool 
which will form the group to whom invitations to take part will be sent. 
 
Analysis of Endpoints  
As this is a pilot study to inform recruitment and completion rates, null hypotheses will 
not be tested. Descriptive statistics for the primary and secondary endpoints will be 
summarised by year of training (1 to 4) and by elderly medicine experience as a 
specialist trainee (dichotomised to yes/no). 
Ethics 
The main ethical consideration of the study concerns the initial invitation to the GP 
trainees. This study aims to test their ability to recognise TIA but if we were to inform 
them that this was the motivation for the study then their diagnostic ability would not be 
truly tested. Also, given that patients do not present with ‘clues’ as to their underlying 
diagnosis before they are assessed, real life decision making is tested by not alerting 
trainees to the true nature of the research question. As such I believe that not 
disclosing the research question is justified so that not only are trainees fairly 
assessed but also the training that they receive is fairly assessed as well. GP trainees 
are familiar with clinical vignettes in the exam situation where no hint is given as to the 
underlying diagnostic possibilities. 
Participant Confidentiality 
GP trainee identity will not be recorded in the clinical cases questionnaire or in the 
questionnaire of perceived educational value. All email invitations will be sent from a 
GP training Programme Director in Oxford, who has access to trainees’ email 
addresses as part of their routine work. 
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Chapter 6 Choice of Provider after TIA and minor stroke 
 
6.1  Introduction 
Clinical and demographic characteristics of the patients recruited into OXVASC after the first 
TIA or minor stroke occurring during the study period are presented along with the effects of 
the new GMS contract for primary care and timing of events on the choice of first provider of 
care. 
6.2 Characteristics of the Patients – does QoF influence coding of co-morbidities? 
Table 6.1 shows the numbers of patients with TIA and minor stroke in the first four years of 
OXVASC with basic demographics summarised by diagnostic group. 
Diagnosis TIA Minor stroke 
N 361 436 
Male n (%) 127 (43.5) 222 (50.9) 
Mean age (SD) 74.2 (12.2) 74.2 (12.0) 
Caucasian n (%) 326 (96.7)* 413 (94.7) 
Recurrent event n (%) 95 (26.3) 76 (17.4) 
Previous TIA n (%) 67 (18.6) 58 (13.4) 
Previous Stroke n (%) 48 (13.3) 75 (17.3) 
Previous myocardial infarct n (%) 44 (12.2) 53 (12.2) 
History of angina n (%) 62 (17.2) 63 (14.5) 
History of cardiac failure n (%) 38 (10.5) 43 (9.3) 
Previous peripheral vascular disease n (%) 22 (6.1) 39 (9.0) 
History of hypertension n (%) 186 (51.7) 250 (57.7) 
History of atrial fibrillation n (%) 64 (17.8) 74 (17.1) 
History of diabetes n (%) 38 (10.6) 48 (11.1) 
History of hypercholesterolaemia n (%) 115 (31.9) 99 (22.7) 
Never smoked n (%) 154 (44.0) 176 (40.6) 
Table 6.1 TIA and minor stroke patients ascertained in years 1 to 4 of OXVASC. *% 
calculated from denominator of 337 available TIA patients. 
The TIA and minor stroke patients are very similar in age, gender and ethnicity. 290 patients 
(38%) were aged >80. The prevalences of co-morbid vascular disease and traditional 
vascular risk factors are similar in both groups. However, the presence of such conditions 
and risk factors are obtained from patient report or GP records and represent baseline 
morbidity and risk from previous health service encounters either symptomatic or 
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opportunistic, rather than from the results of blood tests and cardiac or vessel imaging after 
recruitment to the study. As such there may be patients with co-existing risk factors or organ-
specific vascular disease that are not captured in the above table. 
Tables 6.2 and 6.3 show baseline characteristics for TIA and minor stroke patients 
respectively with data summarised for patients recruited in each contract time period. 
Contract  OLD NEW 
N 192 169 
Male n (%) 82 (42.7) 75 (44.4) 
Age mean(SD) 74.0 (12.5) 74.4 (12.0) 
Caucasian n (%) 177 (97.3)* 149 (96.1)* 
Recurrent n (%) 60 (31.3) 35 (20.7) 
Previous TIA n (%) 43 (22.4) 24 (14.2) 
Previous Stroke n (%) 29 (15.1) 19 (11.2) 
Previous myocardial infarction n (%) 26 (13.5) 18 (10.7) 
Angina n (%) 33 (17.2) 29 (17.2) 
Cardiac Failure n (%) 21 (10.9) 17 (10.1) 
Peripheral Vascular Disease n (%) 11 (5.7) 11 (6.5) 
Hypertension n (%) 104 (54.2) 82 (48.5) 
Atrial fibrillation n (%) 39 (20.3) 25 (14.8) 
Diabetes n (%) 20 (10.4) 18 (10.7) 
Hypercholesterolaemia n (%) 53 (27.6) 62 (36.7) 
Never Smoked n (%) 83 (43.2) 71 (42.0) 
Table 6.2 Prevalence of co-morbid cardiovascular conditions and risk factors among 
TIA patients across old and new contract time periods. *Data available from a total of 
337 patients across new and old contract periods. 
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Contract OLD NEW 
N 227 209 
Male n (%) 112 (49.3) 110 (52.6) 
Age mean(SD) 74.4 (11.6) 74.0 (12.4) 
Caucasian n (%) 213 (93.8) 200 (95.7) 
Recurrent n (%) 51 (22.5) 25 (12.0) 
Previous TIA n (%) 35 (15.4) 23 (11.0) 
Previous Stroke n (%) 51 (22.5) 24 (11.5) 
Previous myocardial infarction n (%) 32 (14.1) 21 (10.0) 
Angina n (%) 39 (17.2) 24 (11.5) 
Cardiac Failure n (%) 28 (12.3) 15 (7.2) 
Peripheral Vascular Disease n (%) 23 (10.1) 16 (7.7) 
Hypertension n (%) 126 (55.5) 124 (59.3) 
Atrial fibrillation n (%) 38 (16.7) 36 (17.2) 
Diabetes n (%) 28 (12.3) 20 (9.6) 
Hypercholesterolaemia n (%) 53 (23.3) 46 (22.0) 
Never smoked n (%) 103 (45.4) 73 (34.9) 
Table 6.3 Prevalence of co-morbid cardiovascular conditions and risk factors among 
minor stroke patients across old and new contract time periods 
There is no tendency evident for the prevalence of cardiovascular conditions or risk factors 
for stroke to increase in the new contract time period, indicating that there is no marked 
effect of QoF on the recording of risk factors or disease register conditions (although CKD is 
not included) in this population of patients. 
From the perspective of demographics and baseline co-morbidities I conclude that fair 
comparisons can be made between patients in the old and new contract time periods. 
6.3  Missing data and events occurring on holiday 
In order to test the effect of the GMS contract and GP opening hours in general on patients’ 
choice of provider and delay in calling them, I excluded 25 patients who had events whilst 
out of the UK and where therefore in an unfamiliar healthcare setting at the time of symptom 
onset. Their characteristics are summarised in table 6.4. 
There were no research records to analyse for 4 patients. What information there is on them 
is included in the demographic table for the total of 797 patients. 
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TIA 
Minor 
stroke 
N 12 13 
Age mean 66.6 69.0 
Previous TIA 0 1 
Previous Stroke 0 0 
Previous Myocardial infarction 0 1 
Previous angina 0 0 
Previous heart failure 0 0 
Peripheral vascular disease 0 0 
Previous hypercholesterolaemia 4 3 
Previous hypertension 3 7 
Atrial fibrillation 2 1 
Diabetes 0 2 
Ever smoked 3 8 
Table 6.4 Patients excluded due to event occurring outside the UK. 
Given that these patients had events on holiday they are likely to be more active than the 
general TIA/minor stroke population and as one would predict they have a lower mean age 
than the total population. They have very little established cardiovascular disease but risk 
factors are present.  
6.4  Provider choice in all TIA and minor stroke patients – GMS contract effects 
Table 6.5 shows the numbers (% within each contract time period) of patients whose first 
clinical assessment was either by primary care (registered GP or OOH GP), ED, mentioned 
whilst at another outpatient clinic or occurred whilst hospitalised for another reason, and by 
old and new contract time period. Z tests for the difference between two independent 
proportions were calculated for GP and ED attendances with two-tailed probabilities of type 
2 error in the old and new contract time periods (given the binomial requirement of n (p)>5 
and n(1-p) >5 were met, where n is the denominator for each patient pool in a given contract 
time period and p the proportion attending a given healthcare provider). The combined 
patient group of TIA and minor stroke is presented. 
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 Diagnosis TIA and minor stroke Z for 
comparison 
P for 
comparison  Contract OLD NEW 
Total n 
(%) 
attending 
provider 
GP  306 (75.0) 255 (70.8) 1.29 0.19 
ED 83 (20.3) 90 (25.0) -1.54 0.12 
Other Clinic 6 (1.4) 4 (1.1)   
In Patient 13(3.2) 11 (3.5)   
n (%)  
in-hours  
GP 164 (79.6) 137 (75.7) 0.93 0.35 
ED 31 (15.0) 34 (18.8) -0.098 0.33 
Other clinic 3 (1.5) 3(1.7)   
In Patient 8 (3.9) 7 (3.9)   
n (%)  
out-of-
hours 
GP 131 (70.8) 113(66.9) 0.80 0.42 
ED 49 (26.5) 55 (32.5) -1.25 0.21 
Other Clinic 2 (1.1) 0 (0)   
In Patient 3 (1.6) 1 (0.6)   
Table 6.5 Provider choice overall and by whether symptom onset was in hours or 
OOH and by contract time period 
The majority of patients with TIA and minor stroke seek healthcare from primary care. This 
was found overall within each contract time period and both for events with symptoms 
starting in the in hours period and in the OOH period. No statistically significant differences 
were found between the old contract and new contract time periods in the proportions of 
patients seeking healthcare via primary care or via ED.  
6.5 Provider Choice after TIA symptom onset – GMS contract effects 
Table 6.6 shows the numbers (% within each contract time period) of patients whose first 
clinical assessment was by primary care (either registered GP or OOH GP), ED, mentioned 
whilst at another outpatient clinic or occurred whilst hospitalised for another reason by old 
and new contract time period. Z tests for the difference between two independent 
proportions were calculated for GP and ED attendances with two-tailed probabilities of type 
2 error in the old and new contract time periods. 
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 Diagnosis TIA Z for 
comparison 
P for 
comparison  Contract OLD NEW 
Total n 
(%) 
attending 
provider 
GP  147 (78.6) 114 (70.8) 1.68 0.09 
ED 33 (17.6) 42 (26.1) -1.91 0.06 
Other Clinic 4 (2.1) 4 (2.5)   
In Patient 3 (1.6) 1 (0.6)   
n (%)  
in-hours  
GP 78 (84.8) 63 (71.6) 2.15 0.03 
ED 11 (12.0) 21 (23.9) -2.09 0.04 
Other clinic 1 (1.1) 3(3.4)   
In Patient 2 (2.2) 1 (1.1)   
n (%)  
out-of-
hours 
GP 63 (72.4) 49 (70.0) 0.33 0.74 
ED 21 (24.1) 21 (30.0) -0.83 0.41 
Other Clinic 2 (2.3) 0 (0)   
In Patient 1 (1.1) 0 (0)   
Table 6.6 Provider choice overall and by whether symptom onset was in hours or 
OOH and by contract time period 
The majority of patients with TIA sought healthcare from primary overall and ED was the first 
healthcare provider in 26.1% of patients under the new contract and for 17.6% of patients 
under the old contract. Although this increase was not statistically significant in the combined 
patient group of both in and out of hours onset of TIA symptoms, the sub group of patients 
with events occurring in hours did show statistically significant differences between the 
proportions of patients accessing care from primary care and from ED, with a move away 
from primary care attendance to ED attendance.  
6.6 Provider Choice after minor stroke symptom onset – GMS contract effects 
Table 6.7 shows the first healthcare provider assessment by contract time period and 
whether symptom onset was in hours or OOH for patients with minor stroke. Effect of the 
change in GMS contract was assessed with z tests and p values are two –tailed. 
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 Diagnosis Minor Stroke Z for 
comparison 
P for 
comparison  Contract OLD NEW 
Total n 
(%) 
attending 
provider 
GP  159 (71.9) 141 (70.9) 0.25 0.80 
ED 50 (22.6) 48 (24.1) -0.36 0.72 
Other Clinic 2 (0.9) 0 (0)   
In Patient 10 (4.5) 10 (5.0)   
n (%)  
in-hours  
GP 86 (75.4) 74 (79.6) -0.71 0.48 
ED 20 (17.5) 13 (14.0) 0.70 0.49 
Other clinic 2 (1.8) 0 (0)   
In Patient 6 (5.3) 6 (6.5)   
n (%)  
out-of-
hours 
GP 68 (69.4) 64 (64.6) 0.71 0.48 
ED 28 (28.6) 34 (34.3) -0.87 0.38 
Other Clinic 0 (0) 0 (0)   
In Patient 2 (2.0) 1 (1.0)   
Table 6.7 Provider choice overall and by whether symptom onset was in hours or 
OOH and by contract time period 
Again the majority of patients with minor stroke seek healthcare from primary care in the first 
instance overall and in both the in hours and OOH period. There was no effect of the change 
in GMS contract in proportions of patients within each contract period and time period 
seeking healthcare from either ED or primary care.  
6.7 Use of Primary Care OOH and the GMS Contract 
Given that the majority of patients seek healthcare from primary care after TIA or minor 
stroke and that there is a need to reduce delays to specialist assessment after symptom 
onset, it is of interest to determine the extent to which primary care is used in the OOH 
period and if this was affected by the GMS contract.  
This analysis was restricted to patients who had events in the OOH period and chose 
primary care as their first provider for medical assessment. Of the 244 patients (131 under 
the old contract, 113 under the new contract) a higher proportion of patients used an on call 
GP after an event OOH under the new contract (20.3% vs 32.4 %, 95% confidence interval 
of difference = 8.7 – 23.2%, p=0.034). 
Thus rather than acting as a barrier to accessing healthcare out of hours, there is suggestive 
evidence that the provision of a dedicated OOH provider, rather than members of the 
daytime surgery team working overnight and at weekends, has increased OOH access to 
primary care, at least after symptoms of TIA and minor stroke. 
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6.8 NHS Direct 
Ten patients called NHS direct over the four year period with variable advice including going 
directly to ED as well as seeking a routine GP appointment. They are included in the medical 
provider group in which they first sought care but as a proportion of all cases it is not a 
significant first contact point for advice after the symptom onset of TIA or minor stroke. 
6.9 Demographic Correlates of Provider Choices – Effect of the GMS contract 
Table 6.8 summarises numbers and % of patients with that categorical feature present 
attending either GP or ED for events occurring in hours and OOH, separated by new or old 
contract time periods. Continuous variables of age and Integrated Measure of Deprivation 
2004 (IMD) score are summarised with mean and standard deviation. The majority of 
patients first seek healthcare from primary care and there is no clear demographic subgroup 
where this is reversed. Similarly no pattern of age or IMD appears to correlate with provider 
choice. This general finding of greater primary care use irrespective of age, deprivation, 
being alone at time of onset, correct recognition of cerebrovascular aetiology of symptoms, 
place of residence and previous experience of cerebrovascular disease was seen in both 
new and old contract time periods. Hence the alteration in GP service terms as a result of 
the new contract has not altered patient choices for provider provision after TIA/minor stroke 
within the categories assessed. 
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CONTRACT OLD NEW 
PROVIDER GP ED GP ED 
OOH 
INCIDENT 91 (66.4) 42 (30.7) 85 (58.2) 60 (41.1) 
RECURRENT 31 (64.6) 16 (33.3) 15 (65.2) 7 (30.4) 
ALONE 30 (56.6) 23 (43.4) 23 (54.8) 19 (45.2) 
NOT ALONE 87 (69.0) 35 (27.8) 72 (61.0) 45 (38.1) 
TIA suspected 41 (66.1) 20 (32.3) 47 (77.0) 14 (23.0) 
OWN HOME 100 (67.1) 46 (30.9) 86 (61.0) 54 (38.3) 
WARDEN 3 (42.9) 3 (42.9) 2 (40.0) 3 (60.0) 
CARE HOME 3 (75) 1 (25) 1 (50) 1 (50) 
AGE 72.2 (12.1) 73.6 (14.1) 74.3 (11.4) 72.4 (11.3) 
IMD Score 8.83 (6.14) 9.25 (6.45) 9.72 (6.66) 8.36 (5.07) 
IN 
HOURS 
INCIDENT 103 (70.0) 39 (26.5) 90 (61.6) 52 (35.6) 
RECURRENT 36 (62.1) 21 (36.2) 27 (77.1) 7 (20.0) 
ALONE 32 (66.7) 16 (33.3) 23 (54.8) 19 (45.2) 
NOT ALONE 99 (66.4) 44 (29.5) 83 (67.5) 36 (29.3) 
TIA suspected 49 (77.8) 14 (22.2) 40 (67.8) 18 (30.5) 
OWN HOME 107 (65.6) 51 (30.7) 91 (64.1) 47 (33.1) 
WARDEN 5 (62.5) 3 (37.5) 3 (33.3) 6 (66.7) 
CARE HOME 3 (75.0) 1 (25.0) 4 (66.7) 1 (16.7) 
AGE 75.7 (10.7) 77.9 (12.4) 74.7 (11.7) 77.7 (14.5) 
IMD Score 8.83 (5.56) 8.91 (5.65) 9.20 (6.26) 9.42 (4.61) 
Table 6.8 n (%) for categorical variables, mean (SD) for continuous variables of age 
and IMD score for patients choosing GP or ED in hours and OOH, separated by 
contract time period. 
6.10 Symptoms and Provider Choice 
Table 6.9 summarises the proportion of patients with each symptom who choose either GP 
or ED for their first healthcare contact after symptom onset, separated by contract time 
period. Again the majority of patients initially attend primary care. 
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SYMPTOM Presence 
OLD NEW 
GP ED GP ED 
Motor 
Y 153 (64.6) 46 (31.2) 113 (58.9) 76 (39.6) 
N 122 (67.0) 74 (25.2) 117 (62.9) 53 (28.5) 
Sensory 
Y 84 (77.8) 22 (20.3) 79 (78.2) 22 (21.8) 
N 191 (61.4) 98 (31.5) 151 (54.5) 107 (38.6) 
Speech 
Y 108 (60.3) 63 (35.2) 87 (54.7) 68 (42.8) 
N 167 (69.6) 57 (23.8) 143 (65.3) 61 (27.9) 
Vision 
Y 50 (65.8) 17 (22.4) 54 (62.1) 21 (24.1) 
N 225 (65.6) 103 (30.0) 176 (60.5) 108 (37.1) 
Table 6.9 n (%) of patients with symptoms choosing GP or ED in each contract time 
period 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
85 
 
Chapter 7 Delay in seeking care after TIA and minor stroke 
7.1 Time to call for help – Evidence for combining contract time periods 
For patients seeking care in primary care after events in hours, median (IQR) time to call 
under the old contract compared with the new contract was 4.67 hrs (44.8) vs 3.0 hrs (46.0) 
Mann Witney test z = -0.017 P=0.99. For patients seeking care in primary care after events 
out of hours,  median (IQR) time to call under the old contract compared with the new 
contract was 13.0 hrs (40.5) vs 10.5 hrs (41.5) Mann Whitney test z = -0.60, P=0.55. Delay 
to call primary care has not been influenced by the change in GMS contract. The effect of 
GP opening hours per se will therefore be analysed for the combined old and new contract 
time periods. 
A similar analysis for patients who sought  medical attention in secondary care showed no 
significant difference between the two contract time periods with median (IQR) time to call 
for help under the old contract of 0.75 hrs (2.92) vs 0.71 hrs (2.46) under the new contract, 
Mann Whitney test z = -0.38, P = 0.70. 
7.2 Time to call for help – Combining Incident Events with Recurrent Events 
Median (IQR) time to call for medical attention for patients with incident events was 3.5 hrs 
(24.6) and for patients with recurrent events was 3.2 hrs (26.3), Mann Whitney test z = -0.16, 
P = 0.87. 
Given that there is no statistically significant difference between these groups of patients, 
patients with incident and recurrent events will be analysed together. 
7.3 Time to call for help - Primary vs Secondary Care, Deprivation and Clinical 
Features 
Delay data were available in 721 patients (94% of the 768 included in the analysis of 
provider choice). Of these, the imputation methods for calculating delay were required in 63 
patients (8.7 % of the delay data). Combining new and old contract time periods, there were 
remarkable differences in the times to call for medical attention between those seeking care 
from primary care and those from secondary care. Including all events, the median (IQR) 
time to call for help from primary care was 11.0 hrs (46.0) and from ED was 1.0 hrs (4.0), 
Mann Whitney test z = 9.17, P<0.001. 
Table 7.1 shows the times to call for medical attention by deprivation quartile and by clinical 
features.  
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Grouping  Median (IQR) hours p for comparison 
DEPRIVATION Mean (SD) IMD 
Score 
Least deprived Q1 3.6 (2.7)  5.1 (28.1) 0.19 
Q2 6.2 (0.7) 5.3 (31.3) 
Q3 10.0 (1.5) 6.1 (33.5) 
Most deprived Q4 17.0 (5.1) 7.5 (42.0) 
CLINICAL FEATURES   
Motor symptoms Present 2.1 (20.1) < 0.001 
Absent 9.0 (43.8) 
Sensory symptoms Present 7.5 (37.2) 0.12 
Absent 2.8 (24.5) 
Visual disturbance Present 12.5 (44.0) < 0.001 
Absent 3.0 (24.3) 
Speech disturbance Present 2.5 (19.9) 0.002 
Absent 6.1 (41.2) 
Table 7.1 Median (IQR) delay to call for medical assistance by deprivation quartile and 
by presence of clinical features (as recorded in secondary care) 
There was no significant effect of deprivation on time to call for help but significantly quicker 
times to call for medical help were found for the presence of motor symptoms and speech 
symptoms. Visual symptoms were associated with a significantly longer time to call for help 
and sensory symptoms were associated with a non-significantly longer time to call.  
7.4 Time to call for help – Influence of GP Opening Hours 
In order to assess the effect of opening hours on delay to calling for help, events were 
classified according to whether symptom onset occurred during the GP routine hours of 
opening as defined by the contract period (i.e. including Saturday morning hours of onset for 
patients with events during the old contract).  
For patients choosing primary care as their provider, median (IQR) time to call for help for 
events during opening hours was 4.0 hours (44.5) and for events in the OOH period was 
12.0 hrs (41.0), Mann Whitney test z = -2.48, P = 0.01. 
Thus patients with events out of hours are waiting significantly longer to contact primary 
care. However, patients using primary care have a choice of access for out of hours events – 
either waiting to contact their registered practice or contacting the OOH provider. Those 
seeking help from primary care during the OOH period (28% of those seeking attention from 
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primary care after symptom onset out of hours) did so with a median (IQR) delay of 1.0 hrs 
(2.46) compared with those who waited until their registered practice was open who had a 
median delay of 24.8 hrs (48.5), Mann Whitney test z = -9.60, P <0.001. 
Conversely there was no effect of event timing for delay in patients seeking care from the 
ED. Median (IQR) delay to call after events in hours was 0.73 hrs (1.63) and out of hours 
0.91 hrs (2.35) hours, Mann Whitney test P=0.751. 
 
7.5 Pattern of Calling for Help – Opening Hours Influence 
 
GP opening hours appear to have a greater influence on delay to call rather than the choice 
of provider, particularly for events occurring when practices are closed. In order to assess 
the precise influence of opening hours, the pattern of calling for help is required. If  opening 
hours were truly a significant determinant of healthcare seeking behaviour, patients would 
call at the first available opportunity when the practice reopens. If patients who had waited to 
call did so without a particular urgency i.e. at random points after practices had re-opened 
then it is harder to argue that opening hours per se are having a significant influence on the 
length of time between symptom onset and initiating a healthcare system response. 
Figure 7.1 shows the length of time between the onset of symptoms and the time of the call 
to primary care for the first 72 hours of call delays, in the group of patients who had events in 
the out of hours period but waited until their practice was open before making contact with 
primary care. 
Patients with events on Monday to Thursday overnight and on Sunday overnight show a 
delay to call that appears to decrease linearly as time of symptom onset approaches the 
earliest time that the practice is open i.e. 08:00 in the morning. Similarly patients with events 
during the day on Sunday wait longer and those on Saturday wait longer still.  
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In order to investigate why the scattergram in figure 7.1 appears to demonstrate a simple 
relationship between length of delay and time of symptom onset, the distribution of times that 
patients called the surgery are presented in figure 7.2. It demonstrates that the vast majority 
of patients are indeed calling at the very first opportunity in the morning when the practice re-
opens. 
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Figure 7.1 Delay in calling regular GP after TIA/Minor stroke occurring out of hours 
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This suggests that GP opening hours are a very significant determinant of patients’ 
healthcare seeking behaviour after TIA or minor stroke. Those who choose to seek medical 
attention from primary care after events in the OOH period and wait to do so at their 
registered practice, call at the earliest opportunity. Patients may well know that they have a 
problem that requires medical attention and the fact that the delay to call is dependent on 
opening hours suggests that this is a barrier to meeting Department of Health Stroke 
Strategy Targets for specialist assessment. 
7.6 Early Recurrent Strokes – Do GP Opening hours contribute? 
Of all the patients with major stroke who were ascertained in OXVASC from 2002 to 2006, 
37 had a previous TIA or minor stroke for which they did not seek medical attention. Of 
these, 13 had a TIA or MIS in the OOH period and a recurrent stroke occurring before 
practice reopening. 
. Of the 13 patients with TIA and minor stroke occurring OOH, five had a TIA or minor stroke 
in the extra period of opening hours that a ‘Darzi centre’ would offer. Thus five strokes 
Time of Call to GP Practice 
18-18.30 16-18 14-16 12-14 10-12 8-10 
120 
100 
80 
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Figure 7.2 Number of Patients Calling Their Registered GP Practice After An Out- 
of-Hours Event by Time of Call 
Number of Patients 
90 
 
occurred in a population base of 91,000 people that may have been prevented by extending 
opening hours as long as urgent treatment and assessment could be arranged in secondary 
care. 
7.7 Pattern of calling for help – In Hours Events 
The distribution of delays in calling for help after events that occur when practices are open 
is informative. Although the above analysis demonstrates that for patients seeking care from 
general practice, opening hours clearly influence behaviour for events out of hours, the 
relationship does not appear to be the same for in hours events. Figure 7.3 demonstrates 
the distribution for the first 72 hours of delays in seeking medical attention from general 
practice after in hours events. There is a more diffuse spread of delays with gaps occurring 
due to practice closure. Not all patients take the earliest opportunity to call for help and some 
wait until the following day or day after that, even though there is ample opportunity to 
request care from general practice. 
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Figure 7.3 Delay in calling GP after TIA/Minor Stroke occurring in-hours 
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Chapter 8 Missed TIA in Primary Care 
8.1 Introduction 
One outcome of the initial interface with the healthcare system after TIA is that the diagnosis 
may be missed by the treating clinician. This chapter will present an analysis of high risk TIA 
cases missed in primary care. Derivation datasets for diagnostic prediction rules based on 
clinic-referred patients are subject to a bias in that they do not contain missed TIA cases, as 
they are not referred from primary care. Furthermore, the implementation of diagnostic 
prediction rules will not automatically improve recognition of missed TIA as the clinician who 
first interprets the patients’ narrative needs to suspect the diagnosis in order to use a 
diagnostic rule. 
The patients that are included in the analysis below are those who had a recurrent stroke 
within 30 days of a TIA but presented to medical attention in the time window after TIA and 
before the recurrent stroke. Using clinical features of missed high risk cases i.e. associated 
with early recurrent stroke, a pilot vignette study in GP trainees was developed and 
implemented to ascertain the design parameters for a definitive larger study of recognition of 
high risk TIA cases.  
8.2 Recurrent Stroke after TIA in OXVASC 
Data were available for all patients with ischaemic stroke after TIA, ascertained for the first 
eight years (2002 to 2010). A time to recurrent event of ≤ 30 days after TIA was chosen 
because it could be argued that some presentations, if atypical, are less likely to represent a 
high risk TIA if the recurrent stroke occurs beyond this time window. There were 159 patients 
with TIA and a recurrent stroke ≤ 30 days in the first eight years of OXVASC. Their data is 
summarised in table 8.1. 
The two patients who did not have a diagnosis of TIA but were referred to another specialist, 
were both referred to ophthalmology and had recurrent posterior circulation strokes with 
ophthalmic symptoms as part of their TIA presentation. Five patients were diagnosed but not 
referred, either because the GP escalated pre-existing vascular risk reduction medication or 
because treatment was deemed futile in the face of pre-existing advanced chronic disease 
(e.g. dementia, terminal cancer). 
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Total Number with stroke at ≤ 30 days 159 
No medical attention before recurrent stroke 60  
Medical attention before 
recurrent stroke 
First presentation to A&E 27 
First presentation to GP 45 
Event whilst in patient 9 
Notes unavailable 17 
Outcomes in those first 
presenting to GP 
Diagnosis of TIA - Referral to TIA 
clinic/admit 
31 
No diagnosis of TIA - Referral to other 
specialist 
2 
Diagnosis of TIA  - No referral 5 
No diagnosis of TIA - No referral 8 
Table 8.1 Numbers of patients with stroke ≤ 30 days after TIA accessing healthcare 
through different routes 
Eight patients with early recurrent stroke were seen in primary care after a transient event 
which was not considered to be TIA by the treating GP, but these events were deemed to be 
TIA by a senior neurologist (Professor Peter Rothwell, after reviewing the primary care 
records and the subsequent history taken in secondary care). These eight patients therefore 
did not have investigations or specialist assessment and went on to have a recurrent stroke 
within 30 days of TIA. Of these, seven records had sufficient detail to be used to construct a 
case vignette to examine the decision making of GPs in training when confronted with that 
particular clinical presentation. 17 records were not available to analyse, and there may be 
more patients seen in primary care where the presenting high risk TIA was not diagnosed. 
8.3 ‘Hidden TIA’ and prediction rule development 
High risk patients correctly identified in primary care with TIA who are referred but have a 
recurrent stroke before being seen in clinic are ascertained as a stroke in OXVASC. They 
are not missed, but can be considered ‘hidden’ from prediction rule derivation as such cases 
do not appear in TIA clinic derivation datasets. However, the numbers are small when taken 
annually (31 over 8 years, approximately 4 per year). The clinical features of these patients 
with TIA will require further study, to find out if they would be identified by existing decision 
rules as a TIA, and also identified as high risk. 
8.4 Other missed opportunities – intermediary specialist referral 
Detailed referral data were collected from the first four years of OXVASC and including all 
TIA and minor stroke (797 patients in total). There were 15 patients who had an intermediary 
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specialist referral after presentation to primary care, 14 patients were referred to 
ophthalmology and 1 referred to cardiology. Of the 14 sent to ophthalmology, 6 had 
amaurosis fugax, 4 had posterior circulation TIA and 4 had posterior circulation stroke. 
Table 8.1 shows intermediary referral for the patients with recurrent stroke and it has a 
relatively small contribution to delay to specialist assessment - two cases in the eight year 
dataset that had an early recurrent stroke. 
8.5 Development of case vignettes for assessing diagnosis 
In seven of the high risk TIAs missed in primary care, sufficient detail was present in the 
record of the GP consultation to be used to construct a vignette. In each of the cases in 
Appendix 3 I have suggested a hypothesis concerning one aspect of context or clinical 
feature which may influence decision making, and hence variation in the identified parameter 
can be used to construct alternative cases. 
The cases appear to be mainly from anterior circulation symptoms with one involving the 
posterior circulation. The anterior cases are either transient weakness/sensory loss or 
speech disturbance together with some element in the history that has steered the GP away 
from a vascular cause, or a higher function TIA reflecting dysfunction in parietal cortex, 
rather than the M1, S1 or speech cortical area dysfunctions (which produce the ‘classical’ 
TIA picture). 
8.6 Distractor cases and questionnaire content 
In order to reduce the chance that participants in the TIA recognition study from case 
vignettes would be cued to TIA diagnosis, I created distractor cases of commonly presenting 
conditions in the elderly. One of the distractor cases acts as the paired case for TIA to test 
whether the presence of a focal feature to a non-focal presentation alters management. The 
cases are in Appendix 3. 
8.7 Questionnaire Content  
In order to create a questionnaire that was feasible in length and had a TIA prevalence of not 
more than 50% of questions to avoid cueing, ten vignettes were selected. Three TIA cases 
along with their alternative hypothesis driven vignettes were included. Firstly, an anterior 
circulation TIA during correction of hyperglycaemia (Appendix 3, case 2 matched with similar 
symptoms during persistent hyperglycaemia), a posterior circulation TIA from the history of a 
carer but denied by the patient (Appendix 3, case 4 matched with similar symptoms with 
both carer and patient in agreement) and a further anterior circulation TIA of dressing 
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apraxia presenting as confusion (Appendix 3, case 3 matched with a non-TIA case of 
confusion alone). The remaining four distractor cases were added.  
In response to reading the vignettes, the key questions to answer are ‘What are you going to 
do now?’ and ‘What do you think is the most likely diagnosis?’. The former is more important 
as there are a number of reasons for referral and ‘rule out’ of an important but unlikely 
condition is part of the function of primary care. Thus a GP could think that TIA is not the 
most likely diagnosis, yet feel that a specialist opinion from a TIA clinic would be beneficial, 
given the sequelae of failing to diagnose TIA and control vascular risk. More strokes will be 
prevented from referral of true TIA that GPs think is unlikely and hence the most important 
outcome of a clinical encounter after TIA is referral to a TIA clinic, even if the GP does not 
suspect the condition particularly strongly.  
Free text responses were given so that respondents to the questionnaire could write as 
much as they wished and so that diagnostic choices were not constrained. Two academic 
GPs in the Department of Primary Care Health Sciences took the questionnaire and a time 
of 25 minutes for completion was feasible.  
The questions were presented in randomised order to each respondent via ‘surveymonkey’ 
web hosting via the link https://www.surveymonkey.com/s/DNS6K2N. The questionnaire 
invitation emails to trainee GPs, front sheet for study details and questionnaire content are in 
the appendix. 
8.8 Response and completion rate 
The design of a large scale national assessment of GP trainees’ response to vignettes of 
missed TIAs will require an estimate of response rate to an invitation to participate as well as 
the completion rate of all questions. Given the randomised order of questions, the fraction of 
fully completed questionnaires is important as the completion of matched pairs to ascertain if 
certain parameters are associated with failure to recognise TIA may rely on fully completed 
questionnaires. 
Of 54 GP trainees in the Oxford specialist GP training scheme, a total of 19 started the 
questionnaire, giving a response rate of 35%. A reminder email was sent out two weeks after 
the initial invitation to take part in the questionnaire, which resulted in two additional 
responses. Thus the majority of responses were initiated after the first email invitation with 
little effect of the reminder email. The inference is that those who did not start the 
questionnaire did not simply forget to respond after the initial invitation. 
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Of the 19 trainees responding, 11 completed the questionnaire in full, giving a completion 
rate of 58% for those starting the questionnaire. Three respondents (16%) clicked on the link 
but did not respond to any vignettes. 
8.9 Demographic of Respondents 
Table 8.2 gives the breakdown in the respondents of the year of training and the last 
recognised training post in elderly medicine. Owing to concerns about confidentiality of 
responses, sex and years since qualification were not collected. 
YEAR OF 
TRAINING 
Most recent training post in elderly medicine  
None F1 F2 ST1 ST2 TOTAL 
ST1 1 2 1 0 0 4 
ST2 1 1 1 0 0 3 
ST3 4 1 2 2 1 10 
ST4 0 2 0 0 0 2 
TOTAL 6 6 4 2 1 19 
Table 8.2 Respondents by year of training and most recent training post in elderly 
medicine 
 
8.10 Responses to vignettes – TIA diagnosis 
 
Six paired questions tested the influence of alteration of one clinical parameter on 
recognition of TIA, as well as if the GP trainees would also recognise TIA in the cases that 
had been missed in primary care. 
 
 
Case (parameter changed) All respondents Respondents answering 
both cases 
Case 1 (hyperglycaemia correction) 
Matched case 
2/13 1/11 
7/12 6/11 
Case 2 (patient/carer disagreement) 
Matched case 
7/11 8/11 
10/12 9/11 
Case 3 (dressing apraxia) 
Matched case 
4/15 3/11 
1/12 1/11 
Table 8.3 TIA diagnosis (n/N responding) in cases (originally missed in primary care) 
and in matched cases generated by altering one parameter 
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Table 8.3 shows that TIA was diagnosed by a greater proportion of the trainees when 
symptoms where associated with persistent hyperglycaemia than corrected hyperglycaemia. 
There was almost equivalent diagnosis of TIA irrespective of whether the patient and carer 
agreed on the presence of symptoms and a smaller proportion of trainees diagnosed TIA 
when there was confusion alone rather than confusion and dressing apraxia. 
 
8.11 Response to vignettes – management 
 
Case (parameter changed) All respondents Respondents answering 
both cases 
Case 1 (hyperglycaemia correction) 
Matched case 
3/13 2/11 
6/12 4/11 
Case 2 (patient/carer disagreement) 
Matched case 
7/11 8/11 
8/12 8/11 
Case 3 (dressing apraxia) 
Matched case 
4/15 3/11 
1/12 2/11 
Table 8.4 Specialist referral (n/N responding) in cases (originally missed in primary 
care) and in matched cases generated by altering one parameter 
 
Table 8.4 shows the numbers of trainees that would refer either to a TIA clinic or acutely for 
further management. There are less marked differences in proportions of trainees referring 
patients as a result of alteration of vignette parameters, compared with Table 8.3.   
 
 
8.12 Vignette responses - diagnosis of TIA and referral for investigation 
 
Total number of TIA diagnoses 30 
Decisions to refer after TIA diagnosis 25 
Failure to refer after TIA 
diagnosis 
No. of trainees not referring 
in 2 cases 
2 
No. of trainees not referring 
in 1 case 
1 
Table 8.5 Decisions to refer after TIA diagnosis. 
 
Table 8.5 shows the conversion from TIA diagnosis to referral. Referral was recommended 
in 25/30 diagnoses (83%). Two trainees did not recommend referral after making a TIA 
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diagnosis on two occasions, and one trainee did not recommend referral after one TIA 
diagnosis.  
 
8.13 Feedback from respondents 
 
After a four week period of availability of the internet survey, a summary of the rationale for 
the study, aggregated group performance and invitation to give feedback about the study 
utility for personal learning was sent to the whole group of GP trainees. In order to maintain 
confidentiality of responses, the email addresses of those responding were not recorded and 
so feedback could only be sent to the group of initial invitees. 
 
2/19 responded to the feedback questionnaire. Both respondents found answering the 
vignettes useful but found being given the aggregated group performance more useful. Free 
text comments in general were invited, and one respondent replied saying that the questions 
appeared very similar and that they were not sure if giving similar answers was right. 
However, this respondent found the feedback about the cases very useful. 
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Chapter 9 Summary and Conclusions 
9.1 Healthcare-seeking behaviour after TIA and minor stroke – primary care 
structure, delivery and future research 
9.1.1 Influences on healthcare access after TIA or minor stroke 
Healthcare access after TIA or minor stroke is influenced by choice of healthcare provider, 
time of symptom onset and clinical features of the event but not by deprivation or previous 
history of cerebrovascular disease. The choice of ED or GP was associated with substantial 
differences in median delay to access medical care. Patients seeking care from general 
practice have a median delay that is around three hours greater that those seeking care from 
ED. Furthermore the delay in care seeking for those with events out of hours is substantially 
greater than for those seeking care after events in hours, but only for patients who first seek 
care in general practice. 
Anterior circulation symptoms of speech and unilateral weakness were associated with 
shorter delays to call for medical attention than patients with visual deficit or sensory 
disturbance which has been noted before (82) and interviews with the general public have 
identified that visual symptoms are least likely to prompt an urgent response (85).  
There was no influence of deprivation on median delay as assessed in quartiles of postcode 
deprivation scores unlike previous stroke studies which found lower social position to 
increase delay in accessing healthcare (71). This could be due to a low median IMD score in 
the most deprived group in OXVASC (17 points) compared with the most deprived scores in 
England of over 40.  
The majority of demographic variables were not distributed differently between those 
patients seeking care from GPs and those seeking care from ED. Deprivation, and degree of 
dependency in the community as assessed by class of residency did not appear to influence 
where patients sought care. Fewer patients who were alone at the time of onset sought care 
from GPs in the out of hours period but the in hours period showed similar proportions of 
patients seeking care irrespective of the presence of bystanders. This is particularly relevant 
for delay given the impact that ‘bystanders’ can have on delay to seeking care (76) although 
no significant differences were found in times to call for medical attention between those who 
were and were not alone. 
Timing of events in the 24 hour cycle with respect to opening hours of routine services and 
use of different healthcare providers has not previously been examined for patients with TIA 
and minor stroke. Although calendar day of event and day of seeking care has been 
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examined in a combined group of routine NHS and OXVASC patients (43), delay as a 
continuous variable has not been previously reported in OXVASC after TIA and has been 
mainly reported in cohorts of stroke patients particularly in relation to opportunities for 
thrombolysis (71;75;78) with few studies including patients with TIA (82).  
The importance of practice opening hours in influencing care seeking behaviour is shown 
most simply by the scattergram of time from symptom onset to calling for medical attention 
against time of day of onset for those with events out of hours who seek care from general 
practice. Given that patients seeking care in general practice with events occurring in the out 
of hours period wait until the earliest opportunity to call for help, the practice opening hours 
are influencing their care seeking behaviour. Also, some patients seek care in the days after 
their TIA and the gaps on the scattergram for those with events in hours correspond to times 
of closure of the practice. There are no comparable studies which have investigated how 
practice opening hours influence care seeking behaviour for patients with TIA in other 
healthcare settings. 
9.1.2 The influence of the GMS contract on healthcare access after TIA or minor stroke 
The change in general practitioner contract has had a small and positive influence on 
healthcare access after TIA and minor stroke. The new contract has not affected the 
perception for both in and out of hours events that primary care is the first point of interaction 
with healthcare services. Although there was much media speculation about how the change 
in access to registered practices overnight and at weekends would alter availability of 
primary care, the use of primary care in the out of hours period actually increased after the 
introduction of the new contract in the OXVASC patients. This suggests that patients have 
fewer barriers to seeking an opinion from primary care out of hours than before the 
introduction of the contract. 
9.1.3 Limitations of this analysis 
Call time data were not available for all patients and where there was sufficient evidence call 
time data were imputed using the methods in Chapter 5. However, only a small proportion of 
the data were imputed and their exclusion from the dataset did not affect the magnitude of 
the difference between groups.  Also, it could be argued that there may be potential recall 
bias and recording bias for digit preferences of times to call and onset times which will create 
a distribution of call times that are not smoothly continuous. However, patients were seen 
rapidly after their events when data were recorded and this methodology is similar to those 
of other reports of delays in seeking care for the stroke cohorts identified from acute hospital 
admissions. 
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No multivariable modelling of all potentially relevant factors was carried out on the OXVASC 
data. Specific hypotheses were tested over deprivation, clinical features and service 
availability, so the potential interaction between variables has not been assessed. It could be 
argued that a complete understanding of the causes of delay requires knowledge of how 
these variables interact. The importance of the route to accessing healthcare in determining 
delay was demonstrated in one study which showed that on multivariable analysis, the only 
factors which remained as predictive of delay after stroke were choice of provider and 
bystander response (78). However, the variables chosen in this analysis have been pre-
selected from rational hypotheses of causation of delay rather than from in depth interviews 
with patients who are able to describe why they may have acted as they did. Even if a 
complex pattern of interacting variables could be determined it would not be clear how that 
could be used to inform educational messages for the public or for patients determined to be 
at high risk of stroke or TIA. 
9.1.4 Future research and practice 
The importance of delay during the out of hours period was seen in the OXVASC cohort with 
a number of recurrent strokes observed where patients had events in the OOH period and 
did not have an opportunity to seek care from registered general practices. A small number 
of these occurred during times that newer primary care service models would have been 
open but the protective effect of vascular risk reduction after TIA/minor stroke requires 
urgent treatment and therefore secondary care capacity would need to be able to meet 
demand from seven day general practice if extended hours were to contribute to reducing 
the burden of stroke. 
Public education policies have failed in as much as patients who correctly identify symptoms 
mainly attend primary care, even when they know they may have to wait after events in the 
OOH period. Similarly prior experience of a cerebrovascular event (patients with recurrent 
rather than lifetime incident events) does not lead to the majority of patients seeking care 
from ED, indicating that any previously received education about how to respond to recurrent 
events during previous episodes of care are not effective. 
Although other patients in Oxfordshire identified by referral to NHS TIA clinics also attend 
initially in primary care (43), this may be a UK phenomenon as an international healthcare 
seeking behaviour comparison for presentation after TIA found that most patients with TIA in 
Canada attend ED (141).   
A qualitative analysis of delay after TIA or minor stroke would inform why there are the 
observed associations of delay with clinical factors and service delivery factors. 
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Understanding delay after the onset of symptoms of myocardial infarction has been explored 
with qualitative analysis of patients and their partners’ experiences of decision making (260-
262) as well as in mixed methods studies categorising patterns of responses and predictors 
of those responses (263). The qualitative stroke literature is smaller by comparison 
(264;265) and with no reports of qualitative analyses of delay after TIA. The quantitative 
findings in this thesis could inform the sampling of a qualitative study to include patients with 
events out of hours who sought care in primary care using on call services and those waiting 
until their practice re-opened. The quantitative analysis could be repeated with a later cohort, 
as the most recently recruited patients were from six years ago, to investigate whether 
patterns of consulting have changed with time. 
Thus, one of the key determinants of healthcare seeking behaviour after TIA or minor stroke 
is related to time of onset of symptoms and the availability of different parts of the healthcare 
system, particularly the most familiar setting where patients seek care. These factors have 
not been explored in detail in existing studies of delay after TIA or stroke and there is little 
qualitative work to inform education around how to recognise and respond to symptoms of 
TIA or minor stroke. Nevertheless, this thesis has identified an important aspect of primary 
care’s contribution to delay in specialist assessment after TIA and stroke – most patients 
choose to be seen first in primary care and the structure and delivery of primary care results 
in some patients being subject to long delays in a potentially high risk window for recurrent 
stroke. 
9.2 Hidden and Missed TIA – scale and recognition 
 
9.2.1 GP trainees’ recognition of high risk missed TIA 
The majority of GP trainees did not suspect TIA in two of the missed cases and in these 
cases referral for further investigations and specialist opinion were only recommended by a 
minority of respondents. Although some trainees did suspect TIA in two of the missed cases, 
overall the results suggest that education of trainees over broader presentations of TIA may 
be lacking, but a larger scale study is required to assess this. 
The high risk missed TIA cases were identified from an analysis of routes to care for patients 
with early recurrent stroke after TIA. This showed that patients presenting to primary care 
may not be included in clinic based prediction rule derivation datasets, either because the 
diagnosis is not suspected by the treating GP or a referral is made and a recurrent stroke 
occurs before being seen to confirm the diagnosis. Furthermore, delay to optimal treatment 
could occur due to intermediary specialist referral (e.g. ophthalmology). Although the 
absolute numbers affected were small in this dataset, the presenting cases are all 
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associated with recurrent stroke and are therefore important to recognise. Firm conclusions 
over whether the key problem is deficiency in training or lack of clinical exposure post 
training can’t be drawn as this study was performed to pilot the methodology and determine 
recruitment and completion rates for an appropriately powered test of the question. 
9.2.2. Response and completion rates for a web based survey 
The response rate was small, and approximately half the trainees completed the survey with 
paired data, which is essential to answer questions where vignettes are constructed to test 
the effect of change in one parameter on TIA recognition and appropriate management. The 
reported vignette diagnosis studies had higher rates of response, and with larger sample 
sizes (203-205) among qualified GPs. Allowing for 50 responses for each matched case, 
which was found in one study using permutations to test the effect of cues on diagnosis and 
management of TIA (204), would require 300 invitees if one third respond and half of those 
complete the questionnaire as per the pilot.  
9.2.3 The influence of altering case vignette parameters on TIA recognition and 
management decisions 
The narrative description of the results suggests that single parameter change may be 
associated with TIA detection and referral. Higher rates of TIA diagnosis and referral were 
found in the matched cases where alteration of one parameter was hypothesised to increase 
TIA detection. One pair was constructed to examine if the presence of focal non dominant 
parietal symptoms in a presentation of confusion was treated any differently to a 
presentation of confusion alone – although more trainees suspected TIA in the case with 
parietal symptoms, the majority of trainees did not treat this case differently from transient 
confusion alone. 
9.2.4 Limitations of this analysis 
The main limitation is the size of the sample. A modification to improve the numbers 
completing the survey would be to reduce the number of questions but allow the full range of 
TIA vignettes to be tested by presenting only one or two randomly chosen matched pairs 
with an equivalent number of distractors each time the web questionnaire is accessed. This 
approach was used to allow for 16 permutations  from completing four cases in a single 
questionnaire with 800 respondents (204). 
Increasing the recruitment pool entails contacting multiple deaneries for sufficient numbers 
of GP trainees to be invited to take part. In order to comply with the Data Protection Act, an 
extension would require formal collaboration with other deaneries and fresh ethical 
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applications and owing to time constraints this will be taken forward in the research plans 
following on from this thesis. 
9.2.5 Future research and practice 
Derivation datasets comprising clinic diagnosed TIA patients exclude the correctly 
recognised and very high risk who have a stroke after referral but before assessment, and 
those that are missed by GPs but are high risk and present with recurrent stroke. Dawson et 
al did not systematically search for these patients to include them in a derivation dataset. 
These patients were identified in OXVASC and the research steps following on from this 
thesis will be to understand in more detail the factors that affect recognition (a prerequisite of 
using a TIA referral/decision support tool) as well as expanding clinic based derivation 
datasets.  
In order to improve recognition of TIA, particularly high risk TIA, the presentations of these 
patients should be incorporated into derivation datasets. However, this may require further 
qualitative analysis of textual information, particularly as some non-dominant parietal 
features may be coded as confusion even if descriptions identify focal deficit such as 
dressing apraxia. An alternative strategy would be a prospective systematic data collection 
of all patients who present with a disturbance in their neurological status, either focal or non-
focal such as confusion, in order to get an accurate and systematically derived clinical 
assessment of all presentations that could be relevant to this question along with follow up 
for outcome – such presentations have been termed transient neurological attacks (TNAs) 
(266). 
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SECTION 4 GP and Specialist Disagreement – risk tools and diagnosis 
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Chapter 10 Methods 
10.1 Introduction 
The clinical relevance of discrepancies between GP and specialist histories is that a 
prediction rule derived from specialist records may perform differently in GP records. 
However if there is less disagreement over clinical features for patients with TIA compared 
with those without TIA then accurate identification of true high risk may still be possible even 
if the rule does not perform well in terms of discrimination i.e. for diagnosis. However,  the 
patients who may be truly high risk i.e. have a an ABCD2 score > 4 from a specialist 
assessment might not be scored as such at the first healthcare contact and may not receive 
timely assessment and intervention to reduce early stroke risk. Conversely, patients who are 
at low risk of recurrent stroke may be scored in the higher risk category at the first healthcare 
contact and as such be fast-tracked to an urgent clinic slot.  This is addressed with the 
following research questions 
1. Do GPs’ and specialists’ records of the same patients with suspected TIA agree about the 
clinical features? 
2. Does GP/specialist disagreement vary according to final clinic diagnosis? 
3. What impact does GP/specialist disagreement have on the performance of the ABCD2 
score for accurate triage of patients with TIA? 
To answer these questions, primary care records (referral letters and consultation notes) 
among all referred patients in the cohort 2002 – 2006 were analysed for symptom content 
relevant to the ABCD2 score (motor, speech and duration) and compared with those 
recorded from specialist assessment.  
An ideal test of agreement between GPs and specialists of a risk or diagnostic score would 
randomise the order of history-taking between GP and specialist. Inspite of any systematic 
differences between the history taking of GPs and specialists it is possible that histories can 
change in the ‘re-telling’ and so testing agreement from a history derived score by having a 
non-randomised order of clinician for each patient is a potential criticism. Furthermore the 
history taking is not contemporaneous in most cases as a referral to a clinic is required 
resulting in a delay between the GP history taking and the specialist history taking. Although 
OXVASC patients were seen relatively quickly overall and usually the same day in phase2 of 
the nested EXPRESS study (41), there was still a delay of some hours if not an overnight 
period in between history taking.  
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As there is fixed capacity for urgent slots in hospitals with dedicated TIA clinics (e.g. Oxford 
Radcliffe Hospitals NHS Trust, University Hospitals Birmingham NHS Trust, Addenbrooke’s 
Hospital NHS Trust, personal communication) significant resource is spent in getting patients 
seen urgently. Low risk patients if incorrectly identified could saturate urgent clinic capacity 
thereby reducing space for true high risk patients to be seen. 
Improving the accuracy of referrals from primary care both from a risk perspective and 
diagnostic perspective (reducing the number of referrals for patients who do not have TIA) 
will contribute to reducing delays to optimal risk reducing interventions. The potential for 
existing clinical prediction tools to improve discrimination of TIA from non-TIA in primary care 
is addressed with the following research question 
4. What impact does GP/specialist disagreement have on the discrimination metrics of 
existing clinical prediction tools for TIA diagnosis? 
This was answered by validating the Dawson tool and the ABCD2 score for TIA diagnosis in 
the cohort 2002 – 2006 and comparing the area under the receiver operator characteristic 
(ROC) curve with scores based on primary care records and secondary care records. 
10.2  Calculation of ABCD2 scores 
In OXVASC, GPs are not required to complete a proforma with an ABCD2 score calculated 
or with the component parts for appointment triage via a calculated score. In the following 
analysis the ABCD2 score was calculated from a combination of sources, the referral letter 
from the GP and also the electronic record of the consultation notes. Retrospective 
calculation of ABCD and ABCD2 scores is an established methodology from secondary care 
notes and has been performed in order to examine long term stroke risk in a population of 
patients seen in a TIA clinic, with 14 years of follow up (267).  
These patients are a subset of those included in the analysis of delay as that was a 
population based analysis of all patients with incident TIA, irrespective of their route through 
the healthcare system. The following analysis is restricted to patients who had been referred 
to the research clinic and as such had consultation data and referral letter data. Inferences 
are therefore only generalisable to situations where GPs are referring directly to a TIA clinic, 
rather than including ED assessments or where GPs are referring directly to acute 
physicians. 
All referred patients from primary care both with and without TIA are included in the analysis, 
in contrast to previously published work (227). If the degree of disagreement is different 
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between TIA patients and non-TIA patients then this has implications for urgent clinic 
capacity, particularly if patients without TIA are classed as high risk. 
This approach could be criticised as the GPs were not being asked to calculate an ABCD2 
score. GPs are often required to provide an ABCD2 score at referral but there is potential for 
this to lead to a degree of ‘gaming’ as the score is used to facilitate referral, particularly for 
the non-TIA patients where urgent reassurance may be required for psychological reasons – 
a systematic over-scoring of risk in non-TIA patients would be evidence of this. The present 
analysis is not subject to any degree of score optimisation bias as histories were taken 
without view to score calculation. 
10.3  Analysis of disagreement 
Disagreement for the ABCD2 score was assessed by examining the spread of secondary 
care ABCD2 scores for each GP ABCD2 score, for the whole referred population and for the 
TIA and non-TIA groups separately. Variation in agreement was also assessed within the 
TIA patients, grouped by anterior and posterior circulation territory. Altman-Bland plots (268) 
were constructed by plotting the absolute difference between each patient’s GP and 
secondary care ABCD2 score against the average of the two scores. This gives a graphical 
display of bias from the mean level of disagreement as well as how the spread of score 
differences changes with the average score. The standard deviation (SD) of differences was 
calculated and lines corresponding to mean, and two SDs either side were plotted on the 
graphs. Altman-Bland plots use the average of two methods of measurement as a proxy for 
the likely true underlying value, given that the difference between two scores can be related 
to either score as a statistical artefact (269). 
The agreement between the individual clinical components of the ABCD2 score was 
assessed using Cohen’s kappa for the presence or absence of symptoms. Age, blood 
pressure closest to the event and presence of diabetes was constant across GP and 
specialist records. Cohen’s kappa assesses the agreement that occurs over and above that 
due to chance alone (0 corresponds to chance agreement, 1 to perfect agreement). 
10.4 Impact of GP-specialist disagreement 
The major consequence of disagreement occurs when GPs incorrectly label patients as low 
risk and initiate a slower referral mechanism as set out in the National Stroke Strategy. 
Given the high early risk of stroke, such inappropriately slow referrals could result in 
recurrent strokes occurring in patients waiting to be assessed without appropriate full risk 
factor reduction therapies. 
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The mathematical expectation of strokes occurring in this way was calculated using the 
distribution of secondary care ABCD2 scores and their associated seven day stroke risks 
from validation studies (24). 
10.5  ABCD2 as a diagnostic tool 
If the ABCD2 score has any diagnostic utility it is essential to know firstly in which population 
of patients it has predictive value i.e. GP referrals to a TIA clinic (a screened population) or 
patients seeking care in general practice after transient events (a relatively unscreened 
population) and secondly whether within an identical population of patients the scores are 
different between groups of GPs and groups of specialists.  
One could argue that a diagnostic score has most utility when used by those who need 
support in diagnostic decision making i.e generalists. Specialists, as a result of acquired 
knowledge and skills through training are less likely to need tools to support diagnostic 
decision making. Therefore if the ABCD2 score is to be fairly assessed as a diagnostic tool 
one should know how well it validates in terms of discriminating TIA/minor stroke from non-
cerebrovascular causes of symptoms in a primary care population.  
It is not possible to assess the ABCD2 score for diagnostic discrimination in a primary care 
population presenting after transient symptoms with patients referred routinely to an NHS 
TIA service. This is because the primary care practitioner must already have at least a 
reasonable suspicion for TIA in order to generate the referral. Given that the OXVASC clinic 
has encouraged GPs to send in all patients that they consider to be even remotely at risk, it 
is likely that within this clinic seen cohort of patients there may be more non-TIA diagnoses 
than in a usual NHS service clinic i.e. GPs may be sending more patients than they would do 
otherwise when they have a low index of suspicion for the diagnosis. As such, the OXVASC 
clinic cohort offers an opportunity to assess the discriminating ability of the ABCD2 score in 
a population that may be more representative of a primary care population where patients 
present after transient symptoms than a usual NHS service clinic population. 
10.6  Metrics of validation – calibration and discrimination 
There are two key parameters that measure how well a prediction rule works. Firstly 
calibration, which corresponds to how well a predicted outcome matches the observed 
outcome. In the case of scores, where we do not have predicted probabilities to match with 
observed outcomes within patient groups based on similar predictions, as scores increase 
we would expect a greater chance of the diagnosis being present, in other words, the 
positive predictive value of the score should increase with increasing value of the score. 
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Secondly, a score should discriminate well i.e. the score can partition those with and those 
without a disease. The most valid form of validation is external, in that the score is derived in 
one cohort of patients and then the calibration and discrimination are tested in another 
cohort of patients, preferably not within the same recruitment/data gathering process. 
Discrimination between TIA and non-TIA was assessed using receiver operator 
characteristic (ROC) curves. The plot of the ROC curve demonstrates the trade off between 
increasing detection of TIA i.e. sensitivity with increasing over –diagnosis i.e. false positives 
(= 1-specificity). The area under the curve (AUC) corresponds to the probability that a 
patient with TIA chosen at random will have a higher score than a patient without TIA chosen 
at random, both within the dataset. An AUC of 1 therefore indicates perfect discrimination as 
all TIA patients have higher scores than all non-TIA patients. An AUC of 0.5 indicates that 
the ability of the score to discriminate between TIA and non-TIA is no better than chance. 
The optimal cut point for a score in terms of maximising sensitivity and minimising false 
positive results is the point on the curve that is nearest to the coordinates (0,1) i.e the upper 
left hand corner. 
10.7  Calculation of the Dawson et al TIA recognition tool  
There are a number of validity issues which may limit generalisability of this tool. Firstly, 
diagnostic drift over the 13 year period of ascertainment in the derivation cohort, as a 
number of definitions of TIA have been produced over that time and research published prior 
to the start of the retrospective cohort drew attention to the low diagnostic concordance 
among specialists over TIA (270) . Secondly there is a problem of mixed TIA and minor 
stroke in the validation cohort. Persisting signs may increase the discriminating ability of the 
tool. For example, the presence of persisting upper motor neuron (UMN) facial weakness 
may be clear on examination but not all patients with transient UMN facial weakness would 
be able to discriminate and correctly recollect the difference between UMN and LMN 
weakness they experienced during the period of deficit. Although the prevalence of 
cerebrovascular disease is broadly similar to clinic audit prevalence (271) the results are 
only generalisable to a population referred to a TIA clinic, rather than to those attending in 
primary care after transient symptoms or attending the ED.  
The authors of the recognition tool suggest two cut points – the optimal point is 6.1, but in 
order to reflect the misclassification costs of missing TIA, a 2:1 cost ratio was applied, which 
reduced the optimal score to 5.4. 
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Nevertheless, as this is the only specific TIA diagnostic tool in the literature, it was externally 
validated on OXVASC data for TIA patients, to examine its potential role in supporting 
referral decisions. 
Using vascular risk predictors and age, the features from the history which can increase and 
decrease the probability of the diagnosis are scored according to the table 10.1. 
Variable If Yes If No 
History of TIA/Stroke 0.5 0 
Headache 0 0.5 
Diplopia 1.2 0 
Loss Of Consciousness /Presyncope 0 1.1 
Seizure 0 1.6 
Speech abnormalities 1.3 0 
Unilateral limb weakness 1.7 0 
Upper motor neuron facial weakness 0.6 0 
Age Multiply by 0.04 
Table 10.1 Dawson et al TIA recognition score calculated by summing components. 
10.8  Validation of the Dawson score – primary care and secondary care records 
A diagnostic tool is not useful in the hands of a specialist in a TIA clinic. By definition they 
use skills and knowledge from training to derive a diagnosis and decision tools are more 
likely to be used by generalists as they support a decision making process. This was 
certainly the aim of tool derivation and is also the driving force behind stroke recognition 
tools for paramedics and generalist clinicians. Thus a validation from the records of those 
who are likely to use such a tool will be more helpful to judge the potential effect of 
implementation. 
All cases of TIA ascertained in OXVASC for years 1-4 and all patients with suspected TIA 
referred to the OXVASC TIA clinic were used as the validation data set to examine the 
calibration and discriminatory performance of the TIA recognition tool using secondary care 
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records. This allows an initial comparison with the published data on the tool, which had a 
validation dataset from a TIA clinic using hospital histories to derive the scores.  
Histories from GP consultation records and referral letters were used to populate the 
Dawson et al TIA recognition score. A history of transient facial weakness was deemed to be 
UMN, as this would be how the score would be used in routine practice and calibration and 
discrimination metrics would therefore be generalisable. 
The population of patients used for the validation are those seen first in primary care and 
where the GP has suspected TIA and then later assessed by an OXVASC research fellow 
with final diagnosis decided after discussion with the senior investigating neurologist (PMR). 
Calibration as assessed by predictive value for TIA diagnosis with increasing score and 
discrimination as assessed by ROC curves were calculated for secondary care and for 
primary care histories. 
10.9 Score component analysis 
The distributions of the individual components of the score were assessed with univariate 
analysis by examining the frequency of the presence of predictors in non-TIA and TIA 
patients. Relative risks (RR) of TIA for a given predictor were calculated and p values 
calculated using chi-square for RR values greater than 0, Fisher’s exact test where RR=0 
and t-test for differences in mean age. 
10.10  Impact on referral and safety 
If decisions to refer within the population of patients attending primary care were based on 
this particular decision rule then its impact can be assessed by using follow up of false 
negative patients. If high risk TIA patients are missed then the ascertainment of recurrent 
events in OXVASC will detect this. In other words, making the assumption that patients with 
scores below the cut point would not have been referred, the impact on the tool in terms of 
patient safety can be judged by following up those patients to see if any had a recurrent 
stroke. This is likely to underestimate the safety aspect of implementing the tool, as referred 
patients with true TIA have been investigated and treated with a combination of vascular risk 
reducing interventions. Thus only counting the missed patients with recurrent events is likely 
to under-estimate the risk of using the tool. 
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Chapter 11 Difference in histories and ABCD2 score 
11.1 Measures of risk score agreement  
Table 11.1 shows the numbers of patients (TIA and non-TIA) directly referred to the 
OXVASC clinic from general practice from 2002 to 2006 with ABCD2 score summary 
statistics calculated from the GP records and letters as well as ABCD2 scores from the 
standardised OXVASC proforma completed by secondary care clinicians along with their 
notes and letters. 
 
All 
Patients 
TIA 
Patients 
Non-TIA 
Patients 
N 515 212 303 
GP ABCD2 
Mean (SD) 3.33 (1.5) 3.85 (1.3) 3.19 (1.5) 
Median 
(IQR) 3 (2) 4(2) 3 (2) 
Specialist 
ABCD2 
Mean (SD) 3.46 (1.5) 3.94 (1.4) 2.9 (1.4) 
Median 
(IQR) 4 (3) 4 (2) 3 (2) 
Table 11.1 ABCD2 scores from GP notes and secondary care records for patients 
referred to OXVASC. 
Mean scores are marginally higher for TIA patients than non-TIA patients for both GP and 
specialist scores with this difference being more exaggerated for the hospital based ABCD2 
scores. However the agreement between GP and secondary care is not reflected in these 
summary statistics. 
Figure 11.1 shows a plot of the distribution of hospital ABCD2 scores for patients with the 
same GP ABCD2 score, so for all patients with GP scores of 1, 2, etc, the spread of scores 
that specialists gave can be viewed. Very few patients were referred with either ABCD2 
score of 0 or 7, and for GP ABCD2 scores of 1 to 6, the modal hospital ABCD2 score is the 
same as the GP ABCD2 score with values in the mid range having the widest spread. 
Clearly there is a large range of disagreement at the level of individual patients that is not 
reflected in simple summary statistics. 
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Figure 11.1 Spread of specialist ABCD2 scores for each GP ABCD2 score – all 
patients 
Figure 11.2 shows an Altman-Bland plot of the average of the GP and hospital ABCD2 
scores plotted against the difference between the GP and hospital ABCD2 scores 
(calculated as specialist score – GP score). This method of displaying the data allows for a 
visualisation of not only the spread of difference but also any evident bias over certain 
ranges of scores. Markers are weighted by the number of cases with a given disagreement 
in score at each level of average ABCD2 score. The mean difference was -0.13 points (thick 
dashed line) with standard deviation 1.14 points (2 SDs above and below the mean shown 
as thin dashed lines). The maximum difference between specialist and GP was a score of 4 
points. Given that age, BP and diabetes were kept equal across the scores (as the BP 
chosen was the one soonest after the event taken in primary care), the only variables that 
contribute to the difference are those that are due to the history i.e. clinical features (speech 
disturbance or unilateral weakness, and level of duration 0-10 minutes, 10 -60 minutes, > 60 
FREQUENCY 
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minutes). The extreme differences of four points occur in less than 5% of the data, as shown 
graphically as they lie outside two standard deviations from the mean. 
 
 
Figure 11.2 Specialist ABCD2 score – GP ABCD2 score plotted against average of 
specialist and GP ABCD2 scores (All TIA and non-TIA patients) 
However, the distribution of the differences shows that for higher average scores of ABCD2 
the specialist may be scoring the patients at a higher level, and for lower average ABCD2 
scores, the GP may be scoring patients at a higher level. The extreme positive difference 
values lie at higher average scores and extreme negative values lie at lower average scores. 
11.2 Variation in agreement with diagnosis 
Differences in the level of agreement in score between patients with and without a diagnosis 
of TIA have implications for using information from primary care referrals to prioritise urgent 
clinic slots. Figure 11.3 shows an Altman-Bland plot of specialist ABCD2 score – GP ABCD2 
score against average of specialist and ABCD2 score for each patient who does not have a 
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final diagnosis of TIA, with markers weighted by numbers of cases with a given 
disagreement at each level of average score. The average specialist – GP ABCD2 score is -
0.27 (thick dashed line) and the standard deviation is 1.17 (2 SDs above and below the 
mean shown as thin dashed lines). The spread of disagreement is much wider than in figure 
11.4 which shows the Altman-Bland plot for patients with a TIA diagnosis only. The standard 
deviation is smaller (0.98) and the mean is positive (0.10). 
Figure 11.3 Altman-Bland plot of Specialist ABCD2 – GP ABCD2 score against 
average of Specialist and GP ABCD2 scores (Non-TIA diagnoses) 
Comparing the groups of TIA and non-TIA patients, the distribution of differences between 
specialist and GP ABCD2 scores is significantly different. Means of differences suggest that 
from clinical histories, specialists when compared to GPs tend to score true TIA patients with 
a higher ABCD2 score (mean (specialist – GP) score = 0.10, standard error = 0.07) and tend 
to score non-TIA patients with a lower ABCD2 score (mean (specialist – GP) score = -0.29, 
standard error = 0.07). An independent samples t test of the distributions of differences in 
scores between non-TIA and TIA patients shows that there is evidence to reject the null 
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hypothesis that the distributions are equal (t = -4.09, df = 496, p<0.001) assuming that 
variances are not equal. 
This suggests that although there is measurable disagreement between GPs and specialists 
in the clinical features elicited and recorded that contribute to ABCD2 score calculation there 
is less disagreement for patients with a TIA diagnosis than those who do not have a final 
clinic diagnosis of TIA. Furthermore GPs may be overestimating the ABCD2 score in non-
TIA patients, raising the prospect that non-TIA patients may be accorded high risk status and 
given urgent clinic slots as a result. 
Figure 11.4 Altman-Bland plot of Specialist – GP ABCD2 score against average 
specialist and GP ABCD2 score (All TIA patients). 
11.3 The influence of arterial territory 
Measures of disagreement could also vary within the group of TIA patients. Posterior 
circulation TIAs have the same level of high early risk of recurrent ischaemic stroke as 
anterior circulation TIAs (230). Thus the ability to correctly attribute high early risk is equally 
important in posterior circulation TIA patients. Figures 11.5 and 11.6 display the distribution 
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of differences between specialist and GP ABCD2 scores across the range of average scores 
for anterior and posterior TIA patients respectively. Representations of mean, two standard 
deviations from the mean and the marker size format are as for the preceding plots 
The mean of differences in scores for anterior TIA patients was 0.19 points with SD of 0.90, 
indicating that specialists tend to higher ABCD2 scores than GPs. For posterior TIA patients, 
the mean of differences was -0.24 points with SD of 1.02, indicating that specialists tend to 
lower ABCD2 scores than GPs. Comparing the distributions of the differences between the 
anterior TIA and posterior TIA patients demonstrates that they are unlikely to come from the 
same population of differences using an independent samples t test assuming equal 
variances (t = 2.71 df = 205, p = 0.007). 
Figure 11.5 Altman-Bland plot of specialist – GP ABCD2 score against average 
specialist and GP ABCD2 score (anterior territory TIA) 
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Figure 11.6 Altman-Bland plot of specialist – GP ABCD2 score against average 
specialist and GP ABCD2 score (posterior territory TIA) 
11.4 Clinical Symptoms and disagreement  
Given that the four point differences concern three symptom domains, a further analysis is 
required to determine if there are systematic differences in symptom interpretation across 
diagnostic groups of patients. The clinical domains are unilateral weakness, speech 
disturbance and duration of symptoms. The following analysis examines specialist 
agreement for each domain scored by GPs. 506 patients’ records were available for this 
analysis. 
11.5 Specialist agreement with GP recording of unilateral weakness. 
Unilateral weakness was coded as involving the face, upper limb or lower limb. Bilateral 
weakness is not scored on the ABCD2 score. For the overall group of referred patients, of 
the 38 patients recorded as having facial weakness in primary care, only 26 were coded as 
having facial weakness by specialists. Of 468 patients coded as not having facial weakness 
in primary care, specialists found that facial weakness was in fact present in 30 patients.   
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Table 11.2 shows agreement over the presence of facial weakness between specialists and 
GPs assessed with Cohen’s kappa (with a value of 0 being at chance, and 1 perfect 
agreement). Kappa is summarised for the overall group and then within each diagnostic 
category, for non-TIA patients, anterior TIA patients and posterior TIA patients. 
 
Table 11.2 GP-specialist agreement over presence of facial weakness by diagnostic 
group 
Agreement over presence of this symptom is higher in the non-TIA group but this is partly 
due to the lower prevalence of this symptom. Table 11.3 shows that for the presence of 
unilateral limb weakness the agreement for the overall group is similar in the non-TIA group 
and anterior TIA group. Low symptom prevalences in the specialist group leads to a ‘chance’ 
value of -0.03 (272), although GPs and specialists agree that the majority of posterior TIA 
patients do not have unilateral limb weakness.  
 
 
 
 
 
TERRITORY 
Specialist 
GP-Specialist 
agreement 
Absent Present Kappa S.E. 
All 
Patients 
GP Absent 438 30 
0.51 0.07 Present 12 26 
Total 450 56 
Non-TIA 
GP Absent 278 3 
0.76 0.08 Present 5 14 
Total 283 17 
Anterior 
TIA 
GP Absent  121 27 
0.33 0.09 Present 5 12 
Total 126 39 
Posterior 
TIA 
GP Absent 39   
- - Present 2   
Total 41   
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TERRITORY 
Specialist 
GP-specialist 
agreement 
Absent Present Kappa SE 
All 
Patients 
GP 
Absent 344 35 
0.58 0.04 Present 44 83 
Total 388 118 
Non-TIA 
GP 
Absent 219 10 
0.54 0.06 Present 34 37 
Total 253 47 
Anterior 
TIA 
GP 
Absent 87 24 
0.59 0.06 Present 8 46 
Total 95 70 
Posterior 
TIA 
GP 
Absent 38 1 
-0.03 0.02 Present 2 0 
Total 40 1 
Table 11.3 GP-specialist agreement over presence of unilateral limb weakness by 
diagnostic group 
11.6 Specialist agreement with GP recording of speech disturbance 
Table 11.4 displays the same agreement data for the presence of speech disturbance, as 
recorded by GPs at the initial consultation and by specialists at the second consultation in 
secondary care. Agreement is generally higher across all groups compared with unilateral 
facial and limb weakness with the highest agreement in anterior TIA patients. Given that one 
of the clinical features that leads to a diagnosis of anterior TIA is dysphasia (one of the 
components of speech disturbance) it is not surprising that the highest agreement is in this 
diagnostic group. 
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TERRITORY 
Specialist 
GP-specialist 
agreement 
Absent Present Kappa SE 
All 
Patients 
GP 
Absent 337 25 
0.68 0.04 Present 39 105 
Total 376 130 
Non-TIA 
GP 
Absent 230 8 
0.61 0.06 Present 26 36 
Total 256 44 
Anterior 
TIA 
GP 
Absent 75 14 
0.71 0.06 Present 10 66 
Total 85 80 
Posterior 
TIA 
GP 
Absent 32 3 
0.41 0.2 Present 3 3 
Total 35 6 
Table 11.4 GP-specialist agreement over presence of speech disturbance by 
diagnostic group 
It could be argued that GPs may be only eliciting sufficient symptoms to influence decision 
making e.g. ‘do I have enough information for a referral?’  and as such may not record 
information beyond a minimum to trigger referral. If unilateral weakness was found this 
would be enough to refer for suspected TIA without the presence of speech disturbance as 
well (and although the GPs were not calculating ABCD2 scores, speech adds no extra risk 
points to unilateral weakness).  
Thus GP records may not include certain symptoms if sufficient other symptoms are present 
to justify referral as further information may not influence decisions. As such, the absence of 
a symptom may not be evidence of true discordant history taking between GPs and 
specialists but reflect efficient time management in a consultation.  
To investigate this, the 25 patients where GPs did not record speech disturbance but the 
specialists did record this s as being present were analysed for other symptoms. Of the 25, 
22 (88%) did not have facial weakness and 18 (72%) did not have limb weakness. This 
suggests that disconcordance in history taking is the reason for disagreement, rather than a 
truncated history taken by the GP once a minimal set of features have been elicited to make 
a referral decision. 
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11.7 Specialist agreement with GP recording of duration of symptoms 
The ABCD2 score has three levels of duration of symptoms with increasing scores given to 
longer durations (0-10 minutes = 0, 10–60 minutes = 1, >60 minutes = 2). Duration of 
symptoms are categorised according to these three levels from GP records and compared 
with the levels of duration from the specialist notes. 
Figure 11.5 demonstrates the variation in duration assessments by GPs and specialists for 
non-TIA patients, anterior TIA patients and posterior TIA patients. The level of agreement 
overall is similar within the three diagnostic groups without any evidence of bias in 
assessment of duration specific to one group. As such it is likely that disagreement in 
duration of symptoms adds noise rather than poses any risk of either systematically under 
scoring high risk patients or over scoring low risk patients. 
TERRITORY 
Specialist Duration 
GP-Specialist 
agreement 
0 1 2 Kappa SE 
All 
Patients 
GP 
Duration 
0 54 25 21 
0.49 0.03 
1 33 78 35 
2 17 26 208 
Total 
 
104 129 264 
Non-TIA 
GP 
Duration 
0 31 18 17 
0.49 0.04 
1 13 40 16 
2 9 17 138 
Total 52 75 171 
Anterior 
TIA 
GP 
Duration 
0 16 7 4 
0.47 0.06 
1 16 30 13 
2 5 8 61 
Total 37 45 78 
Posterior 
TIA 
GP 
Duration 
0 7 0 0 
0.44 0.1 
1 5 8 6 
2 3 1 9 
Total 15 9 15 
Table 11.5 GP-specialist agreement over duration of symptoms (coded as score on 
ABCD2) by diagnostic group 
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11.8 Agreement over high and low risk patients 
The purpose of the ABCD and ABCD2 scores are to risk-stratify patients at the first point of 
healthcare contact with a generalist, in order to judge the speed of organising investigations 
and management from specialty services. Therefore it can be argued that the above analysis 
of differences in scores between GPs and specialists and potential sources of those 
differences are only of any real importance if there is significant re-classification of patients 
from high risk to low risk and vice versa. 
Table 11.6 shows the agreement over risk status from ABCD2 scores calculated from GP 
records and the ABCD2 scores from the specialist records, for all referrals and by diagnostic 
group. Assuming that the specialist scores are the current gold standard for risk, as these 
were the derivation and validation sets for the ability of the ABCD2 score to predict early 
recurrent stroke, the table also allows for calculation of sensitivity and specificity of GPs 
ability to detect the high risk cases (as defined by specialist taken histories). 
GPs show reasonable ability to detect risk status as sensitivity is over 87% for all patients 
and for anterior TIA patients. The actual number of high risk posterior TIA patients is low so 
the lower % sensitivity may in this group not be a true reflection of accuracy of detection of 
risk in posterior TIA.  
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TERRITORY 
Specialist risk 
status 
GP Detection Accuracy of high 
risk features 
LOW HIGH Sensitivity Specificity 
All 
Patients 
GP 
risk 
status 
LOW 212 29 
87.7% 77.4% HIGH 62 207 
Total 274 236 
Non-TIA 
GP 
risk 
status 
LOW 146 12 
88.8% 74.5% HIGH 50 95 
Total 196 107 
Anterior 
TIA 
GP 
risk 
status 
LOW 42 12 
89.7% 84% HIGH 8 104 
Total 50 116 
Posterior  
GP 
risk 
status 
LOW 24 5 
61.5% 85.7% HIGH 4 8 
Total 28 13 
Table 11.6 GP-specialist agreement over risk status according to ABCD2 score (high 
risk ≥4) by diagnostic group (sensitivity = number of specialist high risk cases 
identified as high risk by GPs) 
11.9 Expected recurrent strokes  
Of the 17 high risk patients with TIA that were not identified from GP scores, 6 had an 
ABCD2 score of 5, with the rest having a score of 4. The recurrent stroke risks at 7 days for 
ABCD2 scores of 4 and 5 are 5% and 7% respectively (24). Therefore by failing to detect 
high risk status in these patients one would expect  
(11 X 0.05) + (6 X 0.07) = 0.97 strokes. 
Thus for a 90,000 population over a period of 4 years, there may be one excess stroke due 
to a failure to detect high risk status in primary care due to arranging time to specialist 
assessment within 7 days rather than within 24 hours of symptom onset. 
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Chapter 12 ABCD2 for diagnosis  
12.1 Distribution of specialist ABCD2 scores within diagnostic groups 
ABCD2 scores were available for 394 patients with TIA and 338 non-TIA patients. Table 
12.1 shows the mean specialist ABCD2 scores by diagnosis. Mean ABCD2 scores were 
higher for TIA than non-TIA patients (4.04 vs 2.86, Mann Whitney test, z = -10.13, p<0.001).  
Within the TIA group, patients with anterior TIA had significantly higher ABCD2 scores than 
posterior TIA patients (4.23 vs 3.41, Mann Whitney test, z = - 4.5, p < 0.001). 
Diagnostic Group N Mean ABCD2 score SD 
Non-TIA 338 2.86 1.39 
TIA 394 4.04 1.48 
Anterior TIA 302 4.23 1.41 
Posterior TIA 92 3.41 1.56 
Table 12.1 Mean and SD of specialist ABCD2 score by diagnostic group 
The distribution of scores within each diagnostic group is shown in figure 12.1 demonstrating 
the asymmetric distributions of the anterior and posterior TIA scores. Furthermore the 
asymmetry is dissimilar as there are opposite skews with anterior TIA patients having a 
modal score at the upper end of their distribution and the posterior TIA patients having a 
modal score at the lower end of their distribution. 
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Figure 12.1 Distribution of ABCD2 scores in different diagnostic groups 
A formal calibration curve cannot be constructed as the ABCD2 score does not give an 
expected probability of TIA diagnosis, but the prevalence of TIA can be measured at each 
value of the score. Increasing scores are associated with higher prevalence of TIA (figure 
12.2). 
 
Figure 12.2 Prevalence of TIA at each ABCD2 score – all TIA patients and all clinic 
referrals 
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12.3 Discriminating ability of specialist ABCD2 scores for TIA diagnosis 
Figures 12.3 to 12.5 display the ROC plots for discriminating ability of specialist ABCD2 
scores in separating TIA from non-TIA patients overall and for diagnostic sub groups 
dependent on arterial territory. The AUC (figure 12.3) for discriminating TIA from non-TIA is 
0.71 (S.E. 0.02).  
 
Figure 12.3 ROC curve for discrimination of TIA from non-TIA using specialist ABCD2 
scores 
The area under the curve (figure 12.4) for discriminating anterior TIA from non-TIA is higher 
than for the group overall, at 0.75 (S.E. 0.02) and for discriminating posterior TIA from non-
TIA (figure 12.5) is 0.59 (S.E. 0.03). Clearly discriminating performance is much worse for 
posterior TIA and is near chance value. 
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Figure 12.4 ROC curve for discrimination of anterior TIA from non-TIA using specialist 
ABCD2 scores 
 
Figure 12.5 ROC curve for discrimination of posterior TIA from non-TIA using 
specialist ABCD2 scores 
12.4 Summary measures of performance at successive cut points 
Figure 12.6 shows how the sensitivity and specificity vary with choosing increasing cut points 
on the ABCD2 score for diagnosis. At the lowest cut point of 0, all patients are labelled as 
129 
 
TIA with the resultant 100% sensitivity as all those who truly have TIA are correctly 
identified, and specificity is 0% as all those without TIA are falsely identified as having TIA 
creating a maximum false positive rate. At the highest score of 7, specificity is 100% as 
patients without TIA all scored less than 7 and so there are no false positives at this cut 
point. Only a small proportion of patients actually had a score of 7 so choosing this cut point 
only identifies a small fraction of the total patients with TIA, hence the very low sensitivity. 
The curves cross at the value of 4 where sensitivity and specificity are approximately equal 
at 65%. 
 
Figure 12.6 Sensitivity and specificity for the diagnosis of TIA using specialist ABCD2 
scores 
Figure 12.7 shows the change in positive predictive value and negative predictive value with 
increasing ABCD2 score for TIA diagnosis. At the lowest score of 0, positive predictive value 
(PPV) is at prevalence of TIA within the sample but as the cut point increases to restrict PPV 
calculation to patients with higher ABCD2 scores, the value increases but only reaches 
100% at the highest score, as clearly there are patients without TIA who are scoring up to 6 
points. The negative predictive value is 100% until scores of 2 or more are scored, as no 
patients with TIA scored 1 or 0.   
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Figure 12.7 Positive predictive value (PPV) and negative predictive value (NPV) for TIA 
diagnosis at increasing cut points of specialist ABCD2 score 
 
12.5 ABCD2 scores calculated from GP records within diagnostic groups 
Primary care ABCD2 scores were available for 515 patients and mean scores are shown by 
diagnostic group in table 12.2. Mean GP ABCD2 scores were significantly higher for patients 
with TIA than patients without TIA (3.85 vs 3.19, Mann Whitney test, Z = -4.64, p < 0.001). 
Within the TIA group, patients with anterior TIA had significantly higher ABCD2 scores than 
patients with posterior TIA (4.02 vs 3.19, Mann Whitney test, Z = -3.97, p<0.001) 
Diagnosis N Mean ABCD2 SD 
Non-Tia 303 3.19 1.53 
TIA 212 3.85 1.33 
Anterior TIA 169 4.02 1.31 
Posterior TIA 43 3.19 1.24 
Table 12.2 Mean (SD) ABCD2 scores from GP records by diagnostic group 
The distribution of GP ABCD2 scores within each diagnostic group is shown in figure 12.8. 
Non-TIA patients have scores throughout the entire range of the ABCD2 scoring system. 
Within the TIA territory subgroups there are opposite skews for the anterior and posterior TIA 
patients, with more posterior patients scoring at the lower end of their distribution and more 
anterior patients scoring at the upper end of their distribution. 
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Figure 12.8 Distribution of GP ABCD2 scores by diagnostic group 
The prevalence of TIA at each GP ABCD2 score point is shown in figure 12.9. This 
demonstrates that calibration is not as good as with specialist ABCD2 scores, given that 
there is no linear increase in prevalence with each unit increase in score. 
 
Figure 12.9 Prevalence of TIA at each ABCD2 score – all primary care referrals 
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12.6 Discriminating ability of GP ABCD2 scores for TIA diagnosis  
Figures 12.10 – 12.13 display ROC curves for the discriminating performance of GP ABCD2 
scores. For discriminating TIA from non-TIA (figure 12.10), the area under the curve was 
0.62 (S.E. 0.03). However, this overall discriminating performance is due to differential 
performance for the arterial territory sub groups. For anterior TIA discrimination (figure 
12.11), the area under the curve was 0.65 (S.E. 0.03) and for posterior TIA discrimination 
(figure 12.12), the area under the curve was lower than chance at 0.48 (S.E. 0.04). 
 
Figure 12.10 ROC curve for discrimination of TIA from non-TIA using GP ABCD2 
scores 
 
Figure 12.11 ROC curve for discrimination of anterior TIA from non-TIA using GP 
ABCD2 scores 
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Figure 12.12 ROC curve for discrimination of posterior TIA from non-TIA using GP 
ABCD2 scores 
12.7 Summary Measures of test performance at increasing GP ABCD2 cut points. 
Figure 12.13 shows the change in sensitivity and specificity for the diagnosis of TIA using 
GP ABCD2 scores at increasing cut points. A similar pattern to the specialist scores is 
demonstrated. Specificity remains low throughout an acceptable range of sensitivity and only 
increases above 50% when sensitivity has dipped below 60%. 
 
Figure 12.13 Change in sensitivity and specificity with increasing GP ABCD2 cut 
points for diagnosis. 
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Figure 12.14 demonstrates the predictive values of the GP ABCD2 score for TIA diagnosis. 
The negative predictive value remains at 100% until scores of 2 or more are used as cut 
points. The positive predictive value at this cut point remains low indicating significant 
numbers of false positives. 
 
Figure 12.14 Positive predictive value (PPV) and negative predictive value (NPV) for 
TIA diagnosis at increasing cut points of specialist ABCD2 score. 
In contrast to the PPVs from the specialist ABCD2 scores, the PPV using GP ABCD2 scores 
remains below 60% throughout the range of cut points. 
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Chapter 13 Validation of a TIA Recognition Tool 
13.1 Validation using hospital records 
All available patients with TIA in OXVASC were used as the hospital validation dataset as 
well as non-TIA clinic referrals with suspected TIA. 41 patients (5.4% of total patients in this 
analysis), who were referred but recorded as not having TIA, did not have secondary care 
histories of the event. Of these 41, eight patients had a primary care record and were used 
in the primary care validation of the Dawson tool.  
13.2 Distribution of scores by diagnostic group – hospital dataset 
Scores will range from a minimum of (age x 0.04) to a maximum of (8.5 + (age x 0.04)). In 
the hospital dataset, the scores for TIA and non-TIA patients are summarised in table 13.1 
Diagnosis N Mean SD Minimum Maximum 
Non-TIA 330 6.0 1.12 2.42 9.40 
All TIA 394 7.63 1.37 4.36 10.94 
Anterior TIA 302 7.80 1.31 4.36 10.94 
Posterior TIA 92 6.95 1.34 4.46 10.88 
Table 13.1 Summary statistics for TIA tool scores by diagnosis 
Although the overall mean for TIA patients is higher than for non-TIA patients, anterior TIA 
patients have a higher mean score than non-TIA patients. Comparing non-TIA, anterior TIA 
and posterior TIA for TIA tool scores with analysis of variance shows a significant between 
diagnostic group difference (F=170, P<0.001). Post hoc Bonferroni tests show that all groups 
are significantly different in tool scores compared with each other at <0.001 significance 
level. 
Figure 13.1 demonstrates the distribution of scores for non-TIA patients, anterior TIA 
patients and posterior TIA patients. This displays visually that using the prevalence 
calibration data will not yield useful cut points, as only a minority of patients without TIA have 
scores below 4 and only a minority of TIA patients have scores above 10. 
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Figure 13.1 Distribution of TIA recognition scores between non-TIA, anterior TIA and 
posterior TIA 
Figure 13.2 demonstrates the calibration for TIA versus non –TIA, by binning scores and 
examining the prevalence of TIA within each bin. Prevalence of TIA increases with 
successive score unit increases. No patients with a score below 4 have TIA and above 10, 
all patients have TIA. 
 
Figure 13.2 Calibration of TIA recognition score - prevalence of TIA within each 
successive score bin 
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13.3 Tests of discrimination – hospital dataset 
Figure 13.3 shows the plot of the ROC curve for discrimination between TIA and non-TIA 
using hospital records of the clinical history. The area under the curve (AUC) is 0.82 
(standard error 0.02, 95% confidence interval 0.79 to 0.85). However this overall 
performance is over two quite distinct clinical populations of anterior and posterior TIA. 
 
Figure 13.3 ROC curve for discrimination between TIA and non-TIA 
Figures 13.4 and 13.5 demonstrate ROC curves for the ability of the tool to discriminate 
between anterior TIA and non-TIA, and posterior TIA and non-TIA respectively. Clearly there 
is inferior performance for posterior TIA. The AUC for anterior TIA discrimination is 0.85 
(S.E. 0.02, 95% CI 0.82 to 0.88) and for posterior TIA is 0.70 (S.E. 0.03, 95% CI 0.64 to 
0.76). 
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Figure 13.4 ROC curve for discrimination between anterior TIA and non-TIA 
 
 
Figure 13.5 ROC curve for discrimination between posterior TIA and non-TIA 
The distribution of the individual components of the score is assessed in table 13.2 with 
proportions of non-TIA and TIA patients with feature present. Relative risks (RR) >1 indicate 
that the feature is associated with a diagnosis of TIA and relative risks < 1 indicate that the 
absence of the feature is associated with a diagnosis of TIA. Analyses are univariate with p 
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values calculated using chi-square for RR values greater than 0, Fisher’s exact test where 
RR=0 and t-test for mean age. 
 Non-TIA 
Symptom 
/patients 
TIA 
Symptom 
/patients 
RR Lower 
Confidence 
Interval 
Upper 
Confidence 
Interval 
P 
History of 
TIA/stroke 
26/330 119/394 3.83 2.57 5.71 <0.001 
Headache 52/330 40/394 0.64 0.44 0.95 0.03 
Diplopia 10/330 18/394 1.51 0.71 3.22 0.38 
Fit 9/330 0/394 0 0 0 <0.001 
Loss Of 
Consciousnes
s 
59/330 0/394 0 0 0 <0.001 
Speech 51/330 168/394 2.76 2.1 3.64 <0.001 
Face 19/330 85/394 3.75 2.33 6.03 <0.001 
Limb 50/330 146/394 2.44 1.84 3.26 <0.001 
Age mean (SD) 64.72 
(16.62) 
73.64 
(12.33) 
- - - <0.001 
Table 13.2 Distribution of sub-components of tool recognition score: non-TIA vs TIA 
A forwards conditional stepwise multivariate logistic regression for diagnosis of TIA (with a 
probability of 0.05 for entry) demonstrated that all the tool recognition variables were kept in 
the equation apart from the presence of a fit, with overall 72.9% correct classification from 
the model and a Nagelkerke R2 of 0.40 (this is a measure of how much better the model is at 
predicting the  outcome over assuming that each patient has the same chance of the 
outcome as the background prevalence in the group - 1 is perfect prediction and 0 is no 
better than the background). 
Seizure activity has a low prevalence overall in this cohort of patients which may reflect a 
difference in referral practices between OXVASC GPs and GPs in Scotland. This in itself 
may reflect availability of other services where a rapid access to a physician opinion and 
cerebral imaging may be lacking, such as first fit clinics. 
Thus the recognition tool validates well in this cohort of patients in terms of calibration and 
discrimination using secondary care histories, with the majority of variables contributing to 
predictive power. However, there is marked differential performance in discrimination with 
poorer performance in posterior TIA. 
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13.4 Cut points and effects on performance 
The authors of the recognition tool suggest two cut points – the optimal point is 6.1, but in 
order to reflect the misclassification costs of missing TIA, a 2:1 cost ratio was applied, which 
reduced the optimal score to 5.4. Sensitivity, specificity, positive predictive value and 
negative predictive value at the two cut-points are shown in table 13.3. 
Cut point 
Positive 
Predictive 
Value 
Negative 
Predictive 
Value Sensitivity Specificity 
5.4 61% 85% 96% 28% 
6.1 69% 76% 86% 54% 
Table 13.3 Performance of tool at different cut points 
Reducing the cut-point for diagnosis increases the sensitivity but at the expense of 
increasing false positives, as evidenced by a reduction in positive predictive value and 
specificity. This is illustrated more clearly in figures 13.6 and 13.7 which plot the effect of 
changing the diagnostic cut point on sensitivity and specificity as well as positive and 
negative predictive values. 
 
Figure 13.6 Plot of sensitivity and specificity with increasing diagnostic cut point 
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Figure 13.7 Plot of PPV and NPV with increasing diagnostic cut point  
13.5 Validation using primary care records 
The population of patients used are those seen first in primary care and where the GP has 
suspected TIA and then later assessed by an OXVASC research fellow with final diagnosis 
decided after discussion with the senior investigating neurologist (PMR). The records of 513 
patients who were referred from primary care were used in the analysis.  
13.6 Distribution of scores across diagnostic groups - primary care dataset 
Table 13.4 shows summary statistics for the tool scores in primary care. Differences in 
scores between diagnostic groups were tested with analysis of variance which was 
statistically significant for a between group effect (F 53.27, P<0.001). Post hoc Bonferroni 
tests explored which groups accounted for this difference and anterior TIA scores were 
significantly different from non-TIA and posterior TIA (both at p<0.001). Posterior TIA scores 
were not significantly different from non-TIA scores.  
 
 
Diagnosis N Mean SD Minimum Maximum 
Non-TIA 304 6.33 1.10 3.54 9.04 
All TIA 209 7.23 1.22 3.85 10.17 
Anterior TIA 167 7.44 1.21 3.85 10.17 
Posterior TIA 42 6.41 0.90 4.80 8.34 
Table 13.4 Summary statistics for TIA tool scores by diagnosis 
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The distribution of scores is demonstrated between the diagnostic groups in figure 13.8. This 
displays more clearly the lack of difference between the posterior TIA and non-TIA score 
distribution, compared with the anterior TIA distribution.  
 
Figure 13.8 Distribution of scores from GP records by diagnostic group 
Figure 13.9 demonstrates the calibration of the tool with predictive value of each score bin. 
The inter-bin increase is not linear e.g. bins 3 to 4 and 4 to 5 do not show an increase in 
prevalence of TIA whereas there is a large increase from bin 8 to 9 to bin 9 to 10. All patients 
with a score of 10 or more have TIA whereas in the lowest bin with scores (bin 3 to 4) there 
is a small prevalence of TIA.  
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Figure 13.9 Calibration of % prevalence of TIA within successive GP score bins 
13.7 Discrimination between diagnostic groups using primary care records 
The ROC plot for discriminating TIA from non-TIA is shown in figure 13.10, with an AUC of 
0.70 (S.E. 0.02, 95% CI 0.66 to 0.75). However, this overall performance is from the sum of 
two distinct clinical populations, anterior and posterior TIA patients. The AUC for 
discrimination of anterior TIA from non-TIA was 0.75 (S.E. 0.02, 95% CI 0.70 to 0.80). The 
AUC for posterior TIA was 0.52 (S.E. 0.04, 95% CI 0.43 to 0.60), demonstrating that 
discrimination from non-TIA was no better than chance. Figures 13.11 and 13.12 display the 
ROC plots for anterior and posterior discrimination respectively. 
 
Figure 13.10 ROC curve for diagnosis of TIA vs non-TIA using the recognition score 
with primary care records. 
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Figure 13.11 ROC curve for diagnosis of anterior TIA vs non-TIA using the recognition 
score with primary care records. 
 
Figure 13.12 ROC curve for diagnosis of posterior TIA vs non-TIA using the 
recognition score with primary care records. 
In order to investigate which parts of the tool are likely to account for its performance, the 
distribution of the tool components in patients with and without TIA is shown in table 13.5. 
No GPs recorded fits or seizures, although nine patients had their histories re-interpreted in 
secondary care to be related to seizure activity. Therefore fit presence/absence is not shown 
in table 13.5. 
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 Non-TIA 
Symptom / 
patients 
TIA 
Symptom / 
patients 
RR Lower 
confidence 
Interval  
Upper 
confidence 
Interval 
P 
History of 
TIA/stroke 
22/304 53/209 3.50 2.20 5.58 <0.001 
Headache 32/304 19/209 0.86 0.50 1.48 0.70 
Diplopia 8/304 7/209 1.27 0.47 3.46 0.84 
Reduced 
conscious 
level 
24/304 1/209 0.06 0.008 0.45 <0.001 
Speech 61/304 81/209 1.93 1.45 2.56 <0.001 
Face 19/304 19/209 1.45 0.80 2.68 0.30 
Limb 70/304 57/209 1.18 0.88 1.60 0.30 
Age mean (SD) 65.20 
(16.57) 
73.22 
(12.76) 
- - - <0.001 
Table 13.5 Comparison of sub-components of TIA recognition score between TIA and 
non-TIA. 
Again, p values are calculated using chi-squared for dichotomised variables of 
presence/absence of symptoms and using an independent samples t test for comparing 
mean age. Compared with secondary care scores, facial weakness, limb weakness, diplopia 
and headache are no longer significantly differently distributed between patients with and 
without TIA. This may reflect the fact that this is a sub-population of patients i.e. table 13.5 
represents all those patients seeking care in general practice before secondary care, 
whereas table 13.3 is for all referrals to clinic including those patients who first presented in 
ED. However, an alternative explanation is that the histories are differently taken and 
recorded on the same patients.  
To further investigate the sub-components of the score, a forwards stepwise multivariate 
logistic regression, with entry probability of 0.05 to predict TIA diagnosis, using primary care 
recorded variables from the recognition score was carried out. At step 4, no further iterations 
improved model fit and the excluded variables were headache, diplopia, facial weakness and 
limb weakness, with a Nagelkerke R2 of 0.22 and 68% correct classification. 
13.8 Cut points and effects on performance – primary care records 
Table 13.6 shows positive predictive value, negative predictive value, sensitivity and 
specificity of the two diagnostic cut points recommended by Dawson – 6.1 and 5.4.  
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Cut point 
Positive 
Predictive 
Value 
Negative 
Predictive 
Value Sensitivity Specificity 
5.4 
44% 77% 92% 18% 
6.1 
49% 76% 81% 42% 
Table 13.6 Performance of tool at different cut points 
Even at the higher cut point of 6.1, positive predictive value does not improve on published 
clinic prevalence figures of around 50%.  At the recommended cut point of 5.4, to reflect the 
need for greater sensitivity in TIA detection, PPV remains at around the overall level of 40% 
in the cohort, due to a higher false positive rate (82%). Figures 13.13 and 13.14 illustrate 
more clearly the effect of different diagnostic cut points on sensitivity, specificity, PPV and 
NPV. 
 
Figure 13.13 Plot of sensitivity and specificity with increasing diagnostic cut point 
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Figure 13.14 Plot of PPV and NPV with increasing diagnostic cut point  
Specificity remains low at high levels of sensitivity, but there is a sharp decline in sensitivity 
as the false positive rate begins to reduce. 
13.9 Impact on referral and safety 
If decisions to refer within the population of patients attending primary care were based on 
this decision rule then its impact can be assessed by using follow up of false negative 
patients. If high risk TIA patients are missed then the ascertainment of recurrent events in 
OXVASC will detect this. In other words, making the assumption that patients with scores 
below the cut point would not have been referred, the impact on the tool in terms of patient 
safety can be judged by following up those patients to see if any had a recurrent stroke. This 
is likely to underestimate the risk of implementing the tool, as referred patients with true TIA 
have been investigated and treated with a combination of vascular risk reducing 
interventions. Thus only counting the missed patients with recurrent events is likely to under-
estimate the risk of using the tool. 
At both cut points of 6.1 and 5.4, two patients were missed who had a recurrent ischaemic 
stroke within 7 days of the TIA that led them to present to their GP. No additional events 
were ascertained to 90 days after TIA in the ‘false negative’ cohort as defined by either cut 
point. 
Using the 6.1 cut point would have saved 168 referrals, of whom 42 were diagnosed with 
TIA and did not have a recurrent stroke by 90 days of follow up. Using the 5.4 cut point 
would have saved 71 referrals of whom 17 were TIA and didn’t have a recurrent stroke on 90 
days of follow up.  
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The presenting ABCD2 scores are available for these patients who were falsely negative at 
the two cut points and the expected number of strokes can be calculated without treatment 
using the known associated early stroke risk. 
In the 6.1 cut point cohort of 42 false negative recurrence free patients, multiplying the 
frequency of each patient’s ABCD2 score by its 90 day estimated risk gives a total 
expectation of 2.08 strokes, for a 91,000 population over 4 years, alongside the additional 
two cases of stroke. 
In the 5.4 cut point cohort of false negative recurrence free patients, the same calculation of 
mathematical expectation of recurrent strokes is 0.71 for a 91,000 population over 4 years, 
alongside the additional two cases of stroke. 
13.10 Difference in populations or difference in histories? 
The diagnostic tool score performs quite differently in secondary care records and in primary 
care records. Not only are the calibration and discrimination measures different, most 
notably for the discrimination of posterior TIA patients in primary care recorded clinical 
features, but the individual components of the score have different levels of statistical 
significance in their distribution between TIA and non-TIA patients, when one compares 
across primary and secondary care. Fewer items are distributed differently with an 
appropriate degree of significance in the primary care records. 
These differences could be due to a sub-population effect, whereby the total clinic population 
is made up of two quite distinct populations of primary care and ED referred patients which 
in themselves are very different in their distribution of predictors of a TIA diagnosis. 
Alternatively, there could be marked disagreement between GPs and the TIA specialists in 
deciding on the presence or absence of clinical features. This latter explanation was seen in 
chapter 6 where ABCD2 scores were compared between primary and secondary care. 
Figure 13.14 demonstrates an Altman-Bland plot of the difference between specialist and 
GP scores against the average of the specialist and GP scores in patients referred from 
primary care to OXVASC. For all referred patients the mean difference is -0.09 with a 
standard deviation of 0.92. Further plots by diagnostic group (figures 13.16 – 13.18) 
demonstrate a mean difference for non-TIA patients of -0.3 (i.e. GPs score higher than 
specialists), a mean difference of +0.3 for anterior TIA (specialists score higher than GPs) 
and a mean difference of 0.02 for posterior TIA. 
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Figure 13.14 Specialist – GP score against average specialist and GP score for all 
referred patients from primary care; mean difference (thick line), 2 standard 
deviations (broken lines). 
 
Figure 13.15 Specialist – GP score against average specialist and GP score for all 
non-TIA patients; mean difference (thick line), 2 standard deviations (broken lines)  
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Figure 13.16 Specialist – GP score against average specialist and GP score for 
anterior TIA patients; mean difference (thick line), 2 standard deviations (broken lines) 
 
Figure 13.17 Specialist – GP score against average specialist and GP score for 
posterior TIA patients; mean difference (thick line), 2 standard deviations (broken 
lines)  
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From mean values, GPs tend to score patients more highly than specialists for non-TIA and 
lower for anterior TIA. In the overall referred group with suspected TIA, there is no particular 
bias as the anterior and non-TIA patients effectively cancel each other out. This suggests 
that the difference in performance metrics for the Dawson tool between primary and 
secondary care is due to differences in histories and therefore predictor values. 
The foregoing analysis rests on the assumption that if a GP hasn’t recorded a symptom then 
the patient did not have that symptom present. However, patients could have complained of 
symptoms or GPs elicited symptoms that were not recorded in consultation records or 
referral letters.  
As the GPs were not knowingly taking a history with a teleological function to populate a 
diagnostic score, there is no risk of score optimisation bias, which is where certain aspects 
of the history may be amplified with a view to creating a higher score to justify referral. 
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Chapter 14 Summary and Conclusions 
14.1 GP-specialist disagreement and accuracy of triage 
14.1.1 Disagreement between GPs’ and specialists’ records of the same patients with 
suspected TIA  
There was substantial disagreement over the presence or absence of key clinical features 
that determine risk of recurrent stroke from the ABCD2 score – speech disturbance, 
unilateral weakness and duration of symptoms (24). There was greater agreement over 
speech disturbance, less so for unilateral limb weakness and less again for facial weakness, 
with lowest agreement for level of duration of symptoms. This has implications for the 
appropriate usage of TIA clinic slots as incorrect risk assessment of high risk patients as low 
risk increases their time to clinic appointment from 24 hours to seven days (60). 
Disagreement may also reduce the availability of the usually smaller number of urgent clinic 
slots by incorrectly labelling low risk patients as high risk making it harder for clinics to meet 
the high risk patient target of 24 hours. 
14.1.2 GP-specialist disagreement and final clinic diagnosis 
Patients with TIA had a lower mean ABCD2 score from GPs than specialists, but referred 
patients without TIA had a higher mean score from GPs than specialists. Within the category 
of patients with TIA, anterior TIA patients had a lower mean score from GPs than specialists 
and posterior TIA patients had a higher mean score from GPs. The key symptom 
disagreements underpinning these findings were over facial and limb weakness and speech 
disturbance with the lowest agreement over duration of symptoms mainly because it is not a 
dichotomous measure, thereby allowing three values for disagreement rather than two. 
Differences in the prevalence of symptoms in different diagnostic groups, as assessed either 
by GPs or specialists makes the kappa coefficient of agreement less straightforward to 
interpret and identify if there is systematic over or under attribution of symptoms by GPs.  
14.1.3 Impact of GP-specialist disagreement on the performance of the ABCD2 score for 
accurate triage of patients with TIA 
From clinical records of patient histories, GPs would underscore patients at higher predicted 
risk and overscore patients at lower predicted risk. Furthermore in anterior TIA patients GPs 
would underscore and in posterior TIA patients they would overscore when compared with 
specialist scores, which act in this case as a gold standard of risk prediction, given the pre-
existing validation of the ABCD2 score in specialist derived scores. This results in a good but 
not perfect sensitivity to detect high risk cases (as defined by specialists) with the risk that if 
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guidelines for time to assessment are adhered to, a small number of recurrent strokes may 
occur in a relatively small group of high risk patients who are thought to be lower risk, before 
they are investigated and have optimal medical management in place. 
This analysis suggests that the ABCD2 score may not work as well as a predictive tool in 
primary care and therefore may not improve the delay that high risk TIA patients currently 
experience in specialist assessment. A small number of strokes may occur annually as a 
result of incorrectly triaging high risk TIA as low risk thereby incurring a longer delay to clinic 
appointment. 
14.1.4 Limitations of this analysis 
Although this method of retrospective scoring of the ABCD2 score has been used previously 
with specialist records (25;224) there are no published reports of scoring from the primary 
care record at the initial consultation in general practice. However, retrospective scoring 
reduces the chance of score optimisation bias where GPs will know that if a patient has a 
score of 4 or more then they will be seen urgently and this is a more risk averse strategy 
than the patient waiting for a week before a definitive assessment. 
14.1.5 Future Research and Practice 
Even though derivation and validation of the score for early recurrent stroke have been 
carried out on hospital records (23;24;26-29) it has been widely recommended for use in 
primary care (35;36;60) where its validation metrics have not been assessed. The 
phenomenon of derivation and validation in secondary care with implementation 
recommendations to primary care has been noted as a cause of poor performance in 
prognostic models (273). 
To answer the question of the impact of this disagreement would require prospectively 
studying the agreement among consecutively referred patients to a TIA clinic where GPs 
have to use the ABCD2 score as part of the referral process and TIA specialists complete 
the score as well. The level of agreement could be examined in relation to diagnosis and 
time since referral from primary care in case disagreement is higher for longer elapsed time 
periods from the clinical event. Furthermore the key outcome of appropriate urgent clinic slot 
usage could be determined, as well as disagreement over the individual score, although this 
is less meaningful than disagreement over dichotomised risk status. The only similar study 
reported is small, did not examine referring clinician specialty (primary care, ED or general 
physician), did not examine risk status or appropriate urgent slot usage and would not have 
been powered to detect influences on the degree of disagreement (227). 
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14.2 The impact of GP-specialist disagreement on the discrimination metrics of 
existing clinical prediction tools for TIA diagnosis 
14.2.1 ABCD2 score 
For both specialist and GP scores, the sensitivity and specificity plots with increasing ABCD2 
cut offs demonstrate that there are no acceptable values with sufficiently high sensitivity and 
specificity. Furthermore, the predictive value plots for the GP scores display low predictive 
values for increasing cut off points for diagnosis.  
For both specialist and GP ABCD2 scores, the mean values in TIA patients were higher than 
non-TIA patients and anterior TIA scores were higher than posterior TIA scores. For both GP 
and specialist the distribution of anterior and posterior TIA scores had opposite skews with 
peak numbers of patients scoring at the upper end for anterior TIA and at the lower end for 
posterior TIA. Specialist scores appear to calibrate better than GP scores with higher 
specialist scores associated with an increased chance of TIA diagnosis. 
The potential for ABCD2 as a diagnostic rule has been suggested by several authors with 
similar validation methods for discrimination in a TIA clinic population using ROC curves with 
AUC values of 0.68 for TIA, 0.70 for combined TIA and minor stroke (177) and 0.75 for 
combined TIA and minor stroke (224).  The specialist record derived ABCD2 score in 
OXVASC on ROC analysis has an AUC of 0.71 for TIA which is in keeping with these other 
reports but again there is a marked territory variation in performance with an anterior TIA 
discrimination AUC of 0.75 and a posterior TIA value of 0.59. The reports cited above did not 
explore the influence of arterial territory on diagnostic performance. 
However given that for the majority of UK patients GPs will be initially suspecting the 
diagnosis, one should know the diagnostic performance of the ABCD2 score in their hands. 
The GP derived scores again showed lower AUCs for TIA vs non-TIA of 0.62 and for 
posterior TIA vs non-TIA of 0.48 i.e. no better than chance discrimination. 
Inspite of suggestions that the ABCD2 score could be used for diagnosis, its performance as 
a diagnostic tool even in specialist hands is limited. The performance assessed by ROC 
plots demonstrates low AUC values, and no additional value above chance for posterior TIA 
detection. For GP ABCD2 scores, there is no value that offers appropriate sensitivity and 
specificity and the positive predictive values across the range of scores do not rise much 
above general prevalence in the suspected population, indicating that it is not useful for 
refining referral decisions. 
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14.2.2 Dawson tool 
The AUC for the Dawson score was lower in the GP dataset than the specialist dataset, with 
the greatest difference for posterior circulation TIA. Dawson et al  did not report an AUC for 
their model, only the sensitivity/specificity/PPV/NPV for two cut points – an optimal ROC 
derived score and a further cut point reflecting 2:1 costs of misclassification (222). However, 
they did suspect that their tool would have different performance metrics in specialist and GP 
histories, and this is indeed the case from the data presented in this thesis. 
Overall prevalence of TIA in the GP referred patients was similar to the complete group of 
OXVASC clinic referrals (41%) but diagnostic performance in GP derived histories was 
substantially poorer. GP derived scores had lower AUCs than specialist scores (0.70 (S.E. 
0.02) vs 0.82 (S.E. 0.02)) for TIA diagnosis and were at chance on posterior TIA patients 
(0.52 (S.E. 0.04) vs 0.70 (S.E. 0.03) specialist scores)  
At the 5.4 cut point suggested for the recognition tool, the sensitivity (96%) and specificity 
(28%) of the specialist derived score are comparable to those reported by Dawson et al in 
their internal validation (97% and 24%). Interestingly the predictive value of specialist score 
in the OXVASC data although lower than in the Dawson validation sample is in fact a 
substantial improvement on the OXVASC baseline prevalence. The prevalence of TIA in the 
Dawson validation sample was 60% which increased at the tool cut point to 68%, whereas 
using the specialist derived score in OXVASC increased predictive value from 46% baseline 
prevalence to 61% at the 5.4 cut point. 
Although Dawson et al used an outcome of cerebrovascular disease (i.e. TIA and minor 
stroke), the key diagnostic issue in primary care is for patients with resolved or rapidly 
resolving deficits. There is no management dilemma for patients with persisting stable 
deficits at the time of consultation, as there is a clear clinical problem that requires a 
solution. Transient phenomena are more difficult to assess as there are no robust physical 
signs and the history of events along with the contextual information of vascular risk factors 
are the only data available. Thus the outcome of interest is TIA diagnosis and so all patients 
with transient phenomena i.e. TIA patients and those with transient phenomena in the non-
TIA population were used as the validation datatset. The implications of a difference in 
clinical histories between GP and specialist for the same patient is that a diagnostic rule 
using variables from the clinical history is likely to have different validation metrics in GP 
histories and specialist histories. 
The analysis of the Dawson tools’ significant predictors in the hospital records dataset shows 
that diplopia is not distributed differently between patients with and without TIA. Whilst 
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headache is still a significant negative predictor in OXVASC,  the associated p value of 0.03 
is much higher than that associated with the other predictors, and higher than the original 
derivation model in the Glasgow clinic (0.00007 (222) ) suggesting that it does not have such 
a difference in prevalence between TIA and non-TIA in OXVASC. This may represent an 
element of subjectivity of TIA diagnosis, given that all patients with TIA in OXVASC had one 
senior neurologist ultimately determine diagnosis (PMR), and disagreement over TIA 
diagnosis between neurologists has been noted previously (183;270).  
14.2.3 Limitations of this analysis 
The limitations of ABCD2 scoring from primary care records in discussed in 14.1.4. 
Differences in the reported performance of the Dawson score and performance in OXVASC 
may represent the difference between routinely collected clinical records and research 
records. This difference has been noted before particularly for stroke onset times (74). 
Predictors in derivation and validation should be collected systematically (274) and by using 
the content of clinical records there is no guarantee of systematic history taking. However, 
the key associated features of focal deficit such as headache are more likely to be taken 
systematically by a TIA specialist as part of the exclusion of mimic conditions. 
The analysis of individual Dawson tool predictors collected from primary care records 
showed that a number were no longer significant – headache, diplopia, and unilateral 
weakness of face or limb. GPs clinical records were taken as part of routine care rather than 
for research purposes and so the extent of symptom questioning may well be less rigorous 
than a specialist might undertake, contravening the principle of systematic predictor 
measurement (274). However, face and limb weakness do not appear to be differently 
distributed between TIA and non-TIA patients and therefore they drop out as being 
predictors of diagnosis. This is not because they are not elicited, it is because they are 
equally prevalent in both groups of patients.  
There are no other similar studies to compare the effects of territory on diagnostic tool 
performance after presentation with TIA.  However, the performance of the FAST test of 
recognition of stroke was compared between anterior and posterior stroke patients with 
equal sized groups demonstrating differences in sensitivity - 61% of posterior strokes 
compared with 92% of anterior strokes were detected (275). 
14.2.4 Future research and practice 
For GP derived scores at the optimal cut point of 5.4, there is not a large difference in 
predictive values from baseline, with an increase in TIA prevalence from 41% to 44% and 
157 
 
the low specificity of 18% explains why prevalence has only slightly increased – most non-
TIA patients would still be referred at that cut point. 
GPs are most likely referring because there is some feature in the clinical history that makes 
them suspect the diagnosis i.e. the patient presentation resembles the diagnostic pattern. It 
follow that more classical diagnostic features may be present in both TIA and non-TIA 
patients as judged by the doctor who is initially suspecting TIA. Thus patient narratives that 
are interpreted as weakness will generate the suspicion of TIA and hence membership of the 
group of referred patients.  
On the other hand, the diagnostician specialist will be seeking to decide who has and who 
has not had a TIA from clinical history. They will therefore be reinterpreting the report of 
events and those that are not TIA will not have the diagnostic features. This would predict 
that specialists would have lower scores than GPs for non-TIA patients as they would be 
finding fewer of the diagnostic predictors in these patients, which is the case with a mean 
difference of - 0.3 between the specialist score and the GP score. On the other hand, in the 
case of patients with TIA, GPs are under finding diagnostic features which the specialists are 
recording, with a mean difference of + 0.3 between specialist and GP for patients with 
anterior TIA. 
Thus a new prediction tool is required that should be derived from primary care taken 
histories, as those from specialist records are likely to validate poorly with little gain in terms 
of refinement of the referral population. 
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SECTION 5 Prediction Rules for TIA in Primary Care 
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Chapter 15 Methods 
15.1 Introduction 
Primary care records have not been previously explored for their potential to be used in 
deriving predictors for final clinic diagnosis of TIA. Section 4 demonstrated that existing 
decision tools derived from secondary care records are unlikely to be useful for primary care 
to support the diagnosis of TIA. The research questions that address this issue are  
1. Which clinical predictors are included in a prediction rule for TIA diagnosis derived from 
primary care records in suspected TIA? 
2. What are the calibration and discrimination metrics for a model of TIA diagnosis derived 
from primary care records in suspected TIA? 
To answer these questions, the primary care records for all referrals to the TIA clinic in the 
2002 – 2006 OXVASC cohort were analysed for all symptom content and grouped into 
categories of neurological dysfunction. These categories were treated as potential predictors 
and a logistic regression model derived to predict TIA diagnosis. Predicted probabilities from 
the model were used to construct a calibration curve and scores based on the logistic 
regression model (both with and without weighting from beta coefficients) were used to 
assess discrimination from ROC curves. 
We do not know what the true underlying relationship is between predictors and the outcome 
of TIA diagnosis. The different methods of modelling this relationship are just that – different 
models, without any particular claim on the truth. As such we should admit that there is 
‘model uncertainty’ in that there is no clear decision about which model should be used. 
Although logistic regression is commonly used to derive prediction rules for diagnosis there 
are alternative methods of statistical modelling which offer potential advantages - 
classification trees and the random forest method of bootstrapped multiple classification 
trees. The research question that addresses this is  
3. Does choice of statistical model affect discrimination metrics for TIA diagnostic models? 
This question was answered by creating a classification tree to discriminate between TIA 
and non-TIA using the same clinical predictors as the logistic regression model, and by 
creating a random forest again using the same clinical predictors as the logistic regression 
model. In order to compare their metrics using the same methodology, the original full cohort 
dataset was randomly split into training and testing datasets. Then logistic regression, 
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classification tree and random forest models were derived from the training data and 
discrimination measured on the testing data using ROC curves. 
15.2 Coding GP clinical records 
The clinical presentations from histories taken by GPs were coded according to broad 
symptom categories. These categories were formed after grouping all relevant descriptions 
of suspected TIAs and forming groups consisting of the smallest number of patients. This 
maximises the number of symptoms to select whilst allowing pragmatic grouping for smaller 
units within related themes. For example a specific observation that GPs made was that 
some patients reported normal speech but transiently, a particular word which they knew 
eluded them and thus isolated ‘word finding difficulty’ can be identified. However, this could 
also be grouped within a higher category of ‘all speech disturbance’ and is distinct from 
nominal aphasia which is a much more severe symptom affecting classes of words e.g. 
nouns rather than a specific word in the context of otherwise normal speech. 
Cases were excluded if they were seen in accident and emergency first before referral (in 
the UK or abroad) and told that they had a TIA or minor stroke and were asked to see their 
GP for an onward referral. The history that may be recorded in this situation may not be the 
one that a primary care practitioner would have taken if seeing the patient first. These 
patients are attending primary care because the healthcare system demands it having 
attended another part of the service, rather than reflecting a ‘primary care’ population. 
Patients were also excluded if they presented with a non-TIA after recruitment into OXVASC 
with a TIA or minor stroke at initial ascertainment. This is because the decision making 
process may be altered by the fact that the GP (and patient) know that they are in a research 
study with regular follow up where potential recurrent events are assessed. Thus it is not 
similar to a fresh referral where a GP is trying to decide if a patient’s narrative could be a TIA 
and therefore a decision rule that is derived using such cases may not validate well outside 
of the OXVASC research process. 
Patients with symptoms persisting for longer than 24 hours were excluded because they 
pose less of a decision-making problem - a neurological deficit that persists requires 
investigation in order to ascertain the underlying cause. The key decision that this analysis 
aims to support is the decision to refer based on history alone with no neurological deficit on 
clinical examination. Given that only TIA patients ascertained in OXVASC are used in the 
derivation of this diagnostic decision rule, the non-TIA patients should be those that most 
closely mimic TIAs, i.e. they have had transient symptoms without persisting deficit. 
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15.3  Methodologies for diagnostic model derivation – logistic regression 
Logistic regression is one of the commonest used techniques for selecting optimal predictors 
for a dichotomous outcome in clinical prediction research. After selecting plausible predictors 
either from previous research or clinical consensus, each is tested in turn (univariate 
analysis) to see if individually they are predictive of a cerebrovascular diagnosis. Those 
passing a minimum level of statistical significance (probability of the data given that the null 
hypothesis is true < 0.05) are included in a forward stepwise logistic regression. This method 
of analysing relationships seeks to select the fewest number of variables that predict a 
binary outcome (presence or absence of cerebrovascular diagnosis).  
Using the logistic transformation, where the probability that cerebrovascular disease is 
present is transformed to  
 log (odds (probability that cerebrovascular disease present)) 
a linear predictor of that transformation is estimated. Thus for each variable that has 
predictive power after the inclusion of other variables (i.e. is significantly associated with 
cerebrovascular disease presence after adjustment from other included variables), a 
coefficient is derived. Methods of parameter derivation for logistic regression use maximum 
likelihood techniques which use iterative methods to refine parameters and estimate them 
based on convergence to an asymptotic value. The likelihood that is maximised is the 
probability of finding the observed data assuming that the model is true (276).  
In order to calculate the probability that cerebrovascular disease is the cause of symptoms, a 
reverse transformation of the linear variables is needed, weighted by their associated 
parameters e.g. 
                                    
 
      
 
where lp =                      , and    is the ith predictor. 
Logistic regression in essence will derive the strength of prediction that is due to an 
individual clinical predictor, given the presence of other significant predictors in the dataset 
as a whole.  
However, there may be situations where a variable such as presence of a certain symptom 
may only have predictive power in a restricted range of patients, defined by co-existence of 
other features. By itself that variable may not be significantly associated with the outcome 
across the dataset as whole. As such it is unlikely to be identified by logistic regression as a 
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predictor of the outcome, even though it may have utility in terms of discriminating the 
presence of disease in a defined set of patients.  
15.4 Diagnostic rule derivation with regression using GP histories 
Using the categories from analysing GP records of clinical events, all were considered as 
potential predictors alongside age and previous history of TIA/Stroke and were tested to 
examine univariate associations with diagnosis of TIA and those with significant predictive 
ability were selected to go into a forward stepwise logistic regression. The model outputs 
were then used to derive predicted probabilities of TIA and the distributions of predicted 
probabilities were examined for internal calibration and discrimination. 
15.5 Methodologies for diagnostic model derivation – rationale for classification 
trees 
Multivariable logistic regression models use only those variables that still significantly predict 
the presence of TIA after adjusting for other predictors found on univariate analysis. Thus 
the model assesses the strength of a predictor allowing for the presence of other variables 
that also have some predictive value. 
However, it may well be the case that a variable has strong predictive power only in a group 
of patients defined by certain characteristics. In this case that predictor may not be included 
in a logistic regression model as its statistical effect will be diminished by the presence of 
other predictors, unless a specific interaction term is inserted into the logistic regression 
model to explicitly account for the fact that we are interested in the predictive power of this 
variable given the presence of other features. 
With a large number of potential predictors, specifying all the interactions a priori will 
generate a large and complex logistic regression model, as well as a decision rule that is 
even more complex as a given predictor may have a different weighted multiplier in a score 
depending on the co-occurrence of other predictors. Furthermore, even without the 
complexity of specifying interaction terms, the diagnostic scores derived from logistic 
regression models are not straightforward to use, particularly if weighted models are used. 
Rather than calculating a score which is time consuming and error-prone, an alternative 
strategy is to derive an algorithm where the response to certain key questions determines 
the decision to refer for a suspected TIA. 
A classification tree model consists of a number of questions about the predictor variables 
which are asked in a fixed order. This is said to mimic the clinical decision making process 
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with most important predictive variables asked about first (276). A tree is constructed by 
producing partitions or splits in a derivation dataset depending on the value of a predictor – 
either a cut point for continuous predictors such as age or blood pressure, or the presence or 
absence of a binary categorical predictor such as weakness or confusion.  
The splits in the data produce smaller sub groups, and are chosen such that there is 
maximum difference between the subgroups i.e. an age cut off is chosen which produces 
two subgroups with the greatest difference in % TIA within the subgroups. The predictor 
which results in the largest separation in % outcome in the two subgroups is placed at the 
top of the tree as the most important predictor. 
As the tree is ‘grown’ with increasing numbers of predictors used, splitting of the remaining 
data into further subgroups continues until there are too few cases to produce subgroups 
(this can be specified in the modelling) or until there is no more improvement in outcome 
prevalence in subgroups compared with the parent group used to produce the split. 
Two advantages of tree models over logistic regression are simplicity of presentation (and 
usage) and the incorporation of multiple interaction effects, and given the number of 
branches of trees, these interactions can be of high order (i.e. the effect of variable a, given 
a value of variable b and c etc. along the branches of a tree). In logistic regression, such 
interactions would need to be explicitly included and are rarely higher than second order i.e. 
a term for the interaction of two predictors. The process of tree construction assumes that all 
predictors interact with each other. 
However, although interactions are presumed in classification trees, the higher order 
interaction is only modelled in a specific branch of a tree and not modelled along other 
branches. This is because predictors are used to split groups where they produce the 
greatest subgroup differences, and this may be several nodes away from an initial large split 
in the dataset. As such, there may be patients channelled along distant parallel branches of 
a tree that could contribute to an interaction term but are not included in the generation of a 
subgroup split using that interaction, as they were split off at an earlier stage due to the 
presence or absence of another predictor. An interaction term in a logistic regression model 
would be applied across the dataset rather than in a restricted set of patients due to prior 
branching. 
A further disadvantage of classification trees are the categorisation of continuous variables 
needed to produce a split as this reduces information and would not occur in regression 
modelling. However, in the dataset under consideration in this thesis only one clinical 
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predictor is not categorical (age), with the others being the dichotomised presence of 
predictors from clinical histories and thus this is not a particular disadvantage. 
Irrespective of theoretical advantages and disadvantages, a classification tree analysis of the 
GP dataset is warranted to explore the potential for a clearer set of decisions that could 
support referral from primary care to secondary care for suspected TIA, without needing to 
perform potentially complicated calculations in the real time setting of the consultation. If a 
classification tree has similar discriminating performance to a complicated score then it may 
have greater utility as it will be easier to follow and incorporate into history taking and clinical 
assessment. 
15.6  ‘Pruning’ a classification tree 
The ‘rpart’ package in R software (www.r-project.org) was used to generate a classification 
tree with TIA diagnosis as the outcome to be predicted, and all GP clinical variables were 
included alongside age and prior history of cerebrovascular disease as potential predictors. 
This is similar to the initial analysis for the logistic regression method where all potential 
predictors are considered in the univariate analyses for statistical significance. 
Trees can be ‘pruned’ such that a smaller number of branches are used but ensuring that 
they still effectively partition the dataset into patients with and without disease. The pruning 
process is determined by the effectiveness of splits in the data for the distal branches in a 
tree (277). In the basic tree models, the trees grow until there is no more data or the split 
doesn’t result in different prevalences of the outcome in the subgroups compared with the 
parent group at that split. Some splits could produce fairly trivial differences in subgroup 
prevalences and add complexity without adding much to the discriminating ability of the tree 
in the overall dataset.  
A ‘complexity parameter’ can be defined which will only allow a splitting if there is a big 
enough improvement in model fit and if not, then the tree will stop growing (rather than being 
‘pruned back’, the tree is not allowed to grow, so the gardening metaphor behind the 
terminology does not reflect the mathematical processes). 
The complexity parameter takes into account the number of patients at the ‘node’ or decision 
point to be split, the number of nodes in the tree as a whole and the change in the predictive 
ability of the whole tree (the model fit) as a result of the split. The complexity parameter 
informs the tree growing algorithm that a further split is allowed if it reduces the overall lack 
of fit (the residual mean square) by a certain factor (the value of the complexity parameter) 
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Identifying the best value for the complexity parameter comes from a cross-validation 
exercise. The dataset is randomly split into a number of groups and classification trees are 
‘grown’ using the same initial variables but only using the data from outside a given group 
and tested for how accurate its predictions are on data in the given group, by deriving a 
misclassification rate. This is done over a range of different complexity parameters, which 
will therefore result in a range of tree sizes for each attempt to predict the diagnosis in a 
given group. This whole process is repeated for each of the randomly constructed groups, 
one at a time, giving a misclassification rate each time a complexity parameter is tested in 
each of the groups. This results in an estimate across the groups of the misclassification 
error for each potential value of the complexity parameter.  
The ideal complexity parameter (cp) is the one that results in the least error. As tree size 
increases, associated with lower and lower potential values of the cp, a minimum value can 
be identified. However, as this could still be associated with a large tree, the ideal value is 
taken as one that is within one standard error of the minimum value. This allows the choice 
of a cp which is low enough to reduce misclassification but not so low that it will end up 
generating a tree that is as complex as the initial one. 
15.7 Tree based decision rules for GP diagnosis of TIA 
An internal validation was carried out using predicted probabilities from the modelling that 
created the decision nodes in the tree using R software. Discrimination was assessed using 
cumulative frequency plots and corresponding ROC curves to demonstrate the difference 
between unpruned and pruned trees.  
The performance measures of sensitivity, specificity and positive and negative predictive 
values change with progression along the tree. This is equivalent to using only the first one, 
two or three etc. splits and then examining the results in terms of misclassification 
summarised via a 2X2 table after each successive split to give the usual four measures of a 
diagnostic test performance. If the total tree is still too large or complex to use in practice, we 
can examine how using an initial subset of the tree could help support decision making. We 
can consider the utility of the predictor choice and degree of importance in terms of how far 
along the tree they are introduced by examining the cumulative performance at successive 
splits.  
Given the risks of not referring patients with TIA i.e. failing to prevent a recurrent stroke in a 
proportion of patients, it is clearly more harmful to misdiagnose a patient with TIA as non-
TIA, than to misdiagnose a patient without TIA as having had a TIA. Patients without TIA 
who are diagnosed with the aid of a decision rule in primary care will be referred, having 
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been given medication (currently aspirin only according to NICE guidelines) and may be 
investigated. As such the harms of referral for these non-TIA patients are the temporary 
exposure to aspirin and potential harms from any brain imaging (ionizing radiation exposure 
via computed tomography, claustrophobia from magnetic resonance imaging) and financial 
costs to patient and healthcare system of appointments and investigations. 
In order to reflect the fact that misdiagnosing a TIA as a non-TIA is more undesirable than 
misdiagnosing non-TIA as TIA, a cost can be applied to missing a true TIA diagnosis. This 
cost may result in different predictors or different cut points being chosen such that there are 
fewer misclassifications of true TIA as predicted non-TIA compared with a tree without such 
costs. Using the same dataset, a classification tree was derived using a cost matrix 
specifying that the costs of misclassification of true TIA as predicted non-TIA were twice that 
of true non-TIA as predicted TIA. 
15.8 One tree or multiple trees? Potential for ensemble prediction via Random 
Forest analysis 
Where models are used for forecasting in economics and meteorology, combinations of 
predictions from different models have been found to reduce errors and provide more 
accurate estimates than using individual models (278). This approach has not been 
systematically tested in clinical situations with different clinical prediction models for a given 
diagnosis. 
One further consideration in improving prediction is the generalisability of prediction models 
generated using the OXVASC dataset. How sensitive are the methods to slight alterations in 
the prevalence of the clinical features of the patients with and without TIA? If the models are 
‘over-fitted’ i.e. they perform well at internal validation but poorly on external validation, then 
they will have little clinical utility in day to day practice. 
Classification trees are data driven in that all predictors are taken into consideration as 
potentially helpful in splitting a group of data into two sub groups with maximal difference 
between them in the outcome (276). It could therefore be argued that slight alterations in the 
data may result in different predictors being chosen at a given split or a different order of 
similar predictors which would result in different patients being selected for referral or 
reassurance. Methods that can incorporate the influence of perturbations in the derivation 
dataset may offer more reliable prediction at external validation. 
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15.9  Random Forests – theory and potential advantages 
A random forest is a group of classification trees which have all been derived from subsets 
of data, drawn from the same overall dataset (279). A criticism of deriving a single 
classification tree is that it is susceptible to small changes in the data and particularly the 
choice of the first node, i.e. the most important predictor, may differ depending on the 
underlying predictor prevalences within the diagnostic groups (280).  In order to have greater 
confidence in the generalisability of model predictions, the random forest in effect tests 
susceptibility of predictor choice to random changes in training data. 
Each tree is derived from a random two thirds of the original dataset, termed the ‘training 
set’, which implies that one third of the data is not used to construct the tree (and that third of 
the data is given the label ‘out of bag’). For successive trees, each one is derived using a 
different randomly chosen two thirds of the dataset. Thus some data points may be used 
multiple times or possibly not at all. Each tree selects predictors from a randomly chosen 
subset of all predictors at each node (the size of this subset can be varied) (277). 
The random forest is comprised of all the trees that are derived by the underlying algorithm - 
the total number of trees can be set for each forest derivation but no more accuracy is 
gained beyond 500 trees (280).  
Each tree can be validated on the data not used in its derivation i.e. the one third of data that 
is ‘out of bag’, by comparing the predicted diagnosis using the tree with the actual diagnosis 
for each patient in the out of bag dataset. This can be averaged over all 500 trees in the 
forest to produce an average ‘out of bag’ error rate. This is calculated as a misclassification 
rate and is presented as a simple 2X2 table. 
However, the actual discriminatory performance of the forest is measured by allowing each 
tree in the forest to classify a set of data. Thus in this case there will be 500 predictions of 
the presence of TIA for each patient, which are summarised to give one output. The 
classification output is by ‘vote counting’ where a simple majority of trees ‘wins’ so if for a 
given patient in a test dataset 260 trees in the forest predict TIA and 240 trees predict ‘not 
TIA’ then that patient is predicted to have a TIA. The output of predicted probability of TIA is 
given as the proportion of trees that classify a patient as TIA, so for the above example the 
predicted probability of TIA is 260/500 = 0.52.  
The importance of variables used by the trees in the forest is determined by two measures. 
One assesses how well the predictor creates two sub groups that are different with respect 
to the outcome, in this case TIA prevalence (this is termed a reduction in ‘node impurity’ as 
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two sub groups should be created with one having a higher TIA prevalence than the parent 
node and one with a lower TIA prevalence than the parent node). This is known as the Gini 
index and a variable is more important if it results in a greater decrease in ‘impurity’ after it is 
used to split a node. The Gini importance is an indication of how often it was used by the 
different classification trees in the forest and the size of the discriminative value. 
The other measure describes the importance of predictors by assessing how much 
prediction accuracy reduces if they contain random noise rather than the original datapoints. 
This is calculated by taking all the classification trees using a certain predictor, and then 
adding ‘noise’ or random error to the values of that predictor in the out of bag data but 
leaving the other predictors intact in the out of bag data. Then the trees make predictions 
from the ‘permuted’ out of bag data and the prediction error is compared to that found using 
the unadulterated out of bag data (279). By surveying all the classification trees in a forest, 
the importance of different predictors can be found and their relative importance 
characterised. Of the two measures, the Gini measure is thought to be more robust (281). 
Variable selection by a random forest analysis has been used to determine the importance 
of predictors for clinical conditions such as depression in patients with rheumatoid arthritis 
(282). 
15.10  Derivation of a Random Forest using Primary Care data for diagnosis 
The ‘randomForest’ package in R software was used to generate a random forest for TIA 
diagnosis using GP histories in the full referral dataset. This allows for a comparison of the 
predictors that the different modelling techniques select.  
A random forest will provide perfect discrimination of its training data as the classification 
trees are grown to maximal depths, even down to single patients in the final nodes and so 
separate datasets are required to derive sensitivity and specificity. The classification error 
from the out of bag data does not allow for adjusting the threshold probability for diagnosis 
as a majority vote is used for classification and as such varying sensitivity and specificity 
over a range of thresholds is not possible. 
Therefore in order to test the predictions from a random forest, I decided to split the primary 
care patient dataset into two randomly chosen and equal halves. This is so that a forest can 
be derived from one half, and then the actual prediction probability used from the other half 
to construct a receiver operator characteristic curve. This allows calculation of sensitivity and 
specificity for comparable metrics with the outputs from the other prediction methodologies. 
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15.11  Comparison with other modelling techniques 
In order to create a fair comparison, the logistic regression model and the classification tree 
model were re-derived using the same derivation dataset, and then validation metrics 
calculated by applying them to the same validation dataset. This is not an external validation 
as both datasets are from the same underlying population. All three methods were 
graphically compared on an ROC plot. 
15.12  Using diagnosis specific cumulative frequency plots to visually display 
discrimination 
One limitation of reading an ROC curve is that there is no way to determine the actual 
optimal score, without further calculation. The area under the ROC curve gives the 
probability that a randomly selected patient with disease will score more highly than a patient 
without disease in pairwise comparisons for the entire group. This statistic does not have a 
clinical interpretation, given that the clinician will be faced with a patient with a suspected 
diagnosis and a score value.  
Differences in distributions of scores between affected and unaffected patients will determine 
the area under the ROC curve. At a given score of a patient with a disease, the probability 
that a patient without disease will score less is determined by the fraction of disease-free 
patients with scores less than that of the randomly selected patient with disease. A 
cumulative frequency plot of the scores of patients with disease alongside a cumulative 
frequency plot of patients without disease displays these differences in distributions that 
determine the area under the ROC. The difference in the cumulative frequency curves of the 
ABCD2 score for patients with and without TIA for example is shown in figure 15.1. As an 
example, a cut point of 3 is displayed with the probability that a patient with TIA will score 
more than 3 and the probability that a patient without TIA will score less than 3. 
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Figure 15.1 Cumulative frequency of specialist ABCD2 scores among TIA and non-TIA 
patients with cut point at score = 3 
The cumulative frequency plot has the advantage of showing how discrimination (as 
measured by the probability of patients with disease scoring more than patients without 
disease) varies with the actual score. If the cumulative frequency plot of patients with 
disease is right shifted from those without disease, then (1-cumulative frequency for disease) 
is greater than (cumulative frequency in non-diseased) and hence the probability of patients 
with disease having higher scores than those without disease will be greater which will 
correspond to a higher area under the ROC curve. If the lines cross over, then patients with 
disease are more likely to score lower than those without disease. 
The relationship between disease specific cumulative frequency plots and the ROC curve 
concerns determination of optimal cut points. Figure 15.2 shows a section of an ROC curve 
near the upper left point (coordinates 0% (1-specificity), 100% sensitivity), and the optimal 
cut point on the curve, which should maximise sensitivity and specificity. 
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Figure 15.2 Optimal cut point on a portion of an ROC curve 
The minimum distance between the curve and the coordinates (0, 1) is the hypotenuse of 
the right angled triangle with sides (1 – sensitivity) and (1 – specificity). This distance is at its 
minimum when (1- sensitivity) and (1 – specificity), constrained by the shape of the curve, 
are at their minimum values (from Pythagoras’ theorem). 
However, (1 – sensitivity) at a given cut point is the % of TIA patients who would test 
negative at that cut point. This equals the cumulative frequency of scores from 0 to that cut 
point, given that all patients below the cut point are going to be diagnosed as test negative.  
(1- specificity) at a given cut point is the % of non-TIA patients who would test positive, 
which equals (1 – cumulative frequency) at that cut point i.e non-TIA patients who would 
score above the cut point. These concepts are illustrated in figure 15.3, with the distance d 
representing the difference between the two curves. 
1-sensitivity 
 
1 - specificity 
Coordinates     
(0,1) 
172 
 
 
Figure 15.3 Cumulative frequency plots of specialist ABCD2 scores for TIA and non-
TIA patients, illustrating derivation of sensitivity and specificity at optimum cut point. 
Given that at any cut point, (1- sensitivity) + (1 – specificity) + d = 1, when (1 – sensitivity) 
and (1 – specificity) are both at a minimum within the confines of their respective curves, d is 
at a maximum. Hence at the optimal ROC curve defined cut point, d on the cumulative 
frequency plot is at a maximum. 
Therefore cumulative frequency plots allow a visual inspection of the optimal cut point 
defined by the vertical distance between the cumulative frequencies. They also allow an 
assessment of where scores fail to discriminate. For example an area under the ROC curve 
of 0.5 could be due to a 0.5 chance of discrimination throughout the range of scores or to 
strong positive discrimination for one half of the score range and strong negative 
discrimination for the other half of the score range. 
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Chapter 16 Coding predictors and logistic regression 
16.1 Coding clinical features from GP records 
The clinical records for 496 referred patients with suspected TIA were available for analysis. 
Table 16.1 lists the symptom categories with included and excluded features. 
The initial univariate analyses of the clinical predictors are shown in Table 16.2. For each 
potential predictor, the prevalence within TIA patients and non-TIA patients are given along 
with the relative risk (RR) with 95% confidence intervals and p values for comparison using 
χ2 distributions (Fisher’s exact test for 0 values). 
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SYMPTOM Included symptoms Excluded symptoms 
Muzzy Head Muzzy/fuzzy/funny feeling in head  
Headache Headache/pressure sensation in 
head 
 
Dizziness Vertigo/dizziness/swimming feeling  
Ataxia Unsteady walking/loss of control of 
arm without weakness/difficulty 
walking without leg weakness 
 
LOC reduced level of 
consciousness/reduced 
responsiveness 
Feeling faint 
Facial weakness unilateral, upper or lower motor 
neuron not specified 
Bilateral weakness 
Limb weakness unilateral arm/hand/leg, 
weakness/heaviness 
Bilateral weakness 
Facial sensation unilateral numbness/paraesthesiae Bilateral sensory change 
Limb sensation unilateral arm/hand/leg, 
numbness/paraesthesiae 
Bilateral sensory change 
Nausea or vomiting   
Altered visual perception distortion/flashes/blurring/arc/zig-
zag, monocular or binocular 
 
Absent visual perception curtain/darkness/dark 
patch/clouding monocular or 
binocular 
 
Diplopia Double vision, horizontal or vertical  
Speech disturbance Slurred speech/global word finding 
difficulties/receptive and expressive 
dysphasia 
 
Word finding difficulty isolated to specific words (rather 
than classes of words e.g. nouns), 
with rest of speech normal 
 
Memory loss Procedural or declarative  
Confusion Patient or witness report  
Table 16.1 Categories of GP symptoms for suspected TIA referrals 
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SYMPTOM No TIA 
n/N 
TIA  
n/N 
RR 
Lower 95% 
CI 
Upper 95% 
CI 
P  
Muzzy Head 6/295 0/201 0 na na 0.08 
Headache 33/295 19/201 0.88 0.61 1.28 0.59 
Dizziness 31/295 11/201 0.62 0.37 1.04 0.06 
Ataxia 18/295 13/201 1.02 0.67 1.57 0.92 
LOC 26/295 1/201 0.09 0.01 0.59 <0.001 
Facial weakness 19/295 19/201 1.24 0.89 1.74 0.32 
Limb weakness 67/295 56/201 1.15 0.92 1.45 0.28 
Facial sensation 18/295 15/201 1.12 0.76 1.65 0.72 
Limb sensation 57/295 19/201 0.57 0.38 0.85 0.003 
Nausea or vomiting 14/295 2/201 0.3 0.08 1.09 0.04 
Altered visual perception 37/295 16/201 0.71 0.47 1.09 0.12 
Absent visual perception 20/295 28/201 1.5 1.14 1.94 0.02 
Diplopia 6/295 7/201 1.32 0.79 1.22 0.5 
Global Speech disturbance 55/295 75/201 1.64 1.34 2.01 <0.001 
Specific word finding difficulty 11/295 5/201 0.76 0.36 1.58 0.58 
Memory loss 27/295 1/201 0.08 0.01 0.57 <0.001 
Confusion 24/295 4/201 0.33 0.13 0.84 0.006 
Table 16.2 Distribution of symptoms between TIA and non-TIA patients  
Significant positive predictors which increase the likelihood of TIA are absence of visual 
perception, and speech disturbance. Significant negative predictors which reduce the 
likelihood of TIA are reduced level of consciousness, unilateral limb sensory change, nausea 
or vomiting, memory loss and confusion. 
16.3 Derivation of the logistic regression model 
Age and history of previous vascular disease are significantly associated with TIA in the GP 
referred population (from chapter 12). These variables were added to the significant 
predictors derived from clinical descriptions found on univariate analysis in table 16.2 in a 
multivariate forward stepwise logistic regression model. 
All included variables survived adjustment and were included in the final model and table 
16.3 displays the beta coefficients in the model with 95% confidence intervals of the 
exponents of the coefficients 
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SYMPTOM B S.E. Wald d.f. p exp(B) 
Lower 
95% CI 
Upper 
95% CI 
Age .041 .008 26.483 1 .000 1.042 1.026 1.058 
Previous 
cerebrovascular 
disease 
1.772 .358 24.518 1 .000 5.885 2.918 11.870 
Reduced level of 
consciousness 
-3.774 1.075 12.318 1 .000 .023 .003 .189 
Unilateral sensory 
limb symptoms 
-.781 .331 5.569 1 .018 .458 .239 .876 
Nausea or 
vomiting 
-1.992 .883 5.085 1 .024 .136 .024 .771 
Loss of vision .999 .359 7.734 1 .005 2.714 1.343 5.486 
Global speech 
disturbance 
.517 .249 4.299 1 .038 1.677 1.029 2.733 
Memory loss -3.302 1.057 9.764 1 .002 .037 .005 .292 
Confusion -2.202 .609 13.080 1 .000 .111 .034 .365 
Constant -3.256 .581 31.393 1 .000 .039     
Table 16.3 Predictors of TIA diagnosis from multivariable logistic regression – beta 
coefficients with standard error and associated Wald tests. 
The associated Nagelkerke’s R2 for the model is 0.38, with 72.6% correct categorisations of 
TIA and non-TIA at the final step of addition of predictors. 
16.4 Calibration of the logistic regression model 
The probability that TIA is present is given from the equation 
 
      
 where  
lp = (age X 0.04) + (history of TIA X 1.77) + (loss of vision X 1) + (global speech disturbance 
X 0.52) – (reduced level of consciousness X 3.77) – (unilateral limb sensory symptoms X 
0.78) – (nausea/vomiting X 1.99) – (memory loss X 3.3) – (confusion 2.2) -3.3. 
Predicted probabilities were calculated for each patient and the spread of predicted 
probabilities for TIA and non-TIA patients is shown in figure 16.1. 
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Figure 16.1 Spread of predicted probabilities Non-TIA and TIA 
The predicted probabilities were grouped into deciles and compared with the observed 
chance of TIA for patients within the relevant decile and is displayed in figure 16.2. Within 
the derivation dataset, there is a linear trend for increasing fraction of TIA patients with 
higher deciles of predicted probability but the observed probability is overestimated by the 
model. Nevertheless the model fit from Hosmer-Lemeshow test indicated that observed 
values did not significantly differ from predicted values (p = 0.65) 
 
Figure 16.2 Observed probability within increasing deciles of predicted probability 
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16.5 Constructing the score  
Two scores were constructed from the predictors in the logistic regression model. One was 
weighted by the predictive strength, i.e the beta coefficient and the other score was 
unweighted with a unit change in cumulative score depending on whether it is a positive or 
negative predictor. Table 16.4 summarises the two scores. 
Component Weighted Score Unweighted score 
Present  Absent Present Absent 
History of TIA/Stroke 1.8 0 1 0 
Global speech 
disturbance 
0.5 0 1 0 
Visual loss 1 0 1 0 
Reduced level of 
consciousness 
0 3.8 0 1 
Memory loss 0 3.3 0 1 
Confusion 0 2.2 0 1 
Nausea/vomiting 0 2 0 1 
Unilateral sensory 
change 
0 0.8 0 1 
Age  X by 0.04 X by 0.04 
Table 16.4 Weighted and unweighted scores (from beta coefficients) for GP sourced 
predictors in a TIA diagnostic prediction rule 
16.6 Internal validation of the scores – discrimination using cumulative frequency 
curves and ROC 
Table 16.5 shows mean and standard deviation of weighted and unweighted scores by 
diagnostic group. Comparison with non-TIA scores for each diagnostic category using 
weighted and unweighted scores were carried out with the Mann-Whitney test, given the 
non-normal distribution of scores. 
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Diagnostic 
Group 
N Weighted 
Mean (SD) 
P for 
comparison 
with non-TIA 
Unweighted 
Mean (SD) 
P for 
comparison 
with non-TIA 
Non-TIA 295 13.91 (1.68) - 7.42 (1.08) - 
All TIA 201 15.68 (1.13) <0.001 8.59 (1.0) <0.001 
Anterior TIA 162 15.75 (1.13) <0.001 8.67 (1.01) <0.001 
Posterior 
TIA 
39 15.36 (1.08) < 0.001 8.28 (0.90) <0.001 
Table 16.5 Mean weighted and unweighted scores by diagnostic group. 
Mean scores for anterior TIA and posterior TIA are more similar compared with the ABCD2 
and Dawson scores, where posterior TIA means were closer to non-TIA mean values. The 
discriminative ability of the weighted and unweighted scores was visually displayed using 
cumulative frequency plots.  
Figure 16.3 shows the cumulative percentage of scores for each diagnostic group. The 
vertical distance between the non-TIA line and both the anterior TIA and posterior TIA lines 
throughout the range of scores demonstrates good discrimination across a range of scores. 
The anterior and posterior TIA lines are both right-shifted from the non-TIA line without 
crossover with the non-TIA line. The posterior line closely follows the anterior line indicating 
similar discriminating ability throughout the score range. 
Figure 16.4 shows the same plot for the unweighted score. Comparing this with figure 16.3 
demonstrates a difference in the posterior TIA scores. Both scoring systems offer equivalent 
discrimination for posterior TIA in the first half of the distribution. However at higher values, 
the unweighted posterior TIA line moves closer to the non-TIA line compared with the 
weighted posterior TIA line, indicating that at higher scores the discriminative ability of the 
unweighted score is likely to be weaker compared with the weighted score. 
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Figure 16.3 Cumulative percentage of weighted scores by diagnostic group 
 
Figure 16.4 Cumulative percentage of unweighted scores by diagnostic group 
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The change in sensitivity and specificity with increasing weighted score is shown in figure 
16.5. Compared with the ABCD2 and Dawson scores using primary care records, sensitivity 
is relatively well preserved from the lowest score value although there is a steep drop off as 
specificity rises with the lines meeting at 70%. The variation in sensitivity and specificity for 
the unweighted score is shown in figure 9.6. 
 
Figure 16.5 Change in sensitivity and specificity for the diagnosis of TIA with 
increasing weighted score value 
 
Figure 16.6 Change in sensitivity and specificity for the diagnosis of TIA with 
increasing unweighted score value 
Sensitivity with the unweighted score reduces at an earlier point in the score range 
compared with figure 16.5 and the specificity rises such that the lines meet at 80%. Thus 
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compared with the weighted score, higher specificity can be achieved without as steep a 
drop in sensitivity. 
Figures 16.7 and 16.8 show the change in PPV and NPV for increasing values of the 
weighted and unweighted score. At the lowest value, the PPV is at the prevalence of the 
referred population (40%) as all patients are deemed to have TIA at the lowest cut off.  
 
Figure 16.7 Change in positive predictive value (PPV) and negative predictive value 
(NPV) with increasing value of weighted score 
  
Figure 16.8 Change in positive predictive value (PPV) and negative predictive value 
(NPV) with increasing value of unweighted score 
The unweighted score has a more restricted range of values as the increments in score are 
not greater than 1 and fewer patients score at the lower end of the range. This results in an 
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earlier rise of PPV and fall of NPV as the early component of the distribution is contained 
within the first score points compared with the weighted score which spreads the same 
component out over more score points. 
Figures 16.9 to 16.11 display the ROC curves for both weighted and unweighted scores for 
discrimination of TIA, anterior TIA and posterior TIA from non-TIA. Figure 16.9 shows 
comparable 
 
Figure 16.9 ROC curve for discrimination of TIA from non-TIA using weighted and 
unweighted scores. 
discriminating ability for both scoring systems with AUC values for the weighted score of 
0.81 (S.E. 0.02) and unweighted score of 0.79 (S.E. 0.02). 
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Figure 16.10 ROC curve for discrimination of anterior TIA from non-TIA using 
weighted and unweighted scores. 
Figure 16.10 shows the discrimination of anterior TIA from non-TIA with AUC values for 
weighted scores of 0.82 (S.E. 0.02) and unweighted scores of 0.80 (S.E. 0.02). 
Discrimination of posterior TIA from non-TIA is shown in figure 16.11 with an AUC 0.77 
(S.E.0.04) for the weighted score and 0.74 (S.E. 0.04) for the unweighted score 
 
Figure 16.11 ROC curve for discrimination of posterior TIA from non-TIA  
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Thus both scores have significant discriminating ability across diagnostic groups with the 
weighted score having a marginally but consistently higher AUC. 
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Chapter 17 Classification Tree 
17.1 Classification Tree Derivation 
The initial tree is shown in figure 17.1. It is clearly a complicated structure with 17 terminal 
nodes (final sub groups) formed by 16 separate splits and of these, age is used at 7 splits at 
different cut-off values. This tree classifies 79.6% of patients correctly (compared with 72.6% 
for the logistic regression model).  
Included variables are previous history of cerebrovascular disease, age, reduced level of 
consciousness, memory disturbance, confusion, visual loss, dizziness, and unilateral limb 
sensory disturbance. Most of the included predictors in the tree are ‘negative’ in the sense 
that they are associated with a reduced chance of TIA diagnosis.  
Only previous cerebrovascular disease, age and absence of vision are positive predictors of 
TIA and these are all included with positive beta coefficients in the logistic regression. 
Interestingly speech disturbance is not included as a predictor in the tree, which is a positive 
predictor in the logistic regression, and neither is the logistic regression negative predictor of 
nausea or vomiting. Instead the classification tree identified dizziness as a predictor, which 
was not included in logistic regression modelling although on univariate analysis in chapter 
16 it had a relative risk (RR) of TIA of less than1 but the confidence interval of this RR 
included values greater than 1, with an associated p value just outside statistical significance 
of 0.06. 
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Prcvasc <> 0.5
N; 496 obs; 59.5%
AGE <> 48.171115675
N; 423 obs; 65%
N
64 obs
1 LOC >< 0.5
N; 359 obs; 59.9%
N
23 obs
2 Memory >< 0.5
N; 336 obs; 57.1%
N
22 obs
3 CONFUSION >< 0.5
N; 314 obs; 54.1%
N
19 obs
4 AGE <> 77.00513347
N; 295 obs; 51.5%
Absence_vision <> 0.5
N; 186 obs; 60.2%
AGE >< 72.76386037
N; 165 obs; 64.2%
N
29 obs
5 AGE <> 71.067761805
N; 136 obs; 58.8%
AGE >< 69.94729637
N; 126 obs; 61.9%
N
16 obs
6 AGE <> 65.024298425
N; 110 obs; 58.2%
Altered_vision >< 0.5
N; 76 obs; 67.1%
N
18 obs
7 S_LIMB >< 0.5
N; 58 obs; 60.3%
N
19 obs
8 AGE <> 55.962696785
Y; 39 obs; 53.8%
N
12 obs
9
Y
27 obs
10
Dizziness >< 0.5
Y; 34 obs; 61.8%
N
7 obs
11
Y
27 obs
12
Y
10 obs
13
Y
21 obs
14
Dizziness >< 0.5
Y; 109 obs; 63.3%
N
9 obs
15
Y
100 obs
16
Y
73 obs
17
Total classif ied correct = 79.6 %
 
Figure 17.1 Classification Tree for TIA diagnosis –‘unpruned’ 
There is clearly a cost to having such a complex tree as although more patients may be 
correctly classified it is not likely to be useful in routine practice if there are 16 steps to go 
through in order to generate a decision about referral to a TIA clinic. Also a large and 
complex tree is more likely to overfit the training data and therefore be less useful in clinical 
practice as it will not predict as well. 
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17.2 ‘Pruning’ the classification tree 
A cross-validation exercise was carried out to determine the optimal trade off between 
reducing the size of a potentially large and complex tree and maintaining reasonable 
prediction accuracy. Random sub-groups are formed in the dataset and different sized trees 
are derived from data outside a given sub-group and their prediction accuracy tested on data 
inside that sub-group. This process determines the optimal complexity parameter (CP) which 
determines how large a tree will be. 
Figure 17.2 shows how the error of a particular tree size changes (as a proportion of the 
error in a ‘null model’ which assumes that prevalence of TIA in the whole dataset is the 
chance that an individual has a diagnosis of TIA - the initial position of an infinite CP, which 
will not generate any decision nodes). The dotted line represents a cut off point that is one 
standard error above the minimum value of relative error and any CP that is below this line 
can be considered an appropriate choice. 
 
Figure17.2 Reduction in misclassification error (relative to a classification tree without 
splits) with reducing values of the complexity parameter (CP) 
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Figure 17.2 shows that a CP value of 0.019 is within one standard error of the minimum 
value and represents a reasonable balance between reducing misclassification error and 
keeping tree size and complexity to a minimum. 
A ‘pruned’ classification tree for TIA diagnosis is presented in figure 17.3. It uses eight splits, 
resulting in nine terminal nodes and overall it classifies 74.8% of patients correctly (again 
higher than the 72.6% for the logistic regression model). 
 
Figure 17.3 ‘Pruned’ classification tree for TIA diagnosis 
The included variables are past history of cerebrovascular disease, age (used to split 
patients without a history of cerebrovascular disease at a cut point of 48 yrs and to split 
patients without confusion at a cut point of 77 yrs), reduced level of consciousness (LOC), 
memory disturbance, confusion, visual loss and dizziness. 
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17.3 Predicted probabilities from the classification trees 
Figure 17.4 shows the calibration curve for the probabilities of TIA predicted by the unpruned 
and pruned trees (patients are grouped into deciles of predicted probability, and the 
observed probability within each decile is plotted). Both trees estimate the probability of a 
TIA diagnosis near the ideal calibration line (assuming that the midpoint of the probability 
decile is the ideal for observed probability). 
 
Figure 17.4 Calibration curve for predicted probability deciles of unpruned and pruned 
classification trees 
The cumulative distribution of the probabilities is shown in each diagnostic group in figure 
17.5 for the unpruned tree. Posterior and anterior TIA are discriminated equally well from 
non-TIA with most of the TIA patients having a predicted probability greater than 0.63. 
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Figure 17.5 Cumulative predicted probability from unpruned classification tree by 
diagnostic group 
 
Figure 17.6 Cumulative predicted probability from pruned classification tree by 
diagnostic group 
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Figure 17.6 demonstrates that the increase in cumulative frequency for TIA patients occurs 
at an earlier predicted probability of 0.22. Again, there is no difference in the cumulative 
distribution for anterior and posterior TIA predicted probabilities from the pruned tree. 
17.4 Discrimination – ROC curves 
Figures 17.7 – 17.9 show the ROC curves using the unpruned and pruned trees to 
discriminate between TIA and non-TIA, as well as for the diagnostic sub groups. The AUC 
for discrimination of all TIA from non-TIA was 0.84 (S.E. 0.02) for the unpruned tree and 0.80 
(S.E. 0.02) for the pruned tree (figure 17.7).  Discrimination of anterior TIA from non-TIA for 
the unpruned tree showed an AUC of 0.84 (S.E. 0.02) and for the pruned tree was 0.80 (S.E. 
0.02). Interestingly the discrimination performance for posterior TIA was very similar with 
unpruned tree AUC of 0.86 (S.E. 0.02) and a pruned tree AUC of 0.80 (S.E. 0.03). 
 
Figure 17.7 ROC curve showing discrimination of TIA from non-TIA using unpruned 
and pruned classification trees 
193 
 
 
Figure 17.8 ROC curve showing discrimination of anterior TIA from non-TIA using 
unpruned and pruned classification trees 
 
Figure 17.9 ROC curve showing discrimination of posterior TIA from non-TIA using 
unpruned and pruned classification trees 
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The discriminating ability for anterior and for posterior TIA, as judged by AUC on an ROC 
curve, is identical using the pruned classification tree. The logistic regression model of GP 
histories showed that discriminating anterior TIA from non-TIA was better than discriminating 
posterior TIA from non-TIA (0.82 vs 0.77) although the differences were not as marked as 
discrimination using the Dawson score on GP records (0.75 vs 0.52) or ABCD2 on GP 
records (0.65 vs 0.48).  
17.5 Sensitivities, specificities and predictive values 
 
Figure 17.10 Sensitivity and specificity at successive splits along the pruned 
classification tree 
Figure 17.10 shows the marked variation in sensitivity and specificity which only appear to 
reach acceptable values together at the end of the tree, from split 6 to split 8. The values do 
not linearly progress with increasing splits, i.e. including increasing numbers of predictors. 
Instead there is pronounced variation particularly from split 1 to split 2. This arises because 
the tree construction is focussed on the end result for the total tree, and so large changes in 
performance measures for subsets of the tree are not relevant.  
Figure 17.11 shows the change in positive and negative predictive values at successive 
splits along the tree. Again, both values are widely separated until splits 6 to 8, when they 
converge to jointly acceptable levels. However, the sustained high negative predictive value 
from split 2 to split 6 suggests a potential role in decision support in primary care.  
If a perfectly performing diagnostic rule is not a realistic goal, then perhaps a referral support 
tool could be an alternative for implementation. Such a tool would need to function as a ‘rule 
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out’ test in order to reduce the referral of patients without TIA. A high negative predictive 
value, if it remains high in a significant proportion of the patient group i.e. at a higher split, 
suggests that the test could reliably rule out enough of the patients without TIA to be worth 
implementing in practice. High NPVs occurring at the initial part of the tree only may not be 
as useful as this may only apply to a small fraction of the dataset without impacting 
significantly on referral numbers. 
 
Figure 17.11 Positive predictive value (PPV) and negative predictive value (NPV) at 
successive splits along the pruned classification tree 
17.6 Decision rule based on the pruned tree – structure and impact on referral 
The suggested decision rule for TIA diagnosis is shown in the flow chart in figure 17.12. 
These are the questions that a GP would follow and depending on the answer, would refer 
or not to a TIA clinic. Making a diagnosis in primary care would not currently change 
management for the GP. This is because there is no primary care access to investigations 
such as brain imaging (CT or MRI) or carotid ultrasound within the timeframes required to 
reduce recurrent stroke risk and urgent treatment with the full range of vascular risk reducing 
medications has not been recommended for use until after specialist assessment. Even if a 
perfectly accurate diagnostic tool, in terms of predictive values, were available, a GP would 
still need to refer patients to be seen by a specialist under current limitations on access to 
key timely investigations and National body recommendations for treatment. 
Thus the major role for a diagnostic support tool would be in the more accurate identification 
of patients for referral to a TIA clinic. As such, the most important feature of a diagnostic tool 
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is a high negative predictive value, so that the diagnosis can be ruled out with sufficient 
accuracy in primary care.  
 
Figure 17.12 Decision Algorithm from classification tree for decision to refer for 
specialist assessment, with simpler algorithm stopping at the dashed line 
The cumulative performance of this rule was shown in figures 17.10 and 17.11, with very 
high negative predictive values up to the 5th split (presence or absence of confusion).  If this 
rule were truncated at the fifth split with all patients that do not have confusion referred to 
specialists for assessment then this would simplify the rule considerably (up to the dashed 
line in figure 17.12). It would in essence act as a ‘rule out’ checklist by identifying features 
that would preclude referral, apart from the first split where all those with a history of 
previous cerebrovascular disease would be referred. 
In this dataset, using the rule up to and including the 5th split would have prevented 117 
referrals of patients without TIA (39.7% of all those without TIA), at a cost of missing 5 
patients with TIA (2.5% of all those with TIA). This would have resulted in a 25% reduction in 
referrals overall. 
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However, the key reason to refer a patient with suspected TIA is to reduce the chance of a 
recurrent stroke. The risks of recurrent stroke after TIA are high, and if a referral rule does 
miss cases, then ideally it should not miss patients that are high risk for TIA. 
Theoretically if a patient presents to primary care with classical TIA but also with other 
features that appear in the rule, for example confusion, then it could be argued that they 
would not be referred when there would be compelling clinical grounds to do so.  
17.7 Who does the rule miss? 
Understanding which patients are missed by a decision rule provides potential users of that 
rule with valuable information. Also, where a rule has very different external validation 
performance metrics to its internal validation ones, an awareness of why a rule misses 
patients could help in any modification to improve generalisability. 
In the internal validation of the decision tree, five patients with TIA are missed. Given the 
early age cut off, there are four that are missed at the first split, as they are <48 years old. 
One of these had an inherited disorder of connective tissue supporting vascular structures 
with a visual presentation. The other patients <48 years old had anterior territory 
presentations with one having facial numbness, one with facial weakness and one with 
slurred speech. 
The 5th missed patient was 92 years old without a history of cerebrovascular disease and 
had slurred speech as well as what was described as confusion by the GP. It is likely that 
the confusion may have been a direct result of speech disturbance with a receptive as well 
as the recorded expressive component. 
Each of the five patients was followed up for eight years and no recurrent vascular events 
were recorded over that time period. Thus none of these patients were high risk as 
measured by the occurrence of a recurrent stroke on treatment of their TIA.  
However, it could be argued that given the reduction in recurrent stroke risk due to treatment 
of vascular risk factors post TIA these patients may have been stroke free on follow up,  i.e. 
low risk, because of treatment -  but they may have had a stroke had they not have been 
referred. An assessment of this can be gauged in the short term at least by examining their 
ABCD2 scores for short term stroke risk. 
Of the five missed TIA patients, three had an ABCD2 score of 4, one had a score of 2 and 
one had a score of 1 (all scored by secondary care). Given the estimated stroke risk at 90 
days with these scores, the mathematical expectation of missed strokes at 90 days is  
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{(0.02 x 1) + (0.03 x 1) + (0.075 x 3)} = 0.275 strokes over four years of primary care 
referrals 
The OXVASC population is 91,000 and this can be estimated as 0.0015 of the UK 
population. Thus an approximate estimation of the number of missed strokes at 90 days post 
TIA if this decision tool were to be used in the UK to govern primary care referrals to TIA 
clinics would be 181 over four years, or 45 strokes per year at 90 days post TIA.  
There is no equivalent validated stroke prediction tool for long term stroke risk but it will be 
higher than the 90 day risk. Therefore the cumulative number of missed strokes will increase 
with time as patients with TIA missed by the rule will have recurrent vascular events outside 
the short term 90 day risk window. 
17.8 The effect of weighting misclassification with ‘costs’ 
Applying a misclassification cost resulted in a complex tree with 14 splits and 15 final nodes 
with 77.4% correct classification. Eight predictors were used to generate the splits (age, 
reduced level of consciousness, loss of memory, previous history of cerebrovascular 
disease, confusion, dizziness, altered visual perception and unilateral limb sensory change), 
with age used seven times with seven different cut points.  
A pruned tree was generated after cross-validation showed that the optimal complexity 
parameter was 0.045, and the resulting classification tree had three splits (age, reduced 
level of consciousness and memory loss) and four terminal nodes. This classified 61.5% of 
patients correctly, with 110 true non-TIA patients predicted as non-TIA (37.3% specificity) 
and 6 true TIA patients predicted as non-TIA (97% sensitivity).  
These figures do not improve on the first 5 splits of the unweighted tree used above and 
although the weighted pruned tree is simpler it in fact misses more patients with TIA. The 
cost matrix reduces the number of missed patients overall compared with the total 
unweighted tree but as the initial section of the unweighted tree was used to generate a 
decision rule there has been no improvement in the performance as a rule out algorithm. 
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Chapter 18 Random Forest 
18.1 Choice of Predictors from a random forest - comparison with other techniques 
The contribution made by different variables to TIA diagnosis in the whole GP dataset is 
shown with a list in descending order of importance in figure 18.1. Two methods to 
determine variable importance are displayed; accuracy reduction, which tests the strength of 
a predictor by replacing the predictor with random values and assessing how much worse 
the predictions are, and the ‘Gini’ assessment, which assigns importance in terms of how 
often trees in the forest use a predictor and the improvement in classification that it gives.  
The Gini assessment of importance shows that the nine most important predictors are age, 
previous history of vascular disease, speech disturbance, sex, reduced level of 
consciousness, limb weakness memory disturbance and absence of vision. The Dawson 
tool’s nine predictors do not include sex, memory disturbance or absence of visual 
symptoms, but this was not based on GP recorded clinical features. 
The logistic regression model (Chapter 16) has nine predictors and it shares seven with the 
random forest - age, history of vascular disease, speech disturbance, reduced level of 
consciousness, absence of vision, memory loss and unilateral sensory disturbance in a limb. 
The pruned classification tree has seven predictors and of the most important seven in the 
random forest it shares four - age, history of vascular disease, reduced level of 
consciousness and memory disturbance. 
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Figure 18.1 Variable importance measures in random forest prediction of TIA from 
training dataset 
18.2 Misclassification rate for full dataset of referred patients 
Using the total GP dataset, the random forest reported a misclassification rate of 27.42% 
from the out of bag data, i.e. a correct classification rate of 72.58%. This compares with the 
logistic regression internal validation of 72.6% and the classification tree internal validation of 
79.6% correct classification. The random forest may give a better indication of performance 
at external validation by incorporating variation in predictor prevalences (279).  
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18.3 Derivation from the training dataset – comparing probabilities in the testing 
dataset 
To compare the model methodologies fairly, the techniques of logistic regression, 
classification tree derivation and random forest derivation were repeated on the training 
dataset. Predicted probabilities for TIA in the testing dataset were calculated for the three 
models and the calibration of observed probability within predicted probability deciles is 
shown in figure 18.2. The calibration to the testing dataset demonstrates over and under 
prediction across increasing deciles of predicted probability with no model clearly calibrating 
better than another. The classification tree does not provide the same spread of predicted 
probability as the random forest or logistic regression. 
 
Figure 18.2 Observed probability within each decile of predicted probability for TIA 
diagnosis – logistic regression, classification tree and random forest 
Figure 18.3 demonstrates the cumulative distribution of predicted probabilities from the 
random forest by diagnostic group. Patients with posterior TIA are not disadvantaged by 
using this modelling technique as there is no reduction in the ability to discriminate between 
posterior TIA and non-TIA compared with anterior TIA and non-TIA. 
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Figure 18.3 Cumulative frequency of predicted probability in of TIA by diagnostic 
group using a random forest model 
18.4 Discrimination with different modelling techniques – ROC curves 
Figure 18.4 shows the ROC curve for prediction of TIA diagnosis in the testing dataset, with 
predictions from random forest alongside logistic regression and classification tree models 
from the same derivation dataset. The AUCs are similar with the highest from the logistic 
regression model with 0.80 (S.E. 0.03), classification tree 0.79 (S.E. 0.03) and random forest 
0.72 (S.E. 0.03). 
Figure 18.5 demonstrates similar discriminating ability for anterior TIA from non-TIA in the 
testing dataset, with similar AUCs with logistic regression 0.80 (S.E. 0.03), classification tree 
0.79 (S.E. 0.03) and random forest 0.72 (S.E. 0.03). 
Figure 18.6 demonstrates a similar pattern for discriminating posterior TIA from non-TIA with 
AUCs for logistic regression of 0.81 (S.E. 0.05), classification tree 0.78 (S.E. 0.05) and 
random forest 0.75 (S.E.  0.06). 
Although the random forest predictions show good discrimination for both anterior and 
posterior TIA, they are not as good as predictions from logistic regression or a single 
classification tree in terms of AUC values. 
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Figure 18.4 Discrimination of all TIA from non-TIA – comparison across modelling 
techniques 
 
Figure 18.5 Discrimination of anterior TIA – comparison across modelling techniques 
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Figure 18.6 Discrimination of posterior TIA – comparison across modelling 
techniques 
18.5 Predictive values, sensitivity and specificity with random forest analysis 
As random forests give a predicted probability in terms of vote counting (i.e. the number of 
trees where a particular set of parameter values give a positive diagnosis / the number of 
trees in the forest), rather than relying on the simple majority vote which determines the 
misclassification rate, the predicted probability itself could be used to determine a cut point 
for diagnosis. 
The potential high rule out function is shown more easily in the sensitivity and specificity plot 
in figure 18.7, where a very high sensitivity of 97% is associated with the lowest decile cut 
point of 0.1.  
Figure 18.8 shows the changes in positive and negative predictive value using the random 
forest predictions in the testing dataset for different cut points of predicted probability. 
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Figure 18.7 Sensitivity and specificity of random forest derived predicted probabilities 
of TIA with increasing decile diagnostic cut points  
At the lowest probability decile cut point of 0.1, there is a very high negative predictive value 
so the forest predictions have a good rule out function at this level. Using this cut point as a 
referral tool would reduce non-TIA referrals by 29% whilst missing 3% of patients with TIA. 
The patients missed by the rule did not have recurrent cerebrovascular events at six years of 
follow up.  
 
 Figure 18.8 Positive predictive value and negative predictive value with increasing 
deciles of predicted probability of TIA from a random forest voting 
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Chapter 19 Summary and Discussion 
19.1 Clinical predictors included in a prediction rule for TIA diagnosis derived from 
primary care records in suspected TIA 
A qualitative analysis of routine clinical records and referral letters from GPs identified 
groupings of symptoms which were then tested as potential predictors alongside age and 
past history of vascular disease which are routinely available in primary care. Using forward 
stepwise multivariable logistic regression, a similar process to the approach of Dawson 
(222), a model for prediction of TIA diagnosis was constructed with positive predictors of 
age, previous TIA/CVA, loss of vision and speech disturbance and negative predictors of 
reduced level of consciousness, limb sensory disturbance, nausea or vomiting, memory 
disturbance and confusion.  
Diagnostic models have been viewed as a special case of prediction models (283), where 
data is collected at a certain time and a future state is to be predicted, in this case the 
knowledge of diagnosis after a test to be carried out in the near future. The development 
process for stroke and TIA recognition tools have used predictors from specialist 
assessment of patients. A diagnostic prediction rule for primary care, based on factors 
elicited in primary care was derived and then internally validated. 
Comparing the predictors found by Dawson, the GP model shares only one focal 
neurological predictor that increases the probability of TIA - speech disturbance (excluding 
isolated specific word finding difficulty). The GP model also includes a new focal symptom 
predictor - reduced visual perception (rather than present but altered visual perception). 
Dawson included hemianopic visual disturbance as a potential predictor but did not specify 
whether this was positive phenomena (altered perception) or negative phenomena (reduced 
or absent visual perception) and this did not add predictive value in their logistic regression 
after adjustment by other predictors (222). The only visual symptom in the Dawson model is 
diplopia, which was not a significant predictor in the GP data and so was not included in 
model building. 
Unilateral weakness was not a predictor in the GP model, but both facial and limb weakness 
were independently predictive of TIA in the Dawson model. Sufficient numbers of non-TIA 
cases are felt by GPs to have weakness so that the discriminating ability of this symptom for 
TIA diagnosis disappears. 
The GP model includes a focal neurological symptom as a negative predictor. This is prime 
facie a counter-intuitive finding as focal symptoms are more likely to have focal pathology i.e. 
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regional cerebral dysfunction. However there are a number of peripheral neurological 
aetiologies for localised sensory symptoms such as nerve entrapment or plexus pathological 
changes. A recognised functional presentation (or medically unexplained symptom) in 
neurological clinics is hemisensory syndrome (284), which may also explain why unilateral 
sensory symptoms are negative predictors in GP recorded symptoms (the recording of these 
symptoms in secondary care may be affected by clinicians’ diagnoses). 
There is one shared negative predictor in both models – altered level of consciousness. This 
suggests global rather than regional cerebral dysfunction with a potential cardiac cause due 
to transient reduced effective circulating blood volume.  
GPs did not record data on seizure activity, which may reflect the fact that locally a pre-
defined seizure clinic is in operation and so any patients with suspected ictal activity will be 
referred there or that when complex seizures are present e.g. as a differential for altered 
responsiveness/level of consciousness, GPs do not suspect seizure activity as a cause and 
so it is not recorded in their notes. The prevalence of headache between the TIA and non-
TIA patients was not significantly different, and so was not included as a potential predictor 
in the GP model. 
Nausea or vomiting, memory loss and confusion were additional negative predictors in the 
GP model, and these were not even considered as potential negative predictors by Dawson. 
Their inclusion is a direct effect of the strategy of analysing spontaneous recordings by GPs 
and then assessing predictive strength individually, rather than relying on pre-existing 
secondary care derived scoring systems to identify potential predictors. Although nausea 
and vomiting may be due to posterior circulation TIA and have been identified as appearing 
more commonly in posterior stroke (275) they are a strong negative predictor among GP 
records, possibly as a better identifier of migraine in the GP referred population than 
headache, which was not a significant positive or negative predictor. 
This model shares speech disturbance and reduced consciousness with the Dawson tool but 
importantly only speech disturbance and loss of vision are identified as positive predictors 
from GP histories. Visual symptoms improve the sensitivity of the FAST test to detect 
posterior circulation stroke (275) so their inclusion in a recognition tool may improve 
identification of posterior circulation TIA. However, I separated visual symptoms into altered 
perception and absence of perception i.e. positive and negative phenomena as a natural 
grouping of the symptoms. This grouping resulted in different predictive abilities in this 
dataset.  
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19.2  Calibration and discrimination metrics for a model of TIA diagnosis derived 
from primary care records in suspected TIA 
The logistic regression model calibrated well. The major finding from ROC analysis was that 
posterior TIA patients had similar discrimination compared with anterior TIA. AUCs for 
anterior and posterior TIA discrimination from non-TIA were 0.81 and 0.77 for the weighted 
score and 0.79 and 0.74 for the unweighted score respectively. The NPV is very important in 
primary care as we wish to safely reduce the TIA clinic burden by identifying TIA patients 
while reducing the non-TIA referrals. The weighted score at a cut point of 14 has a sensitivity 
of 98.5% and a specificity of 52% with an NPV of 97% and a PPV of 40%. These metrics are 
an improvement on that reported for the internal validation of the Dawson tool. For an 
increase in 10% of predictive value over baseline prevalence, a smaller fraction of TIA 
patients are missed. For a similar increase in predictive value of 10% over baseline, the 
unweighted score metrics are a sensitivity of 95% and a specificity of 65% which misses 
more patients with TIA but reduces more non-TIA referrals. 
19.3 Choice of statistical model and discrimination metrics for TIA diagnostic 
models 
Although ‘uncertainty’ in modelling is usually restricted to predictor choice and uncertainty 
over parameter values (285), there is a further dimension of uncertainty over the choice of 
statistical model to represent the relationships between predictors and outcome. There are 
few reports in the literature where authors have compared different modelling methodologies 
to reflect such model uncertainty, and they tend to be restricted to situations where there are 
large numbers of physiological variables in complex settings such as intensive care 
(286;287). The approaches of classification trees and ensemble prediction i.e. combining 
multiple model outputs were tested in the GP referral dataset. 
A classification tree was constructed to explore if an alternative prediction methodology to 
logistic regression could be used to derive a decision support tool for TIA referrals from 
primary care. Even without adjusting for the fact that missing a patient with TIA is worse than 
referring a patient without TIA to clinic, a simplified decision algorithm could deliver a referral 
support tool that is very sensitive to TIA diagnosis and does not vary with arterial territory. 
However, a small number of patients with TIA are still missed which on a large enough scale 
would result in patients potentially suffering from preventable recurrent stroke. Adding in a 
weighting factor to try to minimise missing patients with TIA did not improve this. 
Two tree based models were derived, one subject to a complexity parameter for 
simplification. Cumulative predicted probability distributions showed that both anterior and 
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posterior TIA patients were discriminated similarly from non-TIA patients across scores for 
both unpruned and pruned trees. The majority of predictors used in the pruned tree were 
‘rule out’ i.e negative predictors after the first node split from history of TIA/stroke.  
Internal validation showed similar AUC values on ROC curves compared with logistic 
regression and the pruned tree was equal in discriminating anterior and posterior TIA from 
non-TIA (AUCs of 0.80). To further reduce complexity, a simple first section of the tree was 
analysed for its ability to refine a referral population showing a PPV of 53% (an increase of 
12% over baseline prevalence) and an NPV of 96% with a sensitivity of 98%, missing 5 true 
TIA patients in the dataset. Using the methods of Lavallee et al in predicting counterfactual 
stroke risk in treated patients (42), the internal validation metrics suggest that a very small 
number of strokes may occur if this rule is implemented nationally whilst reducing referrals 
by 40%. 
The most important predictors selected by the random forest, taking the first nine to compare 
with the logistic regression models, showed closer similarity to those of the Dawson tool, 
with limb weakness included. Although the classification rate for the random forest derived 
from the whole GP dataset was similar to the internal validation classification rate for logistic 
regression, an experimental comparison by splitting the dataset into testing and training data 
to examine predicted probabilities showed that logistic regression outperformed both random 
forest and single classification tree in terms of discrimination. Nevertheless, as a rule out for 
referral the random forest performed well by reducing referrals by 29% and missing 3% of 
patients with TIA, although cut points of predicted probability were used to decide on an 
optimal point of high negative predictive value, rather than relying on the dichotomous 
random forest output i.e. classified correctly or incorrectly, from majority voting. However, 
there is no clear benefit to the use of such complex models for clinical diagnosis. 
Selecting variables by their performance in one particular dataset may result in a 
phenomenon termed ‘testimation bias’ (285), which is a similar concept to regression to the 
mean. If, in a certain dataset we detect a significant predictor, this could be due to a type 1 
error i.e. in two groups defined by disease presence or absence, by chance there is an 
unequal distribution of a non-causative variable which we would then select for use in a 
prediction model. This would lead to poorer external validation as the predictor is not a true 
predictor of the outcome of having the disease and this is usually a larger problem for 
weaker associations (285). By creating multiple bootstrapped derivation and validation 
datasets, such randomly occurring and weak associations may be less likely to be selected 
from strong performance across the variations in a forest but only for predictors with equal 
categories for responses, such as presence or absence of clinical features (288). Similarly 
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not including one particular predictor because it was not useful in a given dataset also 
creates a bias and Moons et al argue that this may also result in a poorer model (273). 
The use of random forests to improve diagnosis, a problem of classification, has not been 
explored in clinical medicine. The statistical field is young and the methodology is still 
emerging (289) . Nevertheless the three different modelling approaches were given identical 
derivation and testing datasets by splitting the whole set of GP referred data so that 
predicted probabilities from each model could be compared on ROC curves. Despite the 
theoretical advantages of the random forest in terms of variable selection and prediction 
accuracy it had poorer AUC values for all discriminations than logistic regression and 
classification trees.  
19.4  Limitations of this analysis 
No other clinician examined the categorisation of symptoms or suggested alternative 
categorisations. Furthermore although the total derivation dataset was a total pool of 515 
patients, there were a number of referred patients’ records that were not available for 
qualitative analysis (11 TIA patients and 8 non-TIA patients) but this represents a data loss 
of only 4%. 
Another limitation is that the GP variables were not collected systematically by every GP for 
every patient as the GPs were acting as part of their routine practice. A limitation of the 
models developed in this thesis therefore relates to generalisability, given the non-
systematic way in which the clinical variables were recorded. For prognostic models and by 
logical  extension, diagnostic models, clearly defined and systematically collected predictors 
are ideal (274). However, in other settings spontaneous report of new symptoms has been 
used to support clinical recognition particularly for the early features of meningitis with 
parental report rather than clinical notes being used to identify features early in the time 
course of the illness (290). 
19.5 Future Research and Practice  
A GP history derived regression model offers promise at referral refinement whilst 
maintaining the identification of patients with TIA, particularly posterior TIA. However, the 
regression weighted scoring system is complex to use, as it requires not only multiplication 
but addition as well of different numbers either because of the presence or because of the 
absence of a symptom. This may limit the generalisability of logistic regression-derived 
models in general. Removing the weights to create a simpler score may improve usage as 
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the reduction in overall discriminating ability is modest. Nevertheless a simpler rule based 
tool may offer greater ease of use. 
The classification tree output is the simplest to implement without any need for calculation or 
indeed for going through an entire set of variables. The decision tree could identify patients 
that should be referred from very few variables and is therefore simpler to implement. The 
next research steps will address the key limitation of this thesis – non-systematically 
collected predictors without an external validating dataset.  
The different modelling approaches of logistic regression and classification trees have 
produced different diagnostic tools which have very different implementations in terms of 
variable choice and what is done with those variables. Both have the potential to improve 
clinic usage but miss patients with TIA, although an external validation will be required to 
determine likely impact of using outputs from these models.  
It is not known to what extent GPs would use a decision support tool for TIA clinic referrals. 
No tools have yet been established for TIA diagnosis and GPs are therefore used to 
referring a low prevalence condition from instinct and acumen. Qualitative work will therefore 
be required to understand if GPs would be willing to use a tool as a rule out mechanism so 
that a TIA clinic and confirmatory opinion from a specialist would not be needed for 
reassurance, either for themselves or the patient. 
Secondly, in order to ensure as far as possible that predictors are collected in a systematic 
way, the symptom categories with included and excluded descriptions used for derivation of 
tools should be made available to GPs, possibly via clinic referral forms, to create a 
prospectively collected set of clinic referral data at multiple clinic sites for derivation and 
validation datasets. This will also ensure that there is a variation in specialist decisions over 
diagnosis, as relying on one specialist for outcome definition may not capture all patients 
with TIA given the known disagreement between specialists. 
Thirdly, an implementation trial would be needed where GPs are given information about 
likelihood of TIA from their referral which could take a number of forms, such as a flowchart 
with the decision tree, or an online referral tool with live feedback about TIA likelihood from 
inputted data. Outcomes of such a trial would be positive predictive value of GP referral, 
appropriate clinic usage for urgent slots, follow up of patients who are deemed not to have 
TIA by the decision rule to assess rate of stroke above background for a non-TIA population, 
as well as ease of use and how often the rule was countermanded by strong clinical 
suspicion. 
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Chapter 20 Final Conclusions  
The OXVASC registered population does not represent the national population in terms of 
deprivation and this limits generalisation of statistical associations with deprivation or lack 
thereof, in the patient cohort in OXVASC. Inspite of variations between practices in age and 
deprivation structure, presentation of TIA to healthcare has not been affected which allows 
pooling across practice populations to answer research questions over healthcare access 
using observational data.  
Healthcare access after TIA and minor stroke is influenced by choice of provider, timing of 
symptoms and clinical features of the event. The majority of patients after TIA and minor 
stroke seek care in general practice and will wait to be seen at their registered practice if 
their symptoms start in the OOH period. Delay in calling for medical attention is strongly 
influenced by timing of symptom onset and availability of routine primary care at that time, 
unless patients chose ED for their initial healthcare assessment or request an assessment 
from OOH primary care services.  Therefore, the organisation and delivery of primary care 
influences healthcare seeking behaviour after TIA and minor stroke and currently is a barrier 
to achieving the National Stroke Strategy targets, due to delays in access for events 
occurring at weekends. 
Since the introduction of the new GMS contract, the majority of patients with TIA and minor 
stroke continue to present initially to primary care during, and outside of, normal working 
hours. The GMS contract has, however, increased the use of OOH primary care services. 
Therefore the contract has improved utilisation of OOH primary care, at least for patients 
with TIA and minor stroke. 
A pilot study of GP trainees showed a failure to recognise high risk TIA cases from vignettes 
that had been constructed from TIA cases missed in routine clinical practice and associated 
with early recurrent stroke. In order to construct the vignettes, patients with high risk TIA 
were identified by examining primary care records before an acute admission for completed 
stroke. This demonstrated a cohort of patients who, by definition, will not be included in out-
patient clinic databases. This is because such patients are seen in general practice after TIA 
but have a completed stroke and admission before the opportunity to attend a specialist out-
patient clinic or they have consulted in general practice after a TIA but the diagnosis was not 
considered.  
The recruitment and completion rates of the pilot study were low indicating a much larger 
recruitment pool will be needed to answer the question of whether the high risk TIA 
phenotype is initially well understood during training but there is reduced recognition of TIA 
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at later stages in the professional career due to low clinical exposure, or whether such 
clinical presentations are not well recognised throughout training and independent clinical 
practice.  
The alteration of single cues in the vignettes affected recognition and management decisions 
in the pilot sample of trainees. Whilst an appropriately powered study is required to test the 
influence of single parameter change, this suggests that hypotheses for why certain cases 
are missed can be tested using vignettes which can then lead on to an appropriate 
educational intervention. 
Disagreement exists between GP and specialist over the clinical features of TIA, with 
greatest disagreement over duration of symptoms, less for weakness and least for speech 
disturbance. This will affect the performance of prognostic and diagnostic tools that have 
been derived from specialist accounts of events if they are to be used in primary care. 
The disagreement in clinical features is not random in that there is a tendency for specialists 
to document fewer features than described by the GP in patients who do not have TIA and 
vice versa for patients with TIA. This explains the variation in mean differences in ABCD2 
scores between GP and specialists for patients with and without TIA. 
The difference in ABCD2 scores between GP and specialists implies inaccurate risk 
stratification in primary care. This will result in a missed opportunity to prevent a small 
number of early recurrent strokes as a small number of patients with high risk TIA will be 
inaccurately classed as low risk. It will also result in inappropriate use of urgent clinic slots as 
low risk patients with be inaccurately classed as high risk, thereby contributing to difficulties 
in meeting National Stroke Strategy targets for urgent access out-patient clinic assessment 
for patients with high risk TIA. 
The existing tools that have been proposed to aid diagnosis of TIA perform reasonably well 
in specialist records of patients with suspected TIA but perform poorly in validations using 
primary care clinical records, particularly for patients with posterior circulation symptoms. 
Therefore they are not appropriate to be used in primary care. 
The clinical predictors included in a diagnostic model derived from routinely recorded clinical 
notes made by GPs of patients referred with suspected TIA do not match the classical TIA 
phenotype. Furthermore, weakness, an important prognostic marker of recurrent stroke risk, 
was not included as GPs found weakness to be equally prevalent in patients with and 
without TIA. This limits the usefulness of this method of diagnostic model derivation. 
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Nevertheless, the primary care based prediction model calibrated well and showed good 
discrimination for TIA. It did not demonstrate a differential accuracy for anterior and posterior 
TIA symptoms on internal validation. However, as a large number of predictors were 
included, and this complexity is increased by weighting the subsequent diagnostic score 
using the beta coefficients from the regression model, it is likely to be too cumbersome to be 
used in routine practice.  
The choice of statistical technique for derivation of a diagnostic model affects the metrics of 
discrimination. The theoretically advantageous and more complex modelling technique using 
ensemble prediction had inferior performance compared with logistic regression and single 
classification tree methods. Although classification tree models have similar performance in 
terms of accurate identification of patients with TIA, they are likely to be simpler to implement 
and can have high negative predictive values. This is important for primary care as we wish 
to safely rule out the diagnosis, thereby increasing the positive predictive value of referral 
and appropriate usage of TIA clinic slots.  
The limitations of this thesis include the method of imputation for missing data for the 
analysis of call delay, the sample size of the pilot study of GP trainees, the retrospective 
scoring of the ABCD2 score from primary care records, the observational nature of the 
primary care clinical data in that predictors were not systematically collected using 
standardised definitions, I alone coded the primary care clinical data into predictor categories 
of nervous system dysfunction and the derivation dataset for the diagnostic model did not 
include all high risk TIA patients in the OXVASC cohort. 
In order to address some of these limitations and to derive a diagnostic tool that is likely to 
validate well in primary care, a prospective study of all patients presenting to primary care 
with transient symptoms of neurological dysfunction is required. This will include patients 
where the diagnosis of TIA is not recognised, as the cohort will be defined by transient 
alteration of nervous system function irrespective of the underlying aetiology. It will also 
include patients who are recognised as having TIA but go on to have a recurrent stroke 
before being seen in an out-patient clinic (those with hyperacute stroke risk). Furthermore, 
because clinic-based derivation datasets are ‘pre-selected’ by referrers in primary care, the 
data is subject to selection bias. This is likely to explain why weakness is not included in the 
TIA diagnostic model from clinic datasets – patients without TIA were also found to be weak 
and their similarity to the TIA phenotype is why GPs referred them to the TIA clinic. Given 
that a TIA diagnostic rule should be applied to all patients with transient symptoms in order 
to be effective, it should not be derived from patients where GPs have already considered 
the diagnosis and referred. 
215 
 
Nevertheless such a study is challenging. Firstly because of the time required to collect data 
at the initial consultation in primary care and this will reduce recruitment and therefore 
population capture of all the phenomena that could predict TIA diagnosis. Secondly patients 
in primary care commonly present with multiple problems and the transient event may be at 
the end of a list of issues that patients wish to discuss, and GPs may not think of recruitment 
given the complexity of such consultations. Thirdly patients access a primary care opinion 
other than in their registered surgeries. For example, home visits are not usually the ideal 
situation for recruitment partly due to lack of supporting research materials either electronic 
or paper-based and presentation to out of hours primary care is unlikely to result in 
recruitment and data capture given that the clinician will for the most part not be from the 
patients’ own practice. 
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Appendix 1 
Information for MD Examiners 
Where the work was carried out 
Department of Primary Care Health Sciences, University of Oxford, 2nd Floor 23-38 Hythe 
Bridge Street, Oxford OX1 2ET 
Stroke Prevention Unit, Department of Clinical Neurology, University of Oxford, John 
Radcliffe Hospital, Headley Way, Oxford OX3 9DU 
Statement of Work Done 
I conceived and designed the comparison of the OXVASC registered population with the 
national population and was advised by Dr Rafael Perera, (Statistician, Department of 
Primary Care Health Sciences) on the use of Poisson regression. 
I conceived, designed and analysed the study of the influence of primary care delivery and 
the new GMS contract on healthcare seeking behaviour. I collected the data on routes to 
care and delay for patients with TIA, and Dr Arvind Chandratheva (Research Fellow, Stroke 
Prevention Unit) collected the care route and delay data for the minor stroke patients.  
I conceived and designed the study of TIA recognition and collected the data for 
questionnaire development. I designed the questionnaire and collected the respondents' 
data and produced a narrative summary. 
I conceived and designed the study for the comparison of primary and secondary care 
histories and analysed the validation of the ABCD2 and Dawson recognition tools for 
diagnostic accuracy in referred populations. 
I conceived and designed the study for derivation of novel prediction rules using routine 
observational data and collected the predictor variables from the GP records. I analysed the 
data and was advised by Dr Patrick McSharry (Mathematician at the Smith School for 
Enterprise and the Environment, University of Oxford) to use random forests for 
classification but undertook the training in R software and analysis personally. 
Supervision 
Professor David Mant supervised the development of the research questions and 
methodologies as well as the writing of the thesis. 
Professor Peter Rothwell supervised the study of provider choice and delay in presentation 
to healthcare. 
 
Publications arising from this work 
Lasserson DS, Chandratheva A, Giles MF, Mant D, Rothwell PM. Influence of general 
practice opening hours on delay in seeking medical attention after transient ischaemic attack 
(TIA) and minor stroke: prospective population based study. BMJ. 2008 Sep 18;337:a1569. 
doi: 10.1136/bmj.a1569. PubMed PMID: 18801867 
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Ethics Committee Applications 
The TIA recognition study was given favourable opinion by the East Midlands Research 
Ethics Committee via the Integrated Research Application System (ref:11/EM/0252). 
The Oxford Vascular Study ethical approval is from the Oxfordshire Research Ethics 
Committee (ref: CO.043) 
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Appendix 2 
Search Strategy 
Primary searches 
OVIDSP was used as the interface for MEDLINE and EMBASE, incorporating subject 
headings and ‘*’ for wildcard search. Age limits to include all adult patients were specified 
separately for EMBASE and MEDLINE.  
Delay in seeking healthcare after TIA or stroke 
1. transient isch*emic attack 
2. TIA 
3. transient cerebral isch*emia 
4. mini stroke 
5. 1 OR 2 OR 3 OR 4  
6. stroke 
7. Cerebrovascular disease* 
8. Cerebrovascular accident 
9. brain infarct* 
10. cerebral infarct* 
11. cerebellar infarct* 
12. CVA 
13. cerebrovascular disease/di, dm, dt, ep, et, pc, th [Diagnosis, Disease Management, 
Drug Therapy, Epidemiology, Etiology, Prevention, Therapy] 
14. 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 
15. 5 OR 14 
16. delay* 
17. time 
18. timing 
19. timelin* 
20. access 
21. health care access / 
22. 16 OR 17 OR 18 OR 19 OR 20 OR 21 
23. 15 AND 22 
24. patient* perception 
25. patient* recognition 
26. 24 OR 25 
27. 15 AND 26 
28. primary medical care / 
29. primary health care / 
30. 28 OR 29 
31. 15 AND 30 
32. 23 OR 27 OR 31 
33. limit 32 to humans 
34. limit 33 to “ all adult (19 plus years)” 
35. limit 33 to (adult < 18 to 64 > years or aged< 65+ years) 
36. 34 OR 35 
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Relationship between deprivation and stroke  
1. transient isch*emic attack 
2. TIA 
3. transient cerebral isch*emia 
4. mini stroke 
5. 1 OR 2 OR 3 OR 4  
6. stroke 
7. Cerebrovascular disease* 
8. Cerebrovascular accident 
9. brain infarct* 
10. cerebral infarct* 
11. CVA 
12. cerebrovascular disease/di, dm, dt, ep, et, pc, th [Diagnosis, Disease Management, 
Drug Therapy, Epidemiology, Etiology, Prevention, Therapy] 
13. 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 
14. 5 OR 13 
15. economic status 
16. socio*economic status 
17. socio*economic position 
18. depriv* 
19. health inequality 
20. 15 OR 16 OR 17 OR 18 OR 19 
21. 14 AND 20 
22. limit 21 to humans 
23. limit 22 to “ all adult (19 plus years)” 
24. limit 22 to (adult < 18 to 64 > years or aged< 65+ years) 
25. 23 OR 24 
Diagnosis of TIA and stroke 
1. transient isch*emic attack 
2. TIA 
3. transient cerebral isch*emia 
4. mini stroke 
5. 1 OR 2 OR 3 OR 4  
6. stroke 
7. Cerebrovascular disease* 
8. Cerebrovascular accident 
9. brain infarct* 
10. cerebral infarct* 
11. CVA 
12. cerebrovascular disease/di, dm, dt, ep, et, pc, th [Diagnosis, Disease Management, 
Drug Therapy, Epidemiology, Etiology, Prevention, Therapy] 
13. 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 
14. 5 OR 13 
15. diagnosis/   
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16. computer assisted diagnosis/  
17. delayed diagnosis/  
18. diagnostic accuracy/  
19. diagnostic error/  
20. diagnostic reasoning/ 
21. diagnostic test/  
22. diagnostic test accuracy study/  
23. diagnostic value/   
24. differential diagnosis/  
25. early diagnosis/  
26. qualitative diagnosis/   
27. quantitative diagnosis/ 
28. 15 OR 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 
27 
29. 14 AND 28 
30. limit 29 to humans 
31. limit 30 to “ all adult (19 plus years)” 
32. limit 30 to (adult < 18 to 64 > years or aged< 65+ years) 
33. 31 OR 32 
The Cochrane Library search strategies are listed below  
Delay in seeking healthcare after TIA or stroke 
1. transient isch*emic attack 
2. TIA 
3. transient cerebral isch*emia 
4. mini stroke 
5. #1 OR #2 OR #3 OR #4  
6. stroke 
7. Cerebrovascular disease* 
8. Cerebrovascular accident 
9. brain infarct* 
10. cerebral infarct* 
11. cerebellar infarct* 
12. CVA 
13. MeSH descriptor Cerebrovascular Disorders explode all trees 
14. #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 
15. #5 OR #14 
16. delay* 
17. time 
18. timing 
19. timelin* 
20. access 
21. MeSH descriptor Health Services Accessibility explode all trees 
22. #16 OR #17 OR #18 OR #19 OR #20 OR #21 
23. #15 AND #22 
24. patient* perception 
25. patient* recognition 
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26. #24 OR #25 
27. #15 AND #26 
28. MeSH descriptor Primary Health Care explode all trees 
29. #15 AND #28 
30. #23 OR #27 OR #29 
Relationship between deprivation and stroke 
1. transient isch*emic attack 
2. TIA 
3. transient cerebral isch*emia 
4. mini stroke 
5. #1 OR #2 OR #3 OR #4  
6. stroke 
7. Cerebrovascular disease* 
8. Cerebrovascular accident 
9. brain infarct* 
10. cerebral infarct* 
11. cerebellar infarct* 
12. CVA 
13. MeSH descriptor Cerebrovascular Disorders explode all trees 
14. #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 
15. #5 OR #14 
16. economic status 
17. socio*economic status 
18. socio*economic position 
19. depriv* 
20. health inequality 
21. #16 OR #17 OR #18 OR #19 OR #20 
22. #15 AND #21 
 
Diagnosis of TIA and stroke 
1. transient isch*emic attack 
2. TIA 
3. transient cerebral isch*emia 
4. mini stroke 
5. #1 OR #2 OR #3 OR #4  
6. stroke 
7. Cerebrovascular disease* 
8. Cerebrovascular accident 
9. brain infarct* 
10. cerebral infarct* 
11. cerebellar infarct* 
12. CVA 
13. MeSH descriptor Cerebrovascular Disorders explode all trees 
14. #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 
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15. #5 OR #14 
16. MeSH descriptor Delayed Diagnosis explode all trees 
17. MeSH descriptor Diagnosis, Computer-Assisted explode all trees 
18. MeSH descriptor Early Diagnosis explode all trees 
19. MeSH descriptor Diagnostic Errors explode all trees 
20. MeSH descriptor Diagnosis, Differential explode all trees 
21. MeSH descriptor Diagnostic Techniques, Neurological explode all trees 
22. MeSH descriptor Diagnostic Self Evaluation explode all trees 
23. #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 
24. #15 AND #23 
 
Secondary Searches 
Reference lists of articles retrieved from the primary searches were examined for additional 
articles relevant to delay in presenting to healthcare, the link between deprivation and stroke 
and methods to diagnose TIA and stroke.  
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Appendix 3 
TIA case vignettes  
1. A 59 year old man attends surgery. He is concerned by two recent episodes – during 
the first one, he suddenly dropped his keys and noticed that fingers in the right hand 
felt weak. This lasted five minutes and then resolved spontaneously. He had a further 
episode a week later, which came on suddenly whilst writing, and this too resolved 
completely after a few minutes.  He has had no previous medical problems and he is 
a smoker. He has a normal motor and sensory examination with BP 158/72 and a 
regular pulse of 62. 
Alternative – Weakness is not associated with specific tasks (holding keys, 
writing) and therefore comes on ‘suddenly’ (Hypothesis - Does onset unrelated 
to action make GPs more likely to suspect TIA?) 
2. A 44 year old man with a 24 year history of type 1 diabetes attends the surgery for an 
urgent appointment. That morning he woke with general malaise but no fever and 
had a BM of 19.2 and no ketones on his home urine dipstick. He gave himself an 
extra dose of actrapid and went to work where one hour later his colleagues noticed 
that his speech had started to sound slurred, he re-checked his BM and it had come 
down to 4.1. When you see him in the surgery in the afternoon he looked well, was 
afebrile, BP 138/62 P 72 and regular, he had a clear chest, normal heart sounds, 
normal speech and normal motor and sensory exam in the limbs. His BM was 5.1, 
and there was a trace of protein on urine dip. 
Alternative– BM does not fluctuate but remains elevated throughout day, even 
after dose of short-acting insulin (Hypothesis – Does a reducing blood sugar 
make GPs less likely to suspect TIA if focal symptoms are present?) 
3. You are asked to visit an 82 year old man at home. After waking, his wife went 
downstairs to make a cup of tea and on returning upstairs  found him sitting with his 
shirt on back to front and a ‘confused look on his face’. After this he got himself 
dressed and went downstairs. He has a history of controlled hypertension and had a 
hip replacement 2 years ago. He is usually independently mobile and he and his wife 
manage with some support from their son who lives nearby. On examination he is 
orientated in time, person and place and remarks that he “can’t see what all the fuss 
is about”. BP is 151/72, P 68 and regular, he has normal speech, no motor or 
sensory deficit and he is walking normally. Temperature 37.2, chest clear, heart 
sounds normal, normal abdomen and urine dip NAD. 
Alternative – no dressing apraxia present  (Hypothesis – Is confusion treated 
the same as confusion with dressing apraxia?) 
4. You are asked by a carer to visit an 81 year old woman whom you know well. The 
carer noticed that the patient’s speech was a little slurred and she was more 
unsteady than usual yesterday and was concerned. On arrival, the patient has no 
complaints whatsoever and feels well. The patient did not notice any problems 
yesterday. You examine her and find no focal deficit of speech, cranial nerves or 
upper or lower limbs. She is afebrile with a clear chest and nothing on her urine dip. 
She is furniture walking but you remember this as being her usual state from 
previous visits.  
Alternative – the patient also complains of the symptoms in agreement with the 
carer (Hypothesis – Do disconcordant patient/witness histories reduce the 
likelihood that GPs will suspect TIA?) 
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5. A 67 year old woman comes to the surgery and describes a two week history of 
intermittent numbness and weakness on the right hand side, affecting both arm and 
leg, although not always at the same time. The episodes have no obvious 
precipitating cause and seem to resolve spontaneously after a few minutes. She 
feels lethargic and generally unwell. On examination she is afebrile with BP 132/82. 
Not disorientated, with normal power and sensation in upper and lower limbs. 
Alternative – absence of lethargy and general malaise (Hypothesis – does the 
presence of symptoms of systemic upset reduce the likelihood that GPs will 
suspect TIA as the cause of focal symptoms?) 
6. You are taking triage telephone calls during an Out of Hours shift on a Sunday 
morning.  A 48 year old man rings you saying that he has woken up feeling dizzy with 
the room spinning and had to go back to bed. He has no weakness or sensory loss 
and no headache. He has not been vomiting. He has no history of hypertension, 
angina or diabetes and takes no regular medication. He is a smoker 
Alternative – presence of nausea and vomiting (Hypothesis – is vertigo with 
vomiting treated the same as isolated vertigo?) 
7. A 75 year old woman comes to see you and complains of increasing episodes of left 
arm weakness over the last two weeks. A few months before she injured her elbow in 
a car accident but did not sustain a fracture. Her elbow is normal, there is no sensory 
loss and you detect slight thenar eminence wasting in the left hand. Power is 
symmetrical and reflexes are symmetrical. She has a history of asthma, glaucoma, 
sciatica and is a smoker. She takes regular inhalers and no other medication. 
Alternative – no injury to the elbow (Hypothesis – does an alternative but less 
plausible explanation for symptoms reduce the likelihood of a TIA diagnosis?) 
Distractor (non TIA)  cases 
1. A 71 year old man presents for the third time with backache that has not resolved 
with anti-inflammatory medication. He has had several courses of antibiotics for 
recurrent chest infections over the past four months and says he now feels 
breathless walking up stairs. He has hypertension and gout, and takes 
bendrofluazide, amlodipine and allopurinol. He is afebrile BP 152/68, clear chest, 
normal heart sounds with a regular pulse of 78 and no ankle oedema. Urinalysis 
shows ++ proteinuria. Diagnosis - Myeloma 
2. An 81 year old woman who is usually very active and lives alone without support 
comes to her annual review for CKD and ischaemic heart disease. She complains of 
increasing breathlessness initially walking up hill but now she notices it walking up 
stairs. She has had no chest pain. Medications include ramipril 5mg, bisoprolol 
2.5mg, aspirin and simvastatin. Routine bloods taken a year ago were normal with 
eGFR 51. Examination shows a regular pulse of 74, BP 118/72, soft first heart sound 
with apical systolic murmur, bibasal chest crackles and pitting ankle oedema. 
Diagnosis - Heart failure 
3. A 68 year old woman attends morning surgery having experienced visual disturbance 
the day before, where the left side of her vision suddenly became dark for five 
minutes. She covered her left and right eye alternately and the problem was confined 
to the left eye. She has a headache which has been present for two weeks, and is 
throbbing in nature without any nausea. Over the last few months she has been tired 
and generally unwell. She has no past medical history and is on no regular 
medications. Visual fields, fundoscopy and cranial nerve exam are normal. She is 
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afebrile, BP 162/88, regular pulse of 68 with a clear chest, and you hear an early 
ejection systolic murmur. Diagnosis – Temporal arteritis 
4. A 78 year old man attends for the second time in a month with upper abdominal 
discomfort. He has had no change in bowel habit, no rectal bleeding, vomiting or 
haematemesis. However he reports that he is finding it increasingly difficult to 
swallow food and feels that it gets stuck pointing to his mid-chest, although he has no 
problem with liquids. He has nodal osteo-arthritis and hypertension, and takes 
regular co-codamol, lisinopril and prn NSAIDS. He is an ex-smoker and drinks little 
alcohol. On examination there is no abdominal tenderness or organomegaly. 
Diagnosis - Oesophageal neoplasm 
5. The husband of an 85 year old woman requests a home visit. On arrival he describes 
that after waking that morning she was confused and wasn’t sure where she was, but 
her speech sounded normal. Afterwards she seemed much better and got herself 
dressed and came downstairs. She takes bendrofluazide and amlodipine for 
hypertension. On examination she has normal visual fields and cranial nerves, 
normal speech and is orientated in time, person and place. MTS is 10/10. Limb 
examination is normal. She has a clear chest, normal heart sounds with BP 138/71, 
pulse 88 and regular and is afebrile. Urine dip shows a trace of protein only. 
Diagnosis – Transient confusion, to act as the paired case for TIA case 
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Appendix 4 
Materials for GP Trainee High Risk TIA Recognition Study 
1. Email to GP Trainees 
SUBJECT: GP Trainee Questionnaire Study 
Dear Trainee 
The Department of Primary Care Health Sciences, University of Oxford is conducting a 
research study of how GP trainees manage common problems that occur in primary care 
(The Chief Investigator is Dr Daniel Lasserson, Clinical Lecturer). This consists of a 
questionnaire with ten short written cases describing a clinical presentation to a GP. After 
each case there are two questions “What would you do now?” and “What do you think is the 
likely diagnosis?”. You are under no obligation to start or complete the questionnaire. No 
personally identifiable data will be recorded in the questionnaire although it will ask for your 
year of training (ST1 to ST4) and whether you have had training in elderly medicine. The 
questionnaire should take no more than 25 minutes to complete. 
There is a link to the questionnaire in this email below. If you decide to answer the 
questions, I would ask that you find time outside clinical working hours to complete it. 
In four weeks time, the link will close and then the performance of the group as a whole will 
be emailed to all the trainees that were invited to take part. Detailed descriptions of the 
cases will be sent then as well, including suggested optimal answers to the questions. Your 
views will then be sought (anonymously) about the educational value of this exercise. 
Thank you for considering completing the questionnaire 
2. Front sheet of Questionnaire 
GP Trainee Questionnaire Study 
Thank you for considering taking part in this questionnaire research study. Common 
conditions can have a wide range of presentations in general practice and there are some 
diseases where prompt recognition and management in primary care is important for 
improving long term health outcomes. This study has been designed to assess how well 
current training prepares future GPs for the more challenging clinical cases that they might 
encounter in routine practice. 
You have been invited to take part in this study because you are currently training to be a 
GP on the Oxford rotation, either undertaking a hospital based or community based post 
from ST1 to ST4. 
The questionnaire consists of ten case vignettes, which are short descriptions of a 
presentation to a GP either in surgery or at home, with key features from history, 
examination or simple tests that are widely available in primary care. After each description 
there are two questions “What would you do now?” and “What do you think is the likely 
diagnosis?”. The responses are in free text and you can write as much or as little as you 
wish. It should take no longer than 25 minutes to complete and we request that it is 
undertaken outside of clinical working hours. 
You will also be asked which year of training you are in and whether you have undertaken 
elderly medicine as a GP ST in your training so far. No personally identifiable information will 
be recorded and all responses are anonymous. 
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After the questionnaire study period has closed, you will be sent more details on the clinical 
cases and the aggregated performance of all those who undertook the questionnaire. You 
will then be invited to answer a question about how valuable you felt this exercise was for 
your training, which will also be anonymous. 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by East Midlands Research Ethics Committee. 
Given the nature of this study, it is highly unlikely that you will suffer harm by taking part. 
However, the University has arrangements in place to provide for harm arising from 
participation in the study for which the University is the Research Sponsor. 
If you wish to complain about any aspect of the way in which you have been approached or 
treated during the course of this study, you should contact Dr Daniel Lasserson, (email 
Daniel.lasserson@phc.ox.ac.uk or telephone 01865 289357) or you may contact the 
University of Oxford Clinical Trials and Research Governance (CTRG) office on 01865 
572224 or the head of CTRG, email heather.house@admin.ox.ac.uk   
 
Thank you for considering taking part 
Dr Daniel Lasserson 
Clinical Lecturer  
Department of Primary Care Health Sciences 
University of Oxford. 
3. Vignettes used in the questionnaire 
 
The husband of an 85 year old woman requests a home visit. On arrival he describes that 
after waking that morning she was confused and wasn’t sure where she was, but her speech 
sounded normal. Afterwards she seemed much better and got herself dressed and came 
downstairs. She takes bendrofluazide and amlodipine for hypertension. On examination she 
has normal visual fields and cranial nerves, normal speech and is orientated in time, person 
and place. MTS is 10/10. Limb examination is normal. She has a clear chest, normal heart 
sounds with BP 138/71, pulse 88 and regular and is afebrile. Urine dip shows a trace of 
protein only. 
 
A 71 year old man presents for the third time with backache that has not resolved with anti-
inflammatory medication. He has had several courses of antibiotics for recurrent chest 
infections over the past four months and says he now feels breathless walking up stairs. He 
has hypertension and gout, and takes bendrofluazide, amlodipine and allopurinol. He is 
afebrile BP 152/68, clear chest, normal heart sounds with a regular pulse of 78 and no ankle 
oedema. Urinalysis shows ++ proteinuria. 
 
An 81 year old woman who is usually very active and lives alone without support comes to 
her annual review for CKD and ischaemic heart disease. She complains of increasing 
breathlessness initially walking up hill but now she notices it walking up stairs. She has had 
no chest pain. Medications include ramipril 5mg, bisoprolol 2.5mg, aspirin and simvastatin. 
Routine bloods taken a year ago were normal with eGFR 51. Examination shows a regular 
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pulse of 74, BP 118/72, soft first heart sound with apical systolic murmur, bibasal chest 
crackles and pitting ankle oedema 
 
You are asked to visit an 82 year old man at home. After waking, his wife went downstairs to 
make a cup of tea and on returning upstairs found him sitting with his shirt on back to front 
and a confused look on his face. After this he got himself dressed and went downstairs. He 
has a history of hypertension and a left hip replacement due to osteo-arthritis. He and his 
wife manage with some support from their son who lives nearby. On examination he is 
orientated in time, person and place and remarks that he “can’t see what all the fuss is 
about”. BP is 151/72, P 68 and regular, he has normal speech, no motor or sensory deficit 
and he is walking normally. Temperature 37.2, chest clear, heart sounds normal, normal 
abdomen and urine dip NAD. 
 
A 68 year old woman attends morning surgery having experienced visual disturbance the 
day before, where the left side of her vision suddenly became dark for five minutes. She 
covered her left and right eye alternately and the problem was confined to the left eye. She 
has a headache which has been present for two weeks, and is throbbing in nature without 
any nausea. Over the last few months she has been tired and generally unwell. She has no 
past medical history and is on no regular medications. Visual fields, fundoscopy and cranial 
nerve exam are normal. She is afebrile, BP 162/88, regular pulse of 68 with a clear chest, 
and you hear an early ejection systolic murmur 
 
A 44 year old man with type 1 diabetes attends afternoon surgery for an urgent appointment. 
That morning he woke with general malaise but no fever and had a BM of 16.2 and no 
ketones on his home urine dipstick. He gave himself a shot of short acting insulin aspart and 
went to work where one hour later his colleagues noticed that his speech had started to 
sound slurred, he re-checked his BM and it had come down to 4.1. He takes aspart three 
times daily, long acting insulin glargine once daily, simvastatin and ramipril. On examination 
he looks well, is afebrile, BP 138/62 P 72 and regular, he has a clear chest, normal heart 
sounds, normal speech and normal motor and sensory exam in the limbs. His BM is 5.1, and 
there is a trace of protein on urine dip 
 
You visit an 84 year old man who lives alone but has twice daily visits from a carer. He has 
been more withdrawn recently due to depression after the death of his wife and has a history 
of hypertension. Earlier that morning he suddenly felt very unsteady and called out to his 
carer but felt that his speech was slurred. His carer said that she found him holding on to the 
back of the sofa and when she asked him what was wrong he sounded as if he was drunk. 
On examination he has normal speech and is fully orientated. He has normal upper and 
lower limb sensory examination and is walking slowly and cautiously but does not feel 
unsteady. 
 
A 78 year old man attends for the second time in a month with upper abdominal discomfort. 
He has had no change in bowel habit, no rectal bleeding, vomiting or haematemesis. 
However he reports that he is finding it increasingly difficult to swallow food and feels that it 
gets stuck pointing to his mid-chest, although he has no problem with liquids. He has nodal 
osteo-arthritis and hypertension, and takes regular co-codamol, lisinopril and prn NSAIDS. 
He is an ex-smoker and drinks little alcohol. On examination there is no abdominal 
tenderness or organomegaly. 
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You are asked by a carer to visit an 81 year old woman whom you know well, with a past 
history of hypertension and depression, taking amlodipine and venlafaxine. The carer 
noticed that the patient’s speech was a little slurred and she was more unsteady than usual 
yesterday and was concerned. On arrival, the patient does not complain of any symptoms 
and feels well. She did not notice any problems yesterday. You examine her and find no 
focal deficit of speech, cranial nerves or upper or lower limbs. She is afebrile with a clear 
chest, BP 163/88, a regular pulse of 72, urine dip NAD. She is furniture walking but you 
remember this as being her usual state from previous visits. 
 
You see a 49 year old man with type 1 diabetes in an Out of Hours clinic on a Saturday 
morning. The day before he felt unwell on waking and his post breakfast BM was 18.2. He 
didn’t have any ketones using his own urine dipstick, and gave himself an extra shot of 
actrapid. His BMs were still high before lunch and before his evening meal (13.3, 15.8). His 
partner noticed that his speech was slurred later that evening and his BM at the time was 
9.1. She thought he should see a doctor, so he contacted the OOH service this morning but 
now feels better with BM 6.2. He takes actrapid three times daily and once daily insulatard. 
On examination he has normal speech, normal motor and sensory exam in the limbs and 
normal gait. BP is 118/64 and pulse 58 regular. Urinalysis NAD. 
